{"id":41069,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/indenture-healthsouth-corp-and-the-bank-of-new-york.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"indenture-healthsouth-corp-and-the-bank-of-new-york","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/finance\/indenture-healthsouth-corp-and-the-bank-of-new-york.html","title":{"rendered":"Indenture &#8211; HealthSouth Corp. and The Bank of New York"},"content":{"rendered":"<pre>\n================================================================================\n\n\n\n\n                            HEALTHSOUTH CORPORATION,\n                                   as Issuer,\n\n                                       and\n\n                        THE BANK OF NEW YORK, as Trustee\n\n                            -----------------------\n\n                                    INDENTURE\n\n                          Dated as of February 1, 2001\n\n                           -----------------------\n\n                     8 1\/2% Senior Notes due 2008, Series A\n\n                     8 1\/2% Senior Notes due 2008, Series B\n\n================================================================================\n\n\n\n                              CROSS-REFERENCE TABLE\n<\/pre>\n<table>\n<caption>\n<p>  TIA                                                                                  Indenture<br \/>\nSection                                                                                 Section<br \/>\n&#8212;&#8212;-                                                                                &#8212;&#8212;&#8211;<br \/>\n<s>   <c>                                                                              <c><br \/>\n310(a)(1)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.10<br \/>\n   (a)(2)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.10<br \/>\n   (a)(3)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n   (a)(4)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A<br \/>\n   (a)(5)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.10<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.08; 7.10; 11.02<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n311(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.11<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.11<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n312(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       2.05<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.03<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.03<br \/>\n313(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.06<br \/>\n   (b)(1)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.06<br \/>\n   (b)(2)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.06<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.06; 11.02<br \/>\n   (d)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.06<br \/>\n314(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       4.02; 4.08; 11.02<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n   (c)(1)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.04; 11.05<br \/>\n   (c)(2)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.04; 11.05<br \/>\n   (c)(3)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n   (d)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n   (e)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.05<br \/>\n   (f)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       N.A.<br \/>\n315(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.01; 7.02<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.05; 11.02<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       7.01<br \/>\n   (d)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.05; 7.01; 7.02<br \/>\n   (e)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.11<br \/>\n316(a) (last sentence)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.       2.09<br \/>\n   (a)(1)(A)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.05<br \/>\n   (a)(1)(B)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.04<br \/>\n   (a)(2)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       8.02<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.07<br \/>\n   (c)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       8.04<br \/>\n317(a)(1)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.08<br \/>\n   (a)(2)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       6.09<br \/>\n   (b)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       2.04<br \/>\n318(a)&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..       11.01<\/p>\n<p><\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                            N.A. means Not Applicable<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nNOTE: This  Cross-Reference  Table shall not, for any purpose, be deemed to be a<br \/>\npart of this Indenture.<\/p>\n<p>                                TABLE OF CONTENTS<\/p>\n<table>\n<caption>\n<p>                                                                                             Page<br \/>\n                                                                                             &#8212;-<\/p>\n<p>                                    ARTICLE 1<\/p>\n<p>                                   DEFINITIONS<\/p>\n<p><s>               <c>                                                                          <c><br \/>\nSection 1.01.     Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..1<br \/>\nSection 1.02.     Other Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.15<br \/>\nSection 1.03.     Incorporation by Reference of Trust Indenture Act&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..16<br \/>\nSection 1.04.     Rules of Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;16<\/p>\n<p>                                    ARTICLE 2<\/p>\n<p>                                    THE NOTES<\/p>\n<p>Section 2.01.     Dating; Incorporation of Form in Indenture; Form of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;16<br \/>\nSection 2.02.     Execution and Authentication; Appointment of Authenticating Agent&#8230;&#8230;&#8230;&#8230;.17<br \/>\nSection 2.03.     Registrar and Paying Agent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.18<br \/>\nSection 2.04.     Paying Agent To Hold Money in Trust&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.18<br \/>\nSection 2.05.     Holder Lists&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;19<br \/>\nSection 2.06.     [Intentionally Omitted]&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.19<br \/>\nSection 2.07.     Replacement Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.19<br \/>\nSection 2.08.     Outstanding Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.19<br \/>\nSection 2.09.     Treasury Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.20<br \/>\nSection 2.10.     Temporary Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;20<br \/>\nSection 2.11.     Cancellation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;20<br \/>\nSection 2.12.     Defaulted Interest&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;20<br \/>\nSection 2.13.     Deposit of Moneys; Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;21<br \/>\nSection 2.14.     &#8220;CUSIP&#8221; Number&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.21<br \/>\nSection 2.15.     Depositary&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..21<br \/>\nSection 2.16.     Registration of Transfers and Exchanges&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;22<br \/>\nSection 2.17.     Restrictive Legends&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..29<\/p>\n<p>                                    ARTICLE 3<\/p>\n<p>                                   REDEMPTION<\/p>\n<p>Section 3.01.     Notices to Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;30<br \/>\nSection 3.02.     Selection of Notes To Be Redeemed&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;30<br \/>\nSection 3.03.     Notice of Redemption&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.31<br \/>\nSection 3.04.     Effect of Notice of Redemption&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;32<br \/>\nSection 3.05.     Deposit of Redemption Price&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;32<br \/>\nSection 3.06.     Notes Redeemed in Part&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<\/p>\n<p><\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                       i<\/p>\n<p>                                    ARTICLE 4<\/p>\n<p>                                    COVENANTS<\/p>\n<table>\n<caption>\n<p>                                                                                              Page<br \/>\n                                                                                              &#8212;-<\/p>\n<p><s>               <c>                                                                          <c><br \/>\nSection 4.01.     Payment of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<br \/>\nSection 4.02.     Reports&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<br \/>\nSection 4.03.     Waiver of Stay, Extension or Usury Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;33<br \/>\nSection 4.04.     Compliance Certificate; Notice of Default; Tax Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..34<br \/>\nSection 4.05.     Payment of Taxes and Other Claims&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<br \/>\nSection 4.06.     Corporate Existence&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..35<br \/>\nSection 4.07.     Maintenance of Office or Agency&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..35<br \/>\nSection 4.08.     Compliance with Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.35<br \/>\nSection 4.09.     Maintenance of Properties and Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;36<br \/>\nSection 4.10.     Limitation on Restricted Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;36<br \/>\nSection 4.11.     Limitation on Additional Indebtedness and Subsidiary Preferred Stock&#8230;&#8230;&#8230;.37<br \/>\nSection 4.12.     Limitation on Asset Sales&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..38<br \/>\nSection 4.13.     Limitation on Transactions with Affiliates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;41<br \/>\nSection 4.14.     Limitation on Liens&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..41<br \/>\nSection 4.15.     Purchase of Notes upon a Change of Control&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;42<br \/>\nSection 4.16.     Limitation on Restrictions on Distributions from Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;..43<br \/>\nSection 4.17.     Limitations on Layering Indebtedness&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<\/p>\n<p>                                    ARTICLE 5<\/p>\n<p>                                SURVIVING ENTITY<\/p>\n<p>Section 5.01.     Limitations on Mergers and Consolidations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.44<br \/>\nSection 5.02.     Successor Substituted&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<\/p>\n<p>                                    ARTICLE 6<\/p>\n<p>                              DEFAULTS AND REMEDIES<\/p>\n<p>Section 6.01.     Events of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.45<br \/>\nSection 6.02.     Acceleration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;46<br \/>\nSection 6.03.     Other Remedies&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.47<br \/>\nSection 6.04.     Waiver of Existing Defaults and Events of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..47<br \/>\nSection 6.05.     Control by Majority&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..48<br \/>\nSection 6.06.     Limitation on Suits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..48<br \/>\nSection 6.07.     Rights of Holders To Receive Payment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;49<br \/>\nSection 6.08.     Collection Suit by Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.49<br \/>\nSection 6.09.     Trustee May File Proofs of Claim&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.49<br \/>\nSection 6.10.     Priorities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..49<br \/>\nSection 6.11.     Undertaking for Costs&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;50<\/p>\n<p><\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                       ii<\/p>\n<table>\n<caption>\n<p>                                                                                             Page<br \/>\n                                                                                             &#8212;-<\/p>\n<p>                                    ARTICLE 7<\/p>\n<p>                                     TRUSTEE<\/p>\n<p><s>               <c>                                                                          <c><br \/>\nSection 7.01.     Duties of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.50<br \/>\nSection 7.02.     Rights of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.51<br \/>\nSection 7.03.     Individual Rights of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..52<br \/>\nSection 7.04.     Trustee&#8217;s Disclaimer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.53<br \/>\nSection 7.05.     Notice of Defaults&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;53<br \/>\nSection 7.06.     Reports by Trustee to Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.53<br \/>\nSection 7.07.     Compensation and Indemnity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.53<br \/>\nSection 7.08.     Replacement of Trustee&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..54<br \/>\nSection 7.09.     Successor Trustee by Consolidation, Merger or Conversion&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.55<br \/>\nSection 7.10.     Eligibility; Disqualification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.55<br \/>\nSection 7.11.     Preferential Collection of Claims Against Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..56<\/p>\n<p>                                    ARTICLE 8<\/p>\n<p>               MODIFICATIONS, AMENDMENTS, SUPPLEMENTS AND WAIVERS<\/p>\n<p>Section 8.01.     Without Consent of Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.56<br \/>\nSection 8.02.     With Consent of Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.57<br \/>\nSection 8.03.     Compliance with TIA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..58<br \/>\nSection 8.04.     Revocation and Effect of Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;58<br \/>\nSection 8.05.     Notation on or Exchange of Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.58<br \/>\nSection 8.06.     Trustee To Sign Amendments, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..59<\/p>\n<p>                                    ARTICLE 9<\/p>\n<p>                       DISCHARGE OF INDENTURE; DEFEASANCE<\/p>\n<p>Section 9.01.     Satisfaction and Discharge of Indenture&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;59<br \/>\nSection 9.02.     Legal Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..60<br \/>\nSection 9.03.     Covenant Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..60<br \/>\nSection 9.04.     Conditions to Legal Defeasance or Covenant Defeasance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.61<br \/>\nSection 9.05.     Application of Trust Money&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.62<br \/>\nSection 9.06.     Repayment to the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;62<br \/>\nSection 9.07.     Reinstatement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..63<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                      iii<\/p>\n<table>\n<caption>\n<p>                                                                                             Page<br \/>\n                                                                                             &#8212;-<\/p>\n<p>                                   ARTICLE 10<\/p>\n<p>                             [INTENTIONALLY OMITTED]<\/p>\n<p>                                   ARTICLE 11<\/p>\n<p>                                  MISCELLANEOUS<\/p>\n<p><s>               <c>                                                                          <c><br \/>\nSection 11.01.    TIA Controls&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;63<br \/>\nSection 11.02.    Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..63<br \/>\nSection 11.03.    Communications by Holders with Other Holders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.64<br \/>\nSection 11.04.    Certificate and Opinion as to Conditions Precedent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.64<br \/>\nSection 11.05.    Statements Required in Certificate and Opinion&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..65<br \/>\nSection 11.06.    Rules by Trustee and Agents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;65<br \/>\nSection 11.07.    Business Days; Legal Holidays&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.65<br \/>\nSection 11.08.    Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..65<br \/>\nSection 11.09.    Waiver of Trial by Jury&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.65<br \/>\nSection 11.10.    Submission to Jurisdiction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.66<br \/>\nSection 11.11.    No Adverse Interpretation of Other Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;66<br \/>\nSection 11.12.    No Recourse Against Others&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.66<br \/>\nSection 11.13.    Successors&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..66<br \/>\nSection 11.14.    Multiple Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;66<br \/>\nSection 11.15.    Table of Contents, Headings, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.66<br \/>\nSection 11.16.    Separability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;66<br \/>\nSection 11.17.    Translation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.67<\/p>\n<p>SIGNATURES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.S-1<\/p>\n<p>EXHIBITS<\/p>\n<p>Exhibit A         Form of Initial Notes<br \/>\nExhibit B         Form of Exchange Notes<br \/>\nExhibit C         Form of Rule 144A Transfer Certificate<br \/>\nExhibit D         Form of Regulation S Transfer Certificate<br \/>\nExhibit E         Form of Rule 144 Transfer Certificate<br \/>\nExhibit F         Form of Accredited Investor Transfer Certificate<\/p>\n<p>                                       iv<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                  INDENTURE,  dated as of February 1, 2001, between  HEALTHSOUTH<br \/>\nCORPORATION,  a corporation incorporated in Delaware (the &#8220;Company&#8221;), as Issuer,<br \/>\nand The Bank of New  York,  a New York  banking  corporation,  as  Trustee  (the<br \/>\n&#8220;Trustee&#8221;).<\/p>\n<p>                  The Company has duly  authorized  the  creation of an issue of<br \/>\nSeries A 8 1\/2% Senior  Notes due 2008 and Series B 8 1\/2% Senior Notes due 2008<br \/>\nand, to provide  therefor,  the Company has duly  authorized  the  execution and<br \/>\ndelivery of this Indenture.  All things  necessary to make the Notes,  when duly<br \/>\nissued and executed by the Company,  and authenticated and delivered  hereunder,<br \/>\nthe valid  obligations  of the Company,  and to make this  Indenture a valid and<br \/>\nbinding agreement of the Company, have been done.<\/p>\n<p>                  Each  party  agrees as  follows  for the  benefit of the other<br \/>\nparties and for the equal and ratable benefit of the Holders:<\/p>\n<p>                                    ARTICLE 1<\/p>\n<p>                                   DEFINITIONS<\/p>\n<p>Section 1.01.     Definitions.<br \/>\n                  &#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                  &#8220;2000 Credit Agreement&#8221; means the Credit Agreement dated as of<br \/>\nOctober 31, 2000 by and among the Company, as borrower, UBS AG, Stamford Branch,<br \/>\nas Administrative Agent, Deutsche Bank AG New York Branch, as Syndication Agent,<br \/>\nthe lenders party  thereto from time to time,  UBS Warburg LLC and Deutsche Bank<br \/>\nSecurities  Inc., as Joint Lead  Arrangers,  and The  Industrial  Bank of Japan,<br \/>\nLimited,  as Documentation  Agent,  together with the related documents thereto,<br \/>\nincluding,  without limitation, any security documents, if any, and all exhibits<br \/>\nand schedules thereto and any agreement or agreements relating to any extension,<br \/>\nrefunding,  refinancing,  successor or replacement facility, whether or not with<br \/>\nthe same lender, and whether or not the principal amount or amount of letters of<br \/>\ncredit  outstanding  thereunder or the interest rate payable in respect  thereof<br \/>\nshall be thereby  increased,  in each case as amended and in effect from time to<br \/>\ntime.<\/p>\n<p>                  &#8220;Acquired  Indebtedness&#8221;  means (i) with respect to any Person<br \/>\nthat becomes a Subsidiary of the Company after the Issue Date,  Indebtedness  of<br \/>\nsuch Person and its  Subsidiaries  existing  at the time such  Person  becomes a<br \/>\nSubsidiary  of the  Company  and (ii) with  respect to the Company or any of its<br \/>\nSubsidiaries, any Indebtedness assumed by the Company or any of its Subsidiaries<br \/>\nin connection with the acquisition of an asset from another Person.<\/p>\n<p>                  &#8220;Additional Interest&#8221; has the meaning provided to such term in<br \/>\nthe Registration Rights Agreement.<\/p>\n<p>                  &#8220;Affiliate&#8221;  of any  specified  Person  means any other Person<br \/>\ndirectly or  indirectly  controlling,  controlled by or under direct or indirect<br \/>\ncommon control with such specified Person.  For the purposes of this definition,<br \/>\n&#8220;control&#8221;  when used with  respect to any  specified  Person  means the power to<br \/>\ndirect the  management  and  policies of such  Person,  directly or  indirectly,<br \/>\nwhether  through the ownership of voting  securities,  by contract or otherwise,<br \/>\nand the terms  &#8220;controlling&#8221; and &#8220;controlled&#8221;  have meanings  correlative to the<br \/>\nforegoing.<\/p>\n<p>                  &#8220;Agent&#8221;  means  any  Registrar,  Paying  Agent,  co-Registrar,<br \/>\nauthenticating agent or agent for service of notices and demands.<\/p>\n<p>                  &#8220;Asset Sale&#8221; for any Person means the sale, lease,  conveyance<br \/>\nor other disposition (including, without limitation, by merger or consolidation,<br \/>\nand whether by operation of law or  otherwise)  of any of that  Person&#8217;s  assets<br \/>\n(including,  without limitation,  the sale or other disposition of Capital Stock<br \/>\nof any Subsidiary of such Person, whether by such Person or by such Subsidiary),<br \/>\nwhether owned on the Issue Date or subsequently  acquired, in one transaction or<br \/>\na series of related  transactions,  in which such Person and\/or its Subsidiaries<br \/>\nsell, lease, convey or otherwise dispose of: (i) all or substantially all of the<br \/>\nCapital Stock of any of such Person&#8217;s Subsidiaries; (ii) assets which constitute<br \/>\nall or  substantially  all of any division or line of business of such Person or<br \/>\nany of its Subsidiaries;  or (iii) any other assets of such Person or any of its<br \/>\nSubsidiaries,  other than in the ordinary course of business, provided, that the<br \/>\nFair Market Value thereof shall be at least 1% of Consolidated  Tangible Assets;<br \/>\nprovided,  however,  that the following  shall not constitute  Asset Sales:  (a)<br \/>\ntransactions  between the Company and any of its Wholly  Owned  Subsidiaries  or<br \/>\namong such Wholly Owned  Subsidiaries;  (b) any  transaction  not  prohibited by<br \/>\nSection 4.10 hereof or that constitutes a Permitted Investment; (c) any transfer<br \/>\nof assets  (including  Capital Stock) that is governed by and in accordance with<br \/>\nArticle 5 hereof or the  creation  of any Lien not  prohibited  by Section  4.14<br \/>\nhereof; or (d) sales of damaged,  worn-out or obsolete equipment or assets that,<br \/>\nin the Company&#8217;s reasonable judgment, are no longer either used or useful in the<br \/>\nbusiness of the Company or its Subsidiaries.<\/p>\n<p>                  &#8220;Attributable Indebtedness&#8221; when used with respect to any Sale<br \/>\nand Leaseback  Transaction  means, as at the time of determination,  the present<br \/>\nvalue  (discounted  at a rate  equivalent  to the interest  rate implicit in the<br \/>\nlease,  compounded on a semiannual basis) of the total obligations of the lessee<br \/>\nfor rental payments,  after excluding all amounts required to be paid on account<br \/>\nof  maintenance  and repairs,  insurance,  taxes,  utilities  and other  similar<br \/>\nexpenses  payable by the lessee  pursuant to the terms of the lease,  during the<br \/>\nremaining term of the lease included in any such Sale and Leaseback  Transaction<br \/>\nor until the earliest date on which the lessee may terminate  such lease without<br \/>\npenalty or upon  payment of a penalty (in which case the rental  payments  shall<br \/>\ninclude such penalty); provided, that the Attributable Indebtedness with respect<br \/>\nto a Sale and Leaseback  Transaction shall be no less than the fair market value<br \/>\nof the property subject to such Sale and Leaseback Transaction.<\/p>\n<p>                  &#8220;Bank  Debt&#8221;  means all  obligations  of the  Company  and its<br \/>\nSubsidiaries, now or hereafter existing under (i) the Credit Agreements, whether<br \/>\nfor principal, interest,  reimbursement of amounts drawn under letters of credit<br \/>\nissued  pursuant  thereto,   guarantees  in  respect  thereof,  fees,  expenses,<br \/>\npremiums,  indemnities or otherwise,  and (ii) any Indebtedness  incurred by the<br \/>\nCompany  to extend,  refund or  refinance,  in whole or in part,  the Bank Debt,<br \/>\nincluding any interest and premium on any such Indebtedness.<\/p>\n<p>                  &#8220;Board of Directors&#8221;  means,  with respect to any Person,  the<br \/>\nboard  of  directors  or  similar  governing  body of such  Person  or any  duly<br \/>\nauthorized committee thereof.<\/p>\n<p>                  &#8220;Board  Resolution&#8221;  means, with respect to any Person, a copy<br \/>\nof a  resolution  certified by the  Secretary or an Assistant  Secretary of such<br \/>\nPerson to have been duly adopted by the Board of Directors of such Person and to<br \/>\nbe in full force and effect on the date of such  certification  and delivered to<br \/>\nthe Trustee.<\/p>\n<p>                                       2<\/p>\n<p>                  &#8220;Capital Stock&#8221; of any Person means any and all shares, rights<br \/>\nto  purchase,  warrants  or  options  (whether  or not  currently  exercisable),<br \/>\nparticipation  or other  equivalents of or interest in (however  designated) the<br \/>\nequity  (including  without   limitation  common  stock,   preferred  stock  and<br \/>\npartnership,  joint  venture and limited  liability  company  interests) of such<br \/>\nPerson (excluding any debt securities that are convertible into, or exchangeable<br \/>\nfor, such equity).<\/p>\n<p>                  &#8220;Capitalized  Lease  Obligations&#8221;  of  any  Person  means  the<br \/>\nobligation  of such  Person to pay rent or other  amounts  under a lease that is<br \/>\nrequired to be capitalized for financial  reporting  purposes in accordance with<br \/>\nGAAP, and the amount of such obligation shall be the capitalized  amount thereof<br \/>\ndetermined in accordance with GAAP.<\/p>\n<p>                  &#8220;Certificated  Note&#8221; means a Note issued in certificated  form<br \/>\nto a Person other than the Depositary.<\/p>\n<p>                  &#8220;Change  of  Control&#8221;  means  the  occurrence  of  any  of the<br \/>\nfollowing:  (i) all or substantially  all of the Company&#8217;s assets are sold as an<br \/>\nentirety  to any  Person  or  related  group of  Persons;  (ii)  there  shall be<br \/>\nconsummated any  consolidation or merger of the Company (A) in which the Company<br \/>\nis not the continuing or surviving  corporation  (other than a consolidation  or<br \/>\nmerger with a Wholly Owned  Subsidiary of the Company in which all shares of the<br \/>\nCompany&#8217;s  Common  Equity  outstanding  immediately  prior to the  effectiveness<br \/>\nthereof  are  changed  into or  exchanged  for the  same  consideration)  or (B)<br \/>\npursuant to which the  Company&#8217;s  Common  Equity would be  converted  into cash,<br \/>\nsecurities or other property,  in each case other than a consolidation or merger<br \/>\nof the Company in which the holders of the Company&#8217;s  Common Equity  immediately<br \/>\nprior to the  consolidation or merger have,  directly or indirectly,  at least a<br \/>\nmajority of the total voting power of all classes of Capital  Stock  entitled to<br \/>\nvote  generally  in the election of  directors  of the  continuing  or surviving<br \/>\ncorporation  immediately after such consolidation or merger in substantially the<br \/>\nsame  proportion as their ownership of the Company&#8217;s  Common Equity  immediately<br \/>\nbefore such transaction;  (iii) any Person, or any Persons acting together which<br \/>\nwould  constitute a &#8220;group&#8221; for purposes of Section  13(d) of the Exchange  Act,<br \/>\ntogether with any affiliates thereof, shall beneficially own (as defined in Rule<br \/>\n13d-3  under the  Exchange  Act) at least 50% of the total  voting  power of all<br \/>\nclasses  of Capital  Stock of the  Company  entitled  to vote  generally  in the<br \/>\nelection of directors of the  Company;  (iv) at any time during any  consecutive<br \/>\ntwo-year period, individuals who at the beginning of such period constituted the<br \/>\nBoard  of  Directors  of the  Company  (together  with any new  directors  whose<br \/>\nelection by such Board of  Directors  or whose  nomination  for  election by the<br \/>\nstockholders  of the Company was approved by a vote of 66-2\/3% of the  directors<br \/>\nthen still in office who were either  directors at the  beginning of such period<br \/>\nor whose election or nomination  for election was previously so approved)  cease<br \/>\nfor any reason to constitute a majority of the Board of Directors of the Company<br \/>\nthen in office;  or (v) the Company is  liquidated or dissolved or adopts a plan<br \/>\nof liquidation or dissolution.<\/p>\n<p>                  &#8220;Commission&#8221; means the Securities and Exchange Commission,  as<br \/>\nfrom time to time constituted, created under the Exchange Act, or if at any time<br \/>\nafter the  execution  of this  Indenture  such  Commission  is not  existing and<br \/>\nperforming the duties now assigned to it under the Trust Indenture Act, the body<br \/>\nperforming such duties at the time.<\/p>\n<p>                  &#8220;Common  Equity&#8221; of any Person means all Capital Stock of such<br \/>\nPerson that is  generally  entitled to (i) vote in the  election of directors of<br \/>\nsuch  Person or (ii) if such  Person  is not a  corporation,  vote or  otherwise<br \/>\nparticipate in the selection of the governing body, partners, managers or others<br \/>\nthat will control the management and policies of such Person.<\/p>\n<p>                                      3<\/p>\n<p>                  &#8220;Company&#8221; means the party named as such in the first paragraph<br \/>\nof this  Indenture  until a successor  replaces such party pursuant to Article 5<br \/>\nhereof and thereafter means such successor.<\/p>\n<p>                  &#8220;Consolidated  Amortization  Expense&#8221;  of any  Person  for any<br \/>\nperiod means the  amortization  expense of such Person and its  Subsidiaries for<br \/>\nsuch  period (to the extent  included in the  computation  of  Consolidated  Net<br \/>\nIncome of such Person),  determined on a consolidated  basis in accordance  with<br \/>\nGAAP.<\/p>\n<p>                  &#8220;Consolidated  Depreciation  Expense&#8221; of any Person  means the<br \/>\ndepreciation expense of such Person and its Subsidiaries for such period (to the<br \/>\nextent included in the  computation of Consolidated  Net Income of such Person),<br \/>\ndetermined on a consolidated basis in accordance with GAAP.<\/p>\n<p>                  &#8220;Consolidated EBITDA&#8221; of any Person means, with respect to any<br \/>\ndetermination  date,  Consolidated Net Income,  plus (i) Consolidated Income Tax<br \/>\nExpense,  plus (ii) Consolidated  Depreciation  Expense, plus (iii) Consolidated<br \/>\nAmortization  Expense,  plus (iv) Consolidated  Interest  Expense,  plus (v) all<br \/>\nother  unusual   non-cash  items  or   non-recurring   non-cash  items  reducing<br \/>\nConsolidated  Net Income of such Person and its  Subsidiaries,  determined  on a<br \/>\nconsolidated  basis  in  accordance  with  GAAP,  and less  all  non-cash  items<br \/>\nincreasing  Consolidated  Net  Income  of  such  Person  and  its  Subsidiaries,<br \/>\ndetermined on a  consolidated  basis in accordance  with GAAP, in each case, for<br \/>\nsuch Person&#8217;s prior four full fiscal quarters for which  financial  results have<br \/>\nbeen reported immediately preceding the determination date.<\/p>\n<p>                  &#8220;Consolidated  Income Tax Expense&#8221;  means,  for any Person for<br \/>\nany period,  the  provision for taxes based on income and profits of such Person<br \/>\nand its  Subsidiaries to the extent such provision for income taxes was deducted<br \/>\nin computing Consolidated Net Income of such Person for such period,  determined<br \/>\non a consolidated basis in accordance with GAAP.<\/p>\n<p>                  &#8220;Consolidated  Interest  Expense&#8221; of any Person for any period<br \/>\nmeans,  without  duplication,  (i) the  Interest  Expense of such Person and its<br \/>\nSubsidiaries for such period,  determined on a consolidated  basis in accordance<br \/>\nwith GAAP, plus (ii) (to the extent not otherwise included within the definition<br \/>\nof Interest  Expense as imputed  interest)  one-third  of the rental  expense on<br \/>\nAttributable  Indebtedness  of such  Person  for  such  period  determined  on a<br \/>\nconsolidated basis, plus (iii) the dividend  requirements of such Person and its<br \/>\nSubsidiaries  with respect to  Disqualified  Stock and with respect to all other<br \/>\nPreferred  Stock of Subsidiaries of such Person (in each case whether in cash or<br \/>\notherwise  (except  dividends  payable  solely in shares of Capital Stock (other<br \/>\nthan Disqualified  Stock) of such Person or such Subsidiary))  paid,  accrued or<br \/>\naccumulated  during such period times a fraction  the  numerator of which is one<br \/>\nand the  denominator  of which is one  minus  the  then  effective  consolidated<br \/>\nFederal, state and local tax rate of such Person, expressed as a decimal.<\/p>\n<p>                  &#8220;Consolidated  Net Income&#8221; of any Person for any period  means<br \/>\nthe net income (or loss) of such  Person and its  Subsidiaries  for such  period<br \/>\ndetermined on a consolidated basis in accordance with GAAP;  provided that there<br \/>\nshall be  excluded  from  such net  income  (to the  extent  otherwise  included<br \/>\ntherein), without duplication:<\/p>\n<p>          (i)       the  net  income  (or  loss)  of any  Person  (other  than a<br \/>\n          Subsidiary of the referent  Person) in which any Person other than the<br \/>\n          referent Person has an ownership  interest,  except to the extent that<br \/>\n          any such income has actually been  received by the referent  Person or<br \/>\n          any of<\/p>\n<p>                                       4<\/p>\n<p>          its Wholly  Owned  Subsidiaries  in the form of  dividends  or similar<br \/>\n          distributions during such period;<\/p>\n<p>          (ii)       except to the extent  includable  in the  consolidated  net<br \/>\n          income of the referent  Person  pursuant to the foregoing  clause (i),<br \/>\n          the net income (or loss) of any Person that accrued  prior to the date<br \/>\n          that (a) such Person becomes a Subsidiary of the referent Person or is<br \/>\n          merged into or  consolidated  with the  referent  Person or any of its<br \/>\n          Subsidiaries  or (b) the  assets of such  Person are  acquired  by the<br \/>\n          referent Person or any of its Subsidiaries;<\/p>\n<p>          (iii)      the net income of any  Subsidiary  of the  referent  Person<br \/>\n          (other  than a  Wholly  Owned  Subsidiary)  to  the  extent  that  the<br \/>\n          declaration or payment of dividends or similar  distributions  by such<br \/>\n          Subsidiary  of that income is not  permitted by operation of the terms<br \/>\n          of its charter or any agreement,  instrument, judgment, decree, order,<br \/>\n          statute, rule or governmental regulation applicable to that Subsidiary<br \/>\n          during such period;<\/p>\n<p>          (iv)      any gain (or loss), together with any related provisions for<br \/>\n          taxes on any such gain,  realized  during such period by the  referent<br \/>\n          Person  or any of its  Subsidiaries  upon (a) the  acquisition  of any<br \/>\n          securities, or the extinguishment of any Indebtedness, of the referent<br \/>\n          Person  or any of  its  Subsidiaries  or (b)  any  Asset  Sale  by the<br \/>\n          referent Person or any of its Subsidiaries;<\/p>\n<p>          (v)      any extraordinary gain or extraordinary  loss,  together with<br \/>\n          any related provision for taxes or tax benefit resulting from any such<br \/>\n          extraordinary  gain or  extraordinary  loss,  realized by the referent<br \/>\n          Person or any of its Subsidiaries during such period; and<\/p>\n<p>          (vi)      in the case of a successor to such Person by  consolidation,<br \/>\n          merger or transfer of its assets,  any earnings of the successor prior<br \/>\n          to such merger, consolidation or transfer of assets.<\/p>\n<p>                  &#8220;Consolidated  Net  Worth&#8221; of any  Person as of any date means<br \/>\nthe  stockholders&#8217;  equity  (including any preferred stock that is classified as<br \/>\nequity  under  GAAP,  other  than  Disqualified  Stock) of such  Person  and its<br \/>\nSubsidiaries  (excluding any equity adjustment for foreign currency  translation<br \/>\nfor any period  subsequent  to the Issue Date) on a  consolidated  basis at such<br \/>\ndate, as determined in accordance  with GAAP,  less all write-ups  subsequent to<br \/>\nthe Issue Date in the book value of any asset owned by such Person or any of its<br \/>\nSubsidiaries.<\/p>\n<p>                  &#8220;Consolidated  Tangible  Assets&#8221;  of any Person as of any date<br \/>\nmeans the total assets of such Person and its Subsidiaries (excluding any assets<br \/>\nthat would be classified as  &#8220;intangible  assets&#8221; under GAAP) on a  consolidated<br \/>\nbasis at such date, as determined  in accordance  with GAAP,  less all write-ups<br \/>\nsubsequent to the Issue Date in the book value of any asset owned by such Person<br \/>\nor any of its Subsidiaries.<\/p>\n<p>                  &#8220;Corporate  Trust  Office&#8221;  means the office of the Trustee at<br \/>\nwhich at any particular  time its corporate  trust business shall be principally<br \/>\nadministered, which office at the date of execution of this Indenture is located<br \/>\nat 101 Barclay  Street,  Floor 21 West,  New York,  New York  10286,  Attention:<br \/>\nCorporate  Trust  Administration,  or such  other  address  as the  Trustee  may<br \/>\ndesignate  from time to time by notice to the  Holders and the  Company,  or the<br \/>\nprincipal corporate trust office of any successor Trustee (or such other address<br \/>\nas a successor  Trustee may designate from time to time by notice to the Holders<br \/>\nand the Company).<\/p>\n<p>                                       5<\/p>\n<p>                  &#8220;Credit Agreements&#8221; means (i) the Credit Agreement dated as of<br \/>\nJune 23,  1998 by and among the  Company,  as  borrower,  Nationsbank,  National<br \/>\nAssociation,  as Administrative Agent and Arranger, J.P. Morgan Securities Inc.,<br \/>\nDeutsche Bank AG and Scotiabanc,  Inc., as Syndication  Agents and Co-Arrangers,<br \/>\nand the other lenders party thereto from time to time, together with the related<br \/>\ndocuments thereto,  including,  without limitation,  any security documents,  if<br \/>\nany, and all  exhibits and  schedules  thereto and any  agreement or  agreements<br \/>\nrelating to any  extension,  refunding,  refinancing,  successor or  replacement<br \/>\nfacility,  whether or not with the same lender, and whether or not the principal<br \/>\namount or amount of letters of credit  outstanding  thereunder  or the  interest<br \/>\nrate  payable in respect  thereof  shall be thereby  increased,  in each case as<br \/>\namended and in effect from time to time and (ii) the 2000 Credit Agreement.<\/p>\n<p>                  &#8220;Default&#8221; means any event,  act or condition that is, or after<br \/>\nnotice or the passage of time or both would be, an Event of Default.<\/p>\n<p>                  &#8220;Disqualified  Stock&#8221;  means any Capital  Stock  that,  by its<br \/>\nterms (or by the terms of any security into which it is convertible or for which<br \/>\nit is  exchangeable),  or  upon  the  happening  of  any  event,  matures  or is<br \/>\nmandatorily  redeemable,  pursuant to a sinking fund obligation or otherwise, or<br \/>\nis  redeemable at the option of the holder  thereof,  in whole or in part, on or<br \/>\nprior to the Stated Maturity date of the Notes.<\/p>\n<p>                  &#8220;DTC&#8221;  means  The  Depository   Trust  Company,   a  New  York<br \/>\ncorporation.<\/p>\n<p>                  &#8220;DTC  Letter  of  Representations&#8221;  shall  mean the  Letter of<br \/>\nRepresentations, dated the Issue Date, among the Company, DTC and the Trustee.<\/p>\n<p>                  &#8220;EBITDA  Coverage  Ratio&#8221; with respect to any period means the<br \/>\nratio of (i) Consolidated  EBITDA of the Company to (ii) the aggregate amount of<br \/>\nConsolidated Interest Expense of the Company for such period; provided, however,<br \/>\nthat if any calculation of the Company&#8217;s  EBITDA Coverage Ratio requires the use<br \/>\nof any quarter prior to the Issue Date, such calculation  shall be made on a pro<br \/>\nforma basis,  giving  effect to the issuance of the Notes and the use of the net<br \/>\nproceeds  therefrom  as if  the  same  had  occurred  at  the  beginning  of the<br \/>\nfour-quarter period used to make such calculation;  and provided further that if<br \/>\nany such calculation  requires the use of any quarter prior to the date that any<br \/>\nAsset Sale was consummated,  or that any Indebtedness was incurred,  or that any<br \/>\nacquisition of a hospital or other  healthcare  facility or any assets purchased<br \/>\noutside the ordinary  course of business was effected,  by the Company or any of<br \/>\nits Subsidiaries,  such calculation  shall be made on a pro forma basis,  giving<br \/>\neffect to each such Asset Sale,  incurrence of Indebtedness  or acquisition,  as<br \/>\nthe  case  may be,  and the use of any  proceeds  therefrom,  as if the same had<br \/>\noccurred  at  the  beginning  of the  four-quarter  period  used  to  make  such<br \/>\ncalculation.<\/p>\n<p>                  &#8220;Eligible Investments&#8221; of any Person means Investments of such<br \/>\nPerson in:<\/p>\n<p>          (i)      direct obligations of, or obligations the payment of which is<br \/>\n          guaranteed  by, the United  States of  America or an  interest  in any<br \/>\n          trust or fund that invests  solely in such  obligations  or repurchase<br \/>\n          agreements, properly secured, with respect to such obligations;<\/p>\n<p>          (ii)      direct obligations of agencies or  instrumentalities  of the<br \/>\n          United States of America  having a rating of A or higher by Standard &amp; Poor&#8217;s Corporation or A2 or higher by Moody&#8217;s Investors Service, Inc.;<\/p>\n<p>                                       6<\/p>\n<p>          (iii)       a   certificate   of   deposit   issued   by,   or   other<br \/>\n          interest-bearing  deposits with, a bank having its principal  place of<br \/>\n          business in the United States of America and having equity  capital of<br \/>\n          not less than $250,000,000;<\/p>\n<p>          (iv)      a  certificate  of  deposit  by,  or other  interest-bearing<br \/>\n          deposits with,  any other bank organized  under the laws of the United<br \/>\n          States of America or any state thereof,  provided that such deposit is<br \/>\n          either (a) insured by the Federal Deposit Insurance Corporation or (b)<br \/>\n          properly  secured by such bank by pledging  direct  obligations of the<br \/>\n          United  States of America  having a market  value of not less than the<br \/>\n          face amount of such deposits;<\/p>\n<p>          (v)       prime  commercial  paper  maturing  within  270  days of the<br \/>\n          acquisition  thereof and, at the time of acquisition,  having a rating<br \/>\n          of A-1 or higher by Standard &amp; Poor&#8217;s Corporation, or P-1 or higher by<br \/>\n          Moody&#8217;s Investors Service, Inc.; or<\/p>\n<p>          (vi)      eligible  banker&#8217;s  acceptances,  repurchase  agreements and<br \/>\n          tax-exempt municipal bonds having a maturity of less than one year, in<br \/>\n          each case having a rating, or that is the full recourse  obligation of<br \/>\n          a person  whose  senior debt is rated A or higher by Standard &amp; Poor&#8217;s<br \/>\n          Corporation or A2 or higher by Moody&#8217;s Investors Service, Inc.<\/p>\n<p>                  &#8220;Equity Offering&#8221; means a primary offering of Capital Stock of<br \/>\nthe Company (other than  Disqualified  Stock or Preferred  Stock)  pursuant to a<br \/>\nregistration  statement  filed  with  the  Commission  in  accordance  with  the<br \/>\nSecurities Act and declared effective by the staff of the Commission.<\/p>\n<p>                  &#8220;Exchange Act&#8221; means the  Securities  Exchange Act of 1934, as<br \/>\namended.<\/p>\n<p>                  &#8220;Exchange  Notes&#8221;  means  the 8 1\/2%  Senior  Notes  due 2008,<br \/>\nSeries B (the terms of which are  identical  to the Initial  Notes  except that,<br \/>\nunless any Exchange Notes shall be issued as Private  Exchange Notes (as defined<br \/>\nin the Registration  Rights  Agreement),  the Exchange Notes shall be registered<br \/>\nunder the Securities  Act, and shall not contain the  restrictive  legend on the<br \/>\nface of the form of the Initial Notes), to be issued in exchange for the Initial<br \/>\nNotes  pursuant to the  registered  Exchange  Offer and a Private  Exchange  (as<br \/>\ndefined in the Registration Rights Agreement).<\/p>\n<p>                  &#8220;Exchange  Offer&#8221; means the  registration by the Company under<br \/>\nthe  Securities  Act  pursuant to a  registration  statement of the offer by the<br \/>\nCompany to each Holder of the Initial  Notes to exchange  all the Initial  Notes<br \/>\nheld by such Holder for the  Exchange  Notes in an  aggregate  principal  amount<br \/>\nequal to the  aggregate  principal  amount  of the  Initial  Notes  held by such<br \/>\nHolder,  all in accordance  with the terms and  conditions  of the  Registration<br \/>\nRights Agreement.<\/p>\n<p>                  &#8220;Exempted  Debt&#8221; means the sum of the following as of any date<br \/>\nof determination:  (i) Indebtedness of the Company and its Subsidiaries incurred<br \/>\nafter  the  Issue  Date and  secured  by Liens not  otherwise  permitted  by the<br \/>\n&#8220;Limitations  on  Liens&#8221;  covenant  and (ii)  Attributable  Indebtedness  of the<br \/>\nCompany and its Subsidiaries in respect of every Sale and Leaseback  Transaction<br \/>\nentered into after the Issue Date.<\/p>\n<p>                  &#8220;Existing  Indebtedness&#8221;  means all of the Indebtedness of the<br \/>\nCompany and its Subsidiaries that is outstanding on the Issue Date.<\/p>\n<p>                                       7<\/p>\n<p>                  &#8220;Fair  Market  Value&#8221;  of any  asset or items  means  the fair<br \/>\nmarket value of such asset or items as  determined in good faith by the Board of<br \/>\nDirectors and evidenced by a resolution of the Board of Directors.<\/p>\n<p>                  &#8220;GAAP&#8221; means  generally  accepted  accounting  principles  set<br \/>\nforth in the opinions and  pronouncements of the Accounting  Principles Board of<br \/>\nthe American  Institute of  Certified  Public  Accountants  and  statements  and<br \/>\npronouncements  of the  Financial  Accounting  Standards  Board or in such other<br \/>\nstatements by such other entity as may be approved by a  significant  segment of<br \/>\nthe accounting profession of the United States, as from time to time in effect.<\/p>\n<p>                  &#8220;guarantee&#8221;  means,  as  applied  to  any  obligation,  (a)  a<br \/>\nguarantee (other than by endorsement or negotiable instruments for collection in<br \/>\nthe ordinary course of business), direct or indirect, in any manner, of any part<br \/>\nof all of such obligation and (b) an agreement,  direct or indirect,  contingent<br \/>\nor otherwise,  the practical effect of which is to assure in any way the payment<br \/>\nor performance (or payment of damages in the event of non-performance) of all or<br \/>\nany part of such  obligation,  including,  without  limiting the foregoing,  the<br \/>\npayment of amounts drawn down under letters of credit.<\/p>\n<p>                  &#8220;Hedging  Obligations&#8221;  of any Person means the obligations of<br \/>\nsuch Person  pursuant to any  interest  rate swap  agreement,  foreign  currency<br \/>\nexchange agreement,  interest rate collar agreement,  option or futures contract<br \/>\nor other similar agreement or arrangement  relating to interest rates or foreign<br \/>\nexchange rates.<\/p>\n<p>                  &#8220;Holder&#8221;  means a Person in whose name a Note is registered on<br \/>\nthe Registrar&#8217;s books or records.<\/p>\n<p>                  &#8220;Indebtedness&#8221;  of any  Person  at  any  date  means,  without<br \/>\nduplication:  (i) all indebtedness of such Person for borrowed money (whether or<br \/>\nnot the  recourse  of the lender is to the whole of the assets of such Person or<br \/>\nonly to a portion  thereof);  (ii) all  obligations of such Person  evidenced by<br \/>\nbonds, debentures, notes or other similar instruments;  (iii) all obligations of<br \/>\nsuch  Person in respect of letters of credit or other  similar  instruments  (or<br \/>\nreimbursement  obligations with respect  thereto);  (iv) all obligations of such<br \/>\nPerson  with  respect  to  Hedging  Obligations  (other  than those that fix the<br \/>\ninterest  rate  on  variable  rate  indebtedness  otherwise  permitted  by  this<br \/>\nIndenture or that protect the Company and\/or its Subsidiaries against changes in<br \/>\nforeign exchange rates);  (v) all obligations of such Person to pay the deferred<br \/>\nand unpaid  purchase  price of property or services,  except trade  payables and<br \/>\naccrued  expenses  incurred  in  the  ordinary  course  of  business;  (vi)  all<br \/>\nCapitalized Lease  Obligations of such Person;  (vii) all Indebtedness of others<br \/>\nsecured by a Lien on any asset of such Person,  whether or not such Indebtedness<br \/>\nis assumed by such Person;  (viii) all Indebtedness of others guaranteed by such<br \/>\nPerson to the extent of such guarantee; (ix) all Attributable Indebtedness;  and<br \/>\n(x) all  Disqualified  Stock of such Person and its  Subsidiaries  and all other<br \/>\nPreferred  Stock of Subsidiaries of such Person valued at the greater of (a) the<br \/>\nvoluntary or involuntary  liquidation  preference of such Disqualified  Stock or<br \/>\nsuch Preferred  Stock, as the case may be, and (b) the aggregate  amount payable<br \/>\nupon purchase,  redemption,  defeasance or payment of such Disqualified Stock or<br \/>\nsuch  Preferred  Stock,  as the case may be. The amount of  Indebtedness  of any<br \/>\nPerson  at any  date  shall  be the  outstanding  balance  at  such  date of all<br \/>\nunconditional obligations plus past due interest as described above, the maximum<br \/>\nliability of such Person for any such  contingent  obligations at such date and,<br \/>\nin the case of clause (vii), the amount of the Indebtedness secured.<\/p>\n<p>                                      8<\/p>\n<p>                  &#8220;Indenture&#8221;  means this  Indenture  as  amended,  restated  or<br \/>\nsupplemented from time to time.<\/p>\n<p>                  &#8220;Initial Notes&#8221; means the 8 1\/2% Senior Notes due 2008, Series<br \/>\nA of the Company issued on the Issue Date and  authenticated and delivered under<br \/>\nthis  Indenture  pursuant to Section 2.02 of this  Indenture and any other notes<br \/>\n(other than  Exchange  Notes)  issued  after the Issue Date in  accordance  with<br \/>\nclause (iii) of the fourth paragraph of Section 2.02.<\/p>\n<p>                  &#8220;Initial  Purchasers&#8221; refers to UBS Warburg LLC, Deutsche Banc<br \/>\nAlex. Brown Inc., Chase Securities Inc., First Union Securities, Inc. and Scotia<br \/>\nCapital (USA) Inc.<\/p>\n<p>                  &#8220;Interest  Expense&#8221;  of any Person  for any  period  means the<br \/>\naggregate  amount of  interest  which,  in  accordance  with GAAP,  would be set<br \/>\nopposite  the  caption  &#8220;interest  expense&#8221;  or any like  caption  on an  income<br \/>\nstatement for such Person (including, without limitation or duplication, imputed<br \/>\ninterest included in Capitalized Lease Obligations,  all commissions,  discounts<br \/>\nand other fees and charges  owed with  respect to letters of credit and bankers&#8217;<br \/>\nacceptance  financing,  the  net  costs  associated  with  Hedging  Obligations,<br \/>\namortization  of  financing  fees and  expenses,  the  interest  portion  of any<br \/>\ndeferred  payment  obligation,  amortization  of discount and all other non-cash<br \/>\ninterest  expense  other  than  interest  amortized  to cost of sales)  plus the<br \/>\naggregate amount, if any, by which such interest expense was reduced as a result<br \/>\nof the amortization of deferred debt restructuring credits for such period.<\/p>\n<p>                  &#8220;Interest  Payment  Date&#8221;  means  the  Stated  Maturity  of an<br \/>\ninstallment  of interest on the Notes as specified in the forms of Note attached<br \/>\nhereto as Exhibits A and B.<\/p>\n<p>                  &#8220;Investments&#8221; of any Person means: (i) all investments by such<br \/>\nPerson  in  any  other  Person  in  the  form  of  loans,  advances  or  capital<br \/>\ncontributions (excluding commission, travel and similar advances to officers and<br \/>\nemployees  made in the ordinary  course of  business);  (ii) all  guarantees  of<br \/>\nIndebtedness or other obligations of any other Person by such Person;  (iii) all<br \/>\npurchases  (or  other   acquisitions  for   consideration)  by  such  Person  of<br \/>\nIndebtedness,  Capital Stock or other  securities of any other Person;  and (iv)<br \/>\nall other items that would be  classified  as  investments  (including,  without<br \/>\nlimitation,  purchases of assets  outside the ordinary  course of business) on a<br \/>\nbalance sheet of such Person prepared in accordance with GAAP.<\/p>\n<p>                  &#8220;Issue  Date&#8221;  means  February  1, 2001,  the date the Initial<br \/>\nNotes are initially issued.<\/p>\n<p>                  &#8220;Joint  Venture&#8221; means any Person at least a majority of whose<br \/>\nrevenues result from healthcare related business of facilities.<\/p>\n<p>                  &#8220;Lien&#8221; means,  with respect to any asset, any mortgage,  lien,<br \/>\npledge,  charge,  security interest or other similar  encumbrance of any kind in<br \/>\nrespect of such asset,  whether or not filed,  recorded or  otherwise  perfected<br \/>\nunder  applicable law (including,  without  limitation,  any conditional sale or<br \/>\nother title retention agreement,  and any financing lease in the nature thereof,<br \/>\nany  agreement to sell,  and any filing of, or agreement to give,  any financing<br \/>\nstatement  (other than notice filings not perfecting a security  interest) under<br \/>\nthe Uniform Commercial Code (or equivalent statutes) of any jurisdiction).<\/p>\n<p>                                       9<\/p>\n<p>                  &#8220;Net  Proceeds&#8221;  with respect to any Asset Sale means (i) cash<br \/>\n(in U.S.  dollars  or freely  convertible  into U.S.  dollars)  received  by the<br \/>\nCompany or any of its  Subsidiaries  from such Asset  Sale  (including,  without<br \/>\nlimitation,  cash received as consideration  for the assumption or incurrence of<br \/>\nliabilities  incurred in connection with or in anticipation of such Asset Sale),<br \/>\nafter (a) provision for all income or other taxes  measured by or resulting from<br \/>\nsuch  Asset  Sale or the  transfer  of the  proceeds  of such  Asset Sale to the<br \/>\nCompany or any of its  Subsidiaries,  (b) payment of all  commissions  and other<br \/>\nfees and expenses related to such Asset Sale and (c) deduction of an appropriate<br \/>\namount to be provided by the Company or any of its Subsidiaries as a reserve, in<br \/>\naccordance with GAAP, against any liabilities associated with the assets sold or<br \/>\notherwise  disposed of in such Asset Sale and  retained by the Company or any of<br \/>\nits Subsidiaries after such Asset Sale (including,  without limitation,  pension<br \/>\nand  other  post-employment  benefit  liabilities  and  liabilities  related  to<br \/>\nenvironmental  matters) or against any  indemnification  obligations  associated<br \/>\nwith the sale or other  disposition of the assets sold or otherwise  disposed of<br \/>\nin such Asset Sale and (ii) all non-cash  consideration  received by the Company<br \/>\nor any of its  Subsidiaries  from  such  Asset  Sales  upon the  liquidation  or<br \/>\nconversion of such consideration into cash.<\/p>\n<p>                  &#8220;Notes&#8221; means the Initial  Notes,  the Exchange  Notes and any<br \/>\nother notes issued after the Issue Date in  accordance  with clause (iii) of the<br \/>\nfourth  paragraph of Section 2.02  treated as a single class of  securities,  as<br \/>\namended or  supplemented  from time to time in accordance with the terms hereof,<br \/>\nthat are issued pursuant to this Indenture.<\/p>\n<p>                  &#8220;Officer&#8221; means,  with respect to any Person,  the Chairman of<br \/>\nthe Board,  the Chief  Executive  Officer,  the Chief Financial  Officer,  Chief<br \/>\nAccounting  Officer,  Treasurer,   President,  any  Vice  President,  secretary,<br \/>\nassistant secretary, director or other authorized signatory of such Person.<\/p>\n<p>                  &#8220;Officers&#8217;  Certificate&#8221;  means a  certificate  signed  by the<br \/>\nChairman  of the Board,  any Vice  Chairman  of the Board,  the Chief  Executive<br \/>\nOfficer, the President or any Vice President and by the Treasurer, any Assistant<br \/>\nTreasurer,  the  Secretary  or any  Assistant  Secretary of the Company in their<br \/>\nofficial  (and  not  individual)  capacities;   provided,  however,  that  every<br \/>\nOfficers&#8217;  Certificate with respect to the compliance with a condition precedent<br \/>\nto the taking of any action under this  Indenture  shall include (i) a statement<br \/>\nthat the officers  making or giving such  Officers&#8217;  Certificate  have read such<br \/>\ncondition and any  definitions or other  provisions  contained in this Indenture<br \/>\nrelating  thereto  and (ii) a statement  as to  whether,  in the opinion of such<br \/>\nofficers, such condition has been complied with.<\/p>\n<p>                  &#8220;Opinion  of  Counsel&#8221;  means a  written  opinion  from  legal<br \/>\ncounsel  (such  counsel  may be an  employee of or counsel to the Company or the<br \/>\nTrustee) that complies with the requirements of this Indenture.<\/p>\n<p>                  &#8220;Permitted  Investments&#8221;  means:  (i)  capital  contributions,<br \/>\nadvances or loans to the Company by any  Subsidiary  or by the Company or any of<br \/>\nits  Subsidiaries  to a Subsidiary  of the  Company;  (ii) the  acquisition  and<br \/>\nholding by the Company and each of its Subsidiaries of receivables  owing to the<br \/>\nCompany and such  Subsidiary,  if created or acquired in the ordinary  course of<br \/>\nbusiness and payable or  dischargeable in accordance with customary trade terms;<br \/>\n(iii) the  acquisition  and holding by the Company and its  Subsidiaries of cash<br \/>\nand Eligible  Investments;  (iv)  Investments in any Person as a result of which<br \/>\nsuch other  Person  becomes a  Subsidiary  of the  Company or is merged  into or<br \/>\nconsolidated  with or transfers  all or  substantially  all of its assets to the<br \/>\nCompany or any of its  Subsidiaries;  and (v) the making of an Investment by the<br \/>\nCompany,  directly  or  through a Wholly  Owned  Subsidiary,  in a Wholly  Owned<br \/>\nSubsidiary formed solely for the purpose of insuring the<\/p>\n<p>                                       10<\/p>\n<p>healthcare  business  and  facilities  owned or  operated  by the  Company  or a<br \/>\nSubsidiary and any physician employed by or on the staff of any such business or<br \/>\nfacility (the &#8220;Insurance Subsidiary&#8221;), provided that the amount invested in such<br \/>\nInsurance Subsidiary does not exceed $15,000,000.<\/p>\n<p>                  &#8220;Permitted  Liens&#8221; means: (i) Liens for taxes,  assessments or<br \/>\ngovernmental charges or claims that either (a) are not yet delinquent or (b) are<br \/>\nbeing contested in good faith by appropriate  proceedings;  (ii) statutory Liens<br \/>\nof   landlords   and   carriers&#8217;,   warehousemen&#8217;s,    mechanics&#8217;,   suppliers&#8217;,<br \/>\nmaterialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of<br \/>\nbusiness and with respect to amounts that either (a) are not yet  delinquent  or<br \/>\n(b) are being contested in good faith by appropriate proceedings and as to which<br \/>\nappropriate reserves or other provisions have been made in accordance with GAAP;<br \/>\n(iii)  Liens  (other than any Lien  imposed by the  Employee  Retirement  Income<br \/>\nSecurity  Act of 1974,  as amended)  incurred or  deposits  due in the  ordinary<br \/>\ncourse of  business  in  connection  with  workers&#8217;  compensation,  unemployment<br \/>\ninsurance and other types of social  security;  (iv) Liens  incurred or deposits<br \/>\nmade to secure the performance of tenders, bids, leases,  statutory obligations,<br \/>\nsurety and appeal  bonds,  progress  payments,  government  contracts  and other<br \/>\nobligations of like nature (exclusive of obligations for the payment of borrowed<br \/>\nmoney),  in  each  case,  incurred  in the  ordinary  course  of  business;  (v)<br \/>\nattachment  or  judgment  Liens  not  giving  rise to a  Default  or an Event of<br \/>\nDefault; (vi) easements,  rights-of-way,  restrictions and other similar charges<br \/>\nor encumbrances not interfering with the ordinary conduct of the business of the<br \/>\nCompany or any of its Subsidiaries;  (vii) leases or subleases granted to others<br \/>\nnot interfering  with the ordinary conduct of the business of the Company or any<br \/>\nof its  Subsidiaries;  (viii) Liens with  respect to any Acquired  Indebtedness,<br \/>\nprovided  that such Liens only extend to assets that were  subject to such Liens<br \/>\nprior to the acquisition of such assets by the Company or its Subsidiaries  and,<br \/>\nwith respect to Indebtedness other than Indebtedness ranking pari passu with the<br \/>\nNotes, not incurred in anticipation or contemplation of such  acquisition;  (ix)<br \/>\nLiens securing Bank Debt or Refinancing  Indebtedness,  provided, in the case of<br \/>\nRefinancing Indebtedness, that such Liens only extend to the assets securing the<br \/>\nIndebtedness  being  refinanced and such refinanced  Indebtedness was previously<br \/>\nsecured by such assets;  (x) purchase  money  mortgages  (including  Capitalized<br \/>\nLease Obligations); (xi) Liens existing on the Issue Date; (xii) Liens on assets<br \/>\nof any  Subsidiary  of the Company  securing  Indebtedness  of such  Subsidiary,<br \/>\nprovided that such Indebtedness is permitted to be incurred by the terms of this<br \/>\nIndenture; (xiii) bankers&#8217; liens with respect to the right of set-off arising in<br \/>\nthe ordinary course of business  against amounts  maintained in bank accounts or<br \/>\ncertificates of deposit in the name of the Company or any Subsidiary;  (xiv) the<br \/>\ninterest of any issuer of a letter of credit in any cash or Eligible  Investment<br \/>\ndeposited  with or for the benefit of such issuer as collateral  for such letter<br \/>\nof credit,  provided that the Indebtedness so  collateralized is permitted to be<br \/>\nincurred by the terms of this Indenture;  (xv) any Lien consisting of a right of<br \/>\nfirst  refusal or option to purchase  the  Company&#8217;s  ownership  interest in any<br \/>\nSubsidiary  or to  purchase  assets  of the  Company  or any  Subsidiary  of the<br \/>\nCompany,  which right of first refusal or option is entered into in the ordinary<br \/>\ncourse of business;  and (xvi) the Lien  granted to the Trustee  pursuant to the<br \/>\ntrust created pursuant to Article 9 hereof and any substantially equivalent Lien<br \/>\ngranted  to  the  respective  trustees  under  the  indentures  for  other  debt<br \/>\nsecurities of the Company.<\/p>\n<p>                  &#8220;Person&#8221; means any individual, corporation, partnership, joint<br \/>\nventure, incorporated or unincorporated association, joint-stock company, trust,<br \/>\nunincorporated   organization   or  government  or  other  agency  or  political<br \/>\nsubdivision thereof or other entity of any kind.<\/p>\n<p>                  &#8220;Preferred Stock&#8221; means with respect to any Person all Capital<br \/>\nStock of such Person which has a preference in liquidation or a preference  with<br \/>\nrespect to the payment of dividends  or  distributions  of  operating  profit or<br \/>\ncash.<\/p>\n<p>                                       11<\/p>\n<p>                  &#8220;Qualified  Institutional  Buyer&#8221;  or  &#8220;QIB&#8221;  shall  have  the<br \/>\nmeaning specified in Rule 144A.<\/p>\n<p>                  &#8220;Record  Date&#8221; for interest  payable on any  Interest  Payment<br \/>\nDate  (except a date for  payment of default  interest)  means the January 15 or<br \/>\nJuly 15  (whether  or not a  Business  Day),  as the  case  may be,  immediately<br \/>\npreceding such Interest Payment Date.<\/p>\n<p>                  &#8220;Redemption  Date&#8221;  when used with  respect  to any Note to be<br \/>\nredeemed means the date fixed for such redemption pursuant to this Indenture.<\/p>\n<p>                  &#8220;Redemption  Price&#8221;  when used with  respect to any Note to be<br \/>\nredeemed means the price fixed for such redemption pursuant to this Indenture.<\/p>\n<p>                  &#8220;Refinancing  Indebtedness&#8221; means Indebtedness that is applied<br \/>\nto  refund,   refinance  or  extend  any  Existing   Indebtedness   (other  than<br \/>\nIndebtedness  under  the  2000  Credit   Agreement),   provided  that:  (i)  the<br \/>\nRefinancing  Indebtedness  is the  obligation  of  the  same  Person  (or if the<br \/>\nIndebtedness  being  refinanced is an obligation of one or more  Subsidiaries of<br \/>\nthe Company, such Refinancing Indebtedness may be incurred by the Company or one<br \/>\nor more  Subsidiaries  of the Company) and is  subordinated  to the Notes, if at<br \/>\nall,  to the same  extent as the  Indebtedness  being  refunded,  refinanced  or<br \/>\nextended;  (ii) the  Refinancing  Indebtedness is scheduled to mature no earlier<br \/>\nthan  the  Indebtedness  being  refunded,  refinanced  or  extended;  (iii)  the<br \/>\nRefinancing  Indebtedness  has a Weighted  Average  Life to Maturity at the time<br \/>\nsuch  Refinancing  Indebtedness is incurred that is equal to or greater than the<br \/>\nWeighted  Average  Life to  Maturity of the  portion of the  Indebtedness  being<br \/>\nrefunded,  refinanced or extended; (iv) the Refinancing  Indebtedness is secured<br \/>\nonly to the extent,  if at all,  and by the assets that the  Indebtedness  being<br \/>\nrefunded,   refinanced  or  extended  is  secured;   and  (v)  such  Refinancing<br \/>\nIndebtedness is in an aggregate  principal  amount that is equal to or less than<br \/>\nthe aggregate  principal  amount then outstanding  under the Indebtedness  being<br \/>\nrefunded,  refinanced  or extended  (except for issuance  costs and increases in<br \/>\nAttributable   Indebtedness  due  solely  to  increases  in  the  present  value<br \/>\ncalculations  resulting  from  renewals  or  extensions  of  the  terms  of  the<br \/>\nunderlying leases in effect on the Issue Date).<\/p>\n<p>                  &#8220;Registration  Rights Agreement&#8221; means the Registration Rights<br \/>\nAgreement  dated as of  February  1, 2001  among  the  Company  and the  Initial<br \/>\nPurchasers.<\/p>\n<p>                  &#8220;Regulation  S&#8221;  means  Regulation  S  promulgated  under  the<br \/>\nSecurities Act.<\/p>\n<p>                  &#8220;Regulation S Restricted  Period&#8221;  means,  with respect to any<br \/>\nNote, the period of forty (40)  consecutive  days beginning on and including the<br \/>\nfirst day after the later of (i) the day on which such Note is first  offered to<br \/>\nPersons  other than  distributors  (as defined in  Regulation  S) in reliance on<br \/>\nRegulation S and (ii) the closing date of the offering of such Note.<\/p>\n<p>                  &#8220;Restricted Payment&#8221; means with respect to any Person: (i) the<br \/>\ndeclaration  of any dividend or the making of any other payment or  distribution<br \/>\nof cash,  securities  or other  property  or assets in respect of such  Person&#8217;s<br \/>\nCapital  Stock  (except that a dividend  payable  solely in Capital Stock (other<br \/>\nthan  Disqualified  Stock) of such  Person  shall not  constitute  a  Restricted<br \/>\nPayment); (ii) any payment on account of the purchase, redemption, retirement or<br \/>\nother  acquisition  for value of such  Person&#8217;s or such  Person&#8217;s  Subsidiaries&#8217;<br \/>\nCapital  Stock or any other  payment or  distribution  made in respect  thereof,<br \/>\neither  directly or  indirectly;  (iii) any payment on account of the  purchase,<br \/>\nredemption,<\/p>\n<p>                                       12<\/p>\n<p>retirement,  defeasance or other  acquisition for value,  prior to any scheduled<br \/>\nprincipal  payment,  sinking fund payment or Stated  Maturity,  of  Subordinated<br \/>\nIndebtedness of the Company or its Subsidiaries;  (iv) the incurrence,  creation<br \/>\nor assumption of any guarantee of  Indebtedness  of any Affiliate  (other than a<br \/>\nSubsidiary  of the Company);  or (v) the making of any  Investment in any Person<br \/>\n(other than Permitted Investments);  provided, however, that with respect to the<br \/>\nCompany and its Subsidiaries,  Restricted Payments shall not include any payment<br \/>\ndescribed  in clause (i),  (ii) or (iii) above made (1) to the Company or any of<br \/>\nits Wholly Owned Subsidiaries by any of the Company&#8217;s Subsidiaries or (2) by the<br \/>\nCompany  to  any of  its  Wholly  Owned  Subsidiaries  or (3) by any  Subsidiary<br \/>\nprovided that the Company or another Subsidiary receives its proportionate share<br \/>\nthereof.<\/p>\n<p>                  &#8220;Restricted  Security&#8221; means any Note (or beneficial  interest<br \/>\ntherein) other than an Exchange Note (or  beneficial  interest  therein),  until<br \/>\nsuch  time  as:  (i)  such  Note  (or  beneficial  interest  therein)  has  been<br \/>\ntransferred pursuant to an effective registration statement under the Securities<br \/>\nAct;  (ii) such Note is a 144A Global  Note and two years have passed  since the<br \/>\nIssue Date;  (iii) such Note is a Regulation S Global Note and the  Regulation S<br \/>\nRestricted Period has expired; or (iv) the Private Placement legend therefor has<br \/>\notherwise been removed  pursuant to Section  2.16(e) hereof or, in the case of a<br \/>\nbeneficial  interest  in a  Global  Note,  such  beneficial  interest  has  been<br \/>\nexchanged  for an  interest  in a Global  Note not  bearing a Private  Placement<br \/>\nLegend.<\/p>\n<p>                  &#8220;Rule 144A&#8221; means Rule 144A  promulgated  under the Securities<br \/>\nAct.<\/p>\n<p>                  &#8220;Sale and Leaseback  Transaction&#8221;  means,  with respect to any<br \/>\nPerson,  an  arrangement  with any bank,  insurance  company or other  lender or<br \/>\ninvestor  or to which such  lender or  investor  is a party,  providing  for the<br \/>\nleasing by such Person or any of its  Subsidiaries  of any  property or asset of<br \/>\nsuch  Person  or any of its  Subsidiaries  which  has been or is  being  sold or<br \/>\ntransferred  by such Person or such  Subsidiary to such lender or investor or to<br \/>\nany  Person to whom  funds  have been or are to be  advanced  by such  lender or<br \/>\ninvestor on the security of such property or asset.<\/p>\n<p>                  &#8220;Secretary&#8217;s  Certificate&#8221;  means a certificate  signed by the<br \/>\nSecretary or any Assistant  Secretary of the Company in his or her official (and<br \/>\nnot individual) capacity.<\/p>\n<p>                  &#8220;Securities Act&#8221; means the Securities Act of 1933, as amended.<\/p>\n<p>                  &#8220;Significant  Subsidiary&#8221;  means a  Subsidiary  of the Company<br \/>\nwhich at the time of  determination  either (i) had tangible assets which, as of<br \/>\nthe Company&#8217;s most recent quarterly  consolidated balance sheet,  constituted at<br \/>\nleast 5% of  Consolidated  Tangible Assets as of such date, or (ii) had revenues<br \/>\nfor the  12-month  period  ending  on the  date  of the  Company&#8217;s  most  recent<br \/>\nquarterly  consolidated statement of income which constituted at least 5% of the<br \/>\nCompany&#8217;s total consolidated revenues for such period.<\/p>\n<p>                  &#8220;Stated  Maturity&#8221;  when used with  respect to any security or<br \/>\nany installment of interest thereon,  means that date specified in such security<br \/>\nas the fixed date on which the principal of such security or such installment of<br \/>\ninterest is due and payable.<\/p>\n<p>                  &#8220;Subordinated   Indebtedness&#8221;   of  any   Person   means   any<br \/>\nIndebtedness  of such  Person  that is  subordinated  in right of payment to the<br \/>\nNotes.<\/p>\n<p>                                       13<\/p>\n<p>                  &#8220;Subsidiary&#8221;  of any Person means (i) any corporation of which<br \/>\nCommon Equity having  ordinary voting power to elect a majority of the directors<br \/>\nof such  corporation  is owned by such  Person  directly  or through one or more<br \/>\nother  Subsidiaries  of such Person and (ii) any entity other than a corporation<br \/>\nin which such Person,  directly or  indirectly,  owns at least 50% of the Common<br \/>\nEquity  of  such  entity  and has the  authority  to  manage  such  entity  on a<br \/>\nday-to-day basis.<\/p>\n<p>                  &#8220;Trust  Indenture Act&#8221; or &#8220;TIA&#8221; means the Trust  Indenture Act<br \/>\nof 1939 (15 U.S.  Code Sections  77aaa-77bbbb)  as in effect on the date of this<br \/>\nIndenture (except as provided in Section 8.03 hereof).<\/p>\n<p>                  &#8220;Trust  Officer&#8221;  shall  mean,  when used with  respect to the<br \/>\nTrustee,  any officer  within the  corporate  trust  department  of the Trustee,<br \/>\nincluding any vice  president,  assistant vice president,  assistant  treasurer,<br \/>\ntrust  officer or any other  officer of the  Trustee  who  customarily  performs<br \/>\nfunctions  similar to those  performed  by the  Persons who at the time shall be<br \/>\nsuch officers,  respectively,  or to whom any corporate trust matter is referred<br \/>\nbecause  of such  Person&#8217;s  knowledge  of and  familiarity  with the  particular<br \/>\nsubject and who shall have direct  responsibility for the administration of this<br \/>\nIndenture.<\/p>\n<p>                  &#8220;Trustee&#8221;  means  the  party  named as such in this  Indenture<br \/>\nuntil a successor  replaces it pursuant to this Indenture and  thereafter  means<br \/>\nthe successor.<\/p>\n<p>                  &#8220;U.S.  Government  Obligations&#8221;  means (a) securities that are<br \/>\ndirect  obligations of the United States of America for the payment of which its<br \/>\nfull faith and credit are pledged or (b)  obligations of a Person  controlled or<br \/>\nsupervised by and acting as an agency or instrumentality of the United States of<br \/>\nAmerica, the payment of which is unconditionally  guaranteed as a full faith and<br \/>\ncredit  obligation by the United States of America,  which,  in either case, are<br \/>\nnot callable or redeemable at the option of the issuer  thereof,  and shall also<br \/>\ninclude a depository  receipt issued by a bank (as defined in Section 3(a)(2) of<br \/>\nthe  Securities  Act) as  custodian  with  respect  to any such U.S.  Government<br \/>\nObligation  or a specific  payment of  principal of or interest on any such U.S.<br \/>\nGovernment  Obligation  held by such  custodian for the account of the holder of<br \/>\nsuch  depository  receipt;  provided  that  (except  as  required  by law)  such<br \/>\ncustodian is not authorized to make any deduction from the amount payable to the<br \/>\nholder of such  depository  receipt from any amount received by the custodian in<br \/>\nrespect of the U.S. Government  Obligation or a specific payment of principal or<br \/>\ninterest on any such U.S.  Government  Obligation held by such custodian for the<br \/>\naccount of the holder of such depository receipt.<\/p>\n<p>                  &#8220;Weighted Average Life to Maturity&#8221; means, when applied to any<br \/>\nIndebtedness  or portion  thereof at any date,  the number of years  obtained by<br \/>\ndividing  (i) the then  outstanding  principal  amount of such  Indebtedness  or<br \/>\nportion  thereof (if applicable)  into (ii) the sum of the products  obtained by<br \/>\nmultiplying  (a) the amount of each then  remaining  installment,  sinking fund,<br \/>\nserial  maturity or other required  payment of principal,  including  payment at<br \/>\nfinal maturity,  in respect thereof,  by (b) the number of years  (calculated to<br \/>\nthe nearest  one-twelfth)  that will elapse  between such date and the making of<br \/>\nsuch payment.<\/p>\n<p>                  &#8220;Wholly Owned Subsidiary&#8221; of any Person means (i) a Subsidiary<br \/>\nof which 100% of the Common Equity (except for director&#8217;s  qualifying  shares or<br \/>\ncertain  minority  interests  owned by other  Persons  solely  due to local  law<br \/>\nrequirements that there be more than one stockholder,  but which interest is not<br \/>\nin excess of what is required for such purpose) is owned directly by such Person<br \/>\nor <\/p>\n<p>                                       14<\/p>\n<p>through one or more other Wholly Owned  Subsidiaries of such Person and (ii) any<br \/>\nentity other than a corporation  in which such Person,  directly or  indirectly,<br \/>\nowns all of the Common Equity of such entity.<\/p>\n<p>Section 1.02.     Other Definitions.<\/p>\n<p>                  The  definitions  of the  following  terms may be found in the<br \/>\nsections indicated as follows:<\/p>\n<p>                                   Term                      Defined in Section<\/p>\n<p>&#8220;Accredited Investors&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         2.01<br \/>\n&#8220;Affiliate Transaction&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         4.13<br \/>\n&#8220;Agent Members&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         2.15<br \/>\n&#8220;Applicable Procedures&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.16<br \/>\n&#8220;Asset Sale Offer&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         4.12<br \/>\n&#8220;Asset Sale Payment Amount&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         4.12<br \/>\n&#8220;Asset Sale Purchase Price&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         4.12<br \/>\n&#8220;Bankruptcy Law&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         6.01<br \/>\n&#8220;Business Day&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..        11.07<br \/>\n&#8220;Change of Control Offer&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         4.15<br \/>\n&#8220;Change of Control Payment Date&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         4.15<br \/>\n&#8220;Change of Control Purchase Price&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         4.15<br \/>\n&#8220;Clearstream&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         2.01<br \/>\n&#8220;Covenant Defeasance&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         9.03<br \/>\n&#8220;Custodian&#8221;&#8230;&#8230;. &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         6.01<br \/>\n&#8220;Depositary&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         2.15<br \/>\n&#8220;Euroclear&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.01<br \/>\n&#8220;Event of Default&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         6.01<br \/>\n&#8220;Excess Proceeds&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         4.12<br \/>\n&#8220;Excess Proceeds Payment Date&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         4.12<br \/>\n&#8220;Global Notes&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.01<br \/>\n&#8220;Legal Defeasance&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         9.02<br \/>\n&#8220;Legal Holiday&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         11.07<br \/>\n&#8220;make whole amount&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   Exhibit A\/Exhibit B<br \/>\n&#8220;Net Proceeds Deficiency&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;         4.12<br \/>\n&#8220;Non-payment Default&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.        10.03<br \/>\n&#8220;Other Debt&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         4.12<br \/>\n&#8220;Paying Agent&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.03<br \/>\n&#8220;Payment Blockage Notice&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;        10.03<br \/>\n&#8220;Payment Blockage Period&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;        10.03<br \/>\n&#8220;Payment Default&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..        10.03<br \/>\n&#8220;Private Placement Legend&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.17<br \/>\n&#8220;Registrar&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.03<br \/>\n&#8220;Regulation S Global Note&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         2.01<br \/>\n&#8220;Restricted Global Note&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.         2.01<br \/>\n&#8220;Successor&#8221;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..         5.01<\/p>\n<p>                                       15<\/p>\n<p>Section 1.03.     Incorporation by Reference of Trust Indenture Act.<\/p>\n<p>                  Whenever this Indenture  refers to a provision of the TIA, the<br \/>\nportion of such provision  required to be incorporated  herein in order for this<br \/>\nIndenture to be qualified under the TIA is incorporated by reference in and made<br \/>\na part  of  this  Indenture.  Unless  otherwise  specified,  terms  used in this<br \/>\nIndenture  that are  defined  by the TIA,  defined  in the TIA by  reference  to<br \/>\nanother statute or defined by Commission rule have the meanings therein assigned<br \/>\nto them.<\/p>\n<p>Section 1.04.     Rules of Construction.<\/p>\n<p>                  Unless the context otherwise requires:<\/p>\n<p>                  (1) a term has the  meaning  assigned  to it  herein,  whether<br \/>\n         defined expressly or by reference;<\/p>\n<p>                  (2) an accounting  term not otherwise  defined has the meaning<br \/>\n         assigned to it in accordance with GAAP;<\/p>\n<p>                  (3) &#8220;or&#8221; is not exclusive;<\/p>\n<p>                  (4)  words in the  singular  include  the  plural,  and in the<br \/>\n         plural include the singular; and<\/p>\n<p>                  (5) words used herein implying any gender shall apply to every<br \/>\n         gender.<\/p>\n<p>                                    ARTICLE 2<\/p>\n<p>                                    THE NOTES<\/p>\n<p>Section 2.01.     Dating; Incorporation of Form in Indenture; Form of Notes.<\/p>\n<p>                  (a) Generally. The Initial Notes and the Trustee&#8217;s certificate<br \/>\nof  authentication  shall be  substantially  in the form of  Exhibit  A, and the<br \/>\nExchange  Notes  and  the  Trustee&#8217;s  certificate  of  authentication  shall  be<br \/>\nsubstantially  in the form of  Exhibit B, each of which is  incorporated  in and<br \/>\nmade part of this Indenture with such appropriate insertions,  substitutions and<br \/>\nother  variations as are required or permitted by this Indenture.  The Notes may<br \/>\nhave notations,  legends or endorsements required by law, stock exchange rule or<br \/>\nusage all in a form  approved by the Company.  Each Note shall be dated the date<br \/>\nof its authentication.<\/p>\n<p>                  (b) Notes Sold  Pursuant to Rule 144A.  The Notes  offered and<br \/>\nsold in  their  initial  distribution  in  reliance  on Rule  144A to  Qualified<br \/>\nInstitutional Buyers shall be issued in the form of a permanent global note (the<br \/>\n&#8220;Restricted   Global  Note&#8221;)  (which  may  be   represented  by  more  than  one<br \/>\ncertificate,  if so required by the  Depositary&#8217;s  rules  regarding  the maximum<br \/>\nprincipal  amount to be represented by a single  certificate),  duly executed by<br \/>\nthe  Company  and  authenticated  by the Trustee as  hereinafter  provided.  The<br \/>\nRestricted  Global Note shall be registered in the name of the Depositary or its<br \/>\nnominee and  deposited  with the Trustee,  at its  Corporate  Trust  Office,  as<br \/>\ncustodian  for  the  Depositary  on  behalf  of  the  purchasers  of  the  Notes<br \/>\nrepresented thereby.<\/p>\n<p>                                       16<\/p>\n<p>                  (c) Notes Sold Pursuant to Regulation S. The Notes offered and<br \/>\nsold in their initial  distribution  in reliance on Regulation S shall be issued<br \/>\nin the form of a permanent  global  note (the  &#8220;Regulation  S Global  Note&#8221; and,<br \/>\ntogether with the  Restricted  Global Note,  the &#8220;Global  Notes&#8221;)  (which may be<br \/>\nrepresented  by more than one  certificate,  if so required by the  Depositary&#8217;s<br \/>\nrules  regarding  the maximum  principal  amount to be  represented  by a single<br \/>\ncertificate),  duly executed by the Company and  authenticated by the Trustee as<br \/>\nhereinafter  provided.  The  Regulation S Global Note shall be registered in the<br \/>\nname of the  Depositary  or its nominee and deposited  with the Trustee,  at its<br \/>\nCorporate  Trust  Office,  as  custodian  for the  Depositary  for credit to the<br \/>\nrespective  accounts  of  The  Euroclear  System  (&#8220;Euroclear&#8221;)  and  Clearsteam<br \/>\nBanking,  societe  anonyme  (&#8220;Clearstream&#8221;).  Prior  to the  termination  of the<br \/>\nRegulation S Restricted Period,  beneficial interests in the Regulation S Global<br \/>\nNote may be held only through Euroclear and Clearstream.<\/p>\n<p>                  (d) Notes  Sold to  Institutional  Accredited  Investors.  The<br \/>\nNotes offered and sold in their initial distribution in reliance on an exemption<br \/>\nfrom  registration  under the Securities Act (other than Rule 144A or Regulation<br \/>\nS) to institutional  &#8220;accredited investors&#8221; (as defined in Rule 501(a)(1),  (2),<br \/>\n(3) or (7) under the Securities Act (&#8220;Accredited Investors&#8221;)) shall be issued in<br \/>\ncertificated, fully registered form without coupons and only in denominations of<br \/>\n$250,000 and integral  multiples of $1,000 in excess  thereof,  duly executed by<br \/>\nthe Company and authenticated by the Trustee as hereinafter provided.<\/p>\n<p>Section 2.02. Execution and Authentication; Appointment of Authenticating Agent.<\/p>\n<p>                  The Notes shall be executed on behalf of the Company by one or<br \/>\nmore Officers of the Company. Such signature may be either manual or facsimile.<\/p>\n<p>                  If an Officer  whose  signature  is on a Note no longer  holds<br \/>\nthat office at the time the Trustee  authenticates  the Note,  the Note shall be<br \/>\nvalid nevertheless.<\/p>\n<p>                  A Note shall not be valid until the Trustee manually signs the<br \/>\ncertificate of  authentication  on the Note.  Such signature shall be conclusive<br \/>\nevidence that the Note has been authenticated under this Indenture.<\/p>\n<p>                  The Trustee shall  authenticate (i) Initial Notes for original<br \/>\nissue  on the  Issue  Date  in the  aggregate  principal  amount  not to  exceed<br \/>\n$375,000,000,  (ii) pursuant to the Exchange Offer,  Exchange Notes from time to<br \/>\ntime for issue only in exchange for a like principal amount of Initial Notes and<br \/>\n(iii)  subject to  compliance  with Section  4.11 hereof,  one or more series of<br \/>\nNotes for original issue after the Issue Date (such Notes to be substantially in<br \/>\nthe form of Exhibit A or B hereto,  as the case may be) in an  unlimited  amount<br \/>\n(and if in the form of Exhibit A hereto the same  principal  amount of  Exchange<br \/>\nNotes in exchange therefor upon consummation of a registered exchange offer), in<br \/>\neach  case  upon  written  orders  of the  Company  in the form of an  Officers&#8217;<br \/>\nCertificate,  which  Officers&#8217;  Certificate  shall,  in the case of any issuance<br \/>\npursuant to clause (iii) above, certify that such issuance is in compliance with<br \/>\nSection 4.11 hereof. In addition,  each such Officers&#8217; Certificate shall specify<br \/>\nthe amount of Notes to be  authenticated,  the date on which the Notes are to be<br \/>\nauthenticated,  whether  the Notes are to be Initial  Notes,  Exchange  Notes or<br \/>\nNotes  issued under clause  (iii) of the  preceding  sentence and the  aggregate<br \/>\nprincipal amount of Notes outstanding on the date of authentication.<\/p>\n<p>                                       17<\/p>\n<p>                  Except as  provided  in section  2.01(d),  the Notes  shall be<br \/>\nissuable only in definitive,  fully  registered form without coupons and only in<br \/>\nminimum denominations of $1,000 and integral multiples thereof.<\/p>\n<p>                  The Trustee,  with the approval of the Company, may appoint an<br \/>\nauthenticating  agent  to  authenticate  Notes.  Any such  appointment  shall be<br \/>\nevidenced by an  instrument  signed by an authorized  officer of the Trustee,  a<br \/>\ncopy of which shall be  furnished to the Company.  An  authenticating  agent may<br \/>\nauthenticate  Notes  whenever  the  Trustee may do so.  Each  reference  in this<br \/>\nIndenture  to  authentication  by the Trustee  includes  authentication  by such<br \/>\nagent,  and shall comply with this Indenture.  An  authenticating  agent has the<br \/>\nsame right as an Agent to deal with the Company or an Affiliate.<\/p>\n<p>Section 2.03.     Registrar and Paying Agent.<\/p>\n<p>                  The Company shall  maintain an office or agency in the Borough<br \/>\nof  Manhattan,  The  City of New  York  where  (a)  Notes  may be  presented  or<br \/>\nsurrendered  for  registration  of transfer or for exchange  (&#8220;Registrar&#8221;),  (b)<br \/>\nNotes may be  presented  or  surrendered  for payment  (&#8220;Paying  Agent&#8221;) and (c)<br \/>\nnotices and demands in respect of Notes and this  Indenture  may be served.  The<br \/>\nRegistrar shall keep a register of the Notes and of their transfer and exchange.<br \/>\nThe  Registrar  shall  provide the Company a current copy of such  register from<br \/>\ntime to time upon  request  of the  Company.  The  Company  may have one or more<br \/>\nco-Registrars and one or more additional  Paying Agents.  The Company may change<br \/>\nany Paying Agent,  Registrar or co-Registrar  without notice to any Holder.  The<br \/>\nCompany may not act as Paying Agent, but may act as Registrar or co-Registrar.<\/p>\n<p>                  The Company shall enter into an appropriate  agency  agreement<br \/>\nwith any  Registrar or Paying Agent not a party to this  Indenture,  which shall<br \/>\nincorporate  the  provisions  of the TIA.  The  agreement  shall  implement  the<br \/>\nprovisions of this Indenture that relate to such Agent. The Company shall notify<br \/>\nthe Trustee in writing of the name and address of any such Agent. If the Company<br \/>\nfails to maintain a Registrar or Paying  Agent,  or agent for service of notices<br \/>\nand demands, or fails to give the foregoing notice, the Company shall notify the<br \/>\nTrustee and the  Trustee  shall to the extent that it is capable act as such for<br \/>\nso long as such failure continues.<\/p>\n<p>                  The Company  initially  appoints the Trustee as Registrar  and<br \/>\nPaying Agent in the Borough of Manhattan, The City of New York.<\/p>\n<p>Section 2.04.     Paying Agent To Hold Money in Trust.<\/p>\n<p>                  Before  10:00 A.M.  New York City time on each payment date of<br \/>\nthe  principal of and\/or  interest on any Notes,  the Company shall deposit with<br \/>\nthe Paying Agent a sum sufficient to pay such principal and interest so becoming<br \/>\ndue. The Company at any time may require a Paying Agent to pay all money held by<br \/>\nit to the Trustee  together  with a complete  accounting  of such sums,  and the<br \/>\nTrustee may at any time  during the  continuance  of any Event of Default  under<br \/>\nSection 6.01(a) or (b) hereof,  upon written request to a Paying Agent,  require<br \/>\nsuch Paying Agent to  forthwith  pay to the Trustee all sums so held in trust by<br \/>\nsuch Paying Agent together with a complete  accounting of such sums.  Upon doing<br \/>\nso,  the Paying  Agent  shall have no  further  liability  for the money.  Funds<br \/>\ndeposited  with the Paying  Agent may be invested as agreed from time to time by<br \/>\nthe Company and the Paying Agent.  All payments made hereunder  shall be in U.S.<br \/>\nlegal tender.<\/p>\n<p>                                       18<\/p>\n<p>Section 2.05.     Holder Lists.<\/p>\n<p>                  The  Trustee  shall  preserve  in  as  current  a  form  as is<br \/>\nreasonably  practicable  the most recent list  available  to it of the names and<br \/>\naddresses of Holders.  If the Trustee is not the  Registrar,  the Company  shall<br \/>\nfurnish to the Trustee at least five Business Days before each Interest  Payment<br \/>\nDate and the Stated  Maturity  Date and at such other  times as the  Trustee may<br \/>\nreasonably  request in  writing,  a list in such form and as of such date as the<br \/>\nTrustee may require of the names and addresses of Holders.<\/p>\n<p>Section 2.06.     [Intentionally Omitted].<\/p>\n<p>Section 2.07.     Replacement Notes.<\/p>\n<p>                  If a mutilated  Note is  surrendered  to the Trustee or if the<br \/>\nHolder of a Note  claims  that a Note has been  lost,  destroyed  or  wrongfully<br \/>\ntaken, the Company shall issue and the Trustee shall  authenticate a replacement<br \/>\nNote if the Trustee&#8217;s  requirements  for  replacement are met. An indemnity bond<br \/>\nmay be required by the Company or the Trustee that is sufficient in the judgment<br \/>\nof the Company and the Trustee to protect the Company,  the Trustee or any Agent<br \/>\nfrom any loss which any of them may suffer if a Note is replaced and evidence to<br \/>\ntheir  satisfaction  of apparent loss,  destruction or theft of such Note may be<br \/>\nrequired by the Company,  the Trustee or any Agent.  The Company and the Trustee<br \/>\nmay charge for their reasonable  out-of-pocket  expenses  (including  reasonable<br \/>\nattorneys&#8217;  fees and  expenses  and any  applicable  taxes) in  replacing a Note<br \/>\npursuant to this Section 2.07. In the event any such mutilated,  lost, destroyed<br \/>\nor  wrongfully  taken  Note has  become  due and  payable,  the  Company  in its<br \/>\ndiscretion  may pay such  Note  instead  of  issuing  a new Note in  replacement<br \/>\nthereof.  If after the delivery of such new Note,  a bona fide  purchaser of the<br \/>\noriginal  Note in lieu of which such new Note was issued  presents  for  payment<br \/>\nsuch  original  Note,  the Company and the Trustee  shall be entitled to recover<br \/>\nsuch new  Note  from  the  person  to whom it was  delivered  or any  transferee<br \/>\nthereof, except a bona fide purchaser, and shall be entitled to recover upon the<br \/>\nsecurity or indemnity provided therefor to the extent of any loss, damage,  cost<br \/>\nor expense incurred by the Company or the Trustee in connection therewith.<\/p>\n<p>                  Every  replacement  Note is an  additional  obligation  of the<br \/>\nCompany.<\/p>\n<p>Section 2.08.     Outstanding Notes.<\/p>\n<p>                  Notes  outstanding at any time are all Notes  authenticated by<br \/>\nthe  Trustee  except  for  those  canceled  by  it,  those  delivered  to it for<br \/>\ncancellation and those described in this Section 2.08 as not outstanding.<\/p>\n<p>                  A Note replaced  pursuant to Section 2.07 hereof (other than a<br \/>\nmutilated Note surrendered for replacement)  ceases to be outstanding unless and<br \/>\nuntil the Trustee  receives proof  satisfactory to it that such replaced Note is<br \/>\nheld by a protected purchaser.<\/p>\n<p>                  If a Paying  Agent  holds on a  Redemption  Date or at  Stated<br \/>\nMaturity  U.S.  legal tender  sufficient  to pay the  principal  of,  make-whole<br \/>\namount,  if any, and accrued interest on Notes (or portions  thereof) payable on<br \/>\nthat date, then on and after that date,  such Notes (or portions  thereof) cease<br \/>\nto be outstanding and interest on them ceases to accrue.<\/p>\n<p>                                       19<\/p>\n<p>Section 2.09.     Treasury Notes.<\/p>\n<p>                  In determining  whether the Holders of the required  principal<br \/>\namount of Notes have  concurred  in any  direction,  waiver,  consent or notice,<br \/>\nNotes  owned by the  Company or any of its  Affiliates  shall be  considered  as<br \/>\nthough they are not  outstanding,  except that for the  purposes of  determining<br \/>\nwhether the Trustee shall be protected in relying on any such direction,  waiver<br \/>\nor consent,  only Notes which a Trust Officer of the Trustee  actually knows are<br \/>\nso owned  shall be so  considered.  The Company  shall  notify the  Trustee,  in<br \/>\nwriting,  when it or any of its  Affiliates  repurchases  or otherwise  acquires<br \/>\nNotes and of the  aggregate  principal  amount of such Notes so  repurchased  or<br \/>\notherwise acquired.<\/p>\n<p>Section 2.10.     Temporary Notes.<\/p>\n<p>                  Until definitive Notes are ready for delivery, the Company may<br \/>\nprepare and the Trustee shall  authenticate  temporary  Notes.  Temporary  Notes<br \/>\nshall be substantially in the form, and shall carry all rights and restrictions,<br \/>\nof  definitive  Notes  but  may  have  variations  that  the  Company  considers<br \/>\nappropriate for temporary Notes.  Without  unreasonable delay, the Company shall<br \/>\nprepare and the Trustee  shall  authenticate  definitive  Notes in exchange  for<br \/>\ntemporary  Notes upon surrender of such temporary  Notes at the office or agency<br \/>\nmaintained pursuant to Section 2.03 hereof.<\/p>\n<p>Section 2.11.     Cancellation.<\/p>\n<p>                  The Company at any time may  deliver  Notes to the Trustee for<br \/>\ncancellation.  The  Registrar  and the Paying Agent shall forward to the Trustee<br \/>\nany Notes  surrendered  to them for transfer,  exchange or payment.  The Trustee<br \/>\nshall  cancel  all  Notes  surrendered  for  transfer,   exchange,   payment  or<br \/>\ncancellation and, unless the Company instructs the Trustee in writing to deliver<br \/>\nthe Notes to the Company,  shall  dispose of such Notes in  accordance  with its<br \/>\nnormal practice.  Subject to Section 2.07 hereof,  the Company may not issue new<br \/>\nNotes to replace Notes in respect of which it has previously paid all principal,<br \/>\nmake-whole  amount,  if any, and interest accrued  thereon,  or delivered to the<br \/>\nTrustee for  cancellation.  The Trustee shall provide the Company with a list of<br \/>\nall Notes that have been  canceled  from time to time as requested in writing by<br \/>\nthe Company.  If the Company  shall acquire any of the Notes,  such  acquisition<br \/>\nshall  not  operate  as  a  redemption  or  satisfaction  of  the   Indebtedness<br \/>\nrepresented  by such  Notes  unless  and until the same are  surrendered  to the<br \/>\nTrustee for cancellation pursuant to this Section 2.07.<\/p>\n<p>Section 2.12.     Defaulted Interest.<\/p>\n<p>                  If the Company  defaults in a payment of principal or interest<br \/>\non the  Notes,  it shall  pay  interest  on  overdue  principal  and on  overdue<br \/>\ninstallments of interest  (without regard to any applicable  grace periods) from<br \/>\ntime to time on demand at the rate per annum  borne by the Notes,  to the extent<br \/>\nlawful.<\/p>\n<p>                  If the Company defaults in a payment of interest on the Notes,<br \/>\nit shall pay the defaulted  interest,  plus (to the extent  lawful) any interest<br \/>\npayable  on the  defaulted  interest,  to  the  Persons  who  are  Holders  on a<br \/>\nsubsequent  special  Record  Date,  which date shall be the  fifteenth  day next<br \/>\npreceding the date fixed by the Company for the payment of defaulted interest or<br \/>\nthe next succeeding Business Day if such date is not a Business Day. At least 15<br \/>\ndays before the  subsequent  special Record Date, the Company shall mail to each<br \/>\nHolder, as of a recent date selected by the<\/p>\n<p>                                       20<\/p>\n<p>Company, with a copy to the Trustee, a notice that states the subsequent special<br \/>\nRecord Date, the payment date and the amount of defaulted interest, and interest<br \/>\npayable on such defaulted interest, if any, to be paid.<\/p>\n<p>                  Notwithstanding  the  foregoing,  any  interest  which is paid<br \/>\nprior to the expiration of the 30-day period set forth in Section 6.01(a) hereof<br \/>\nshall be paid to Holders as of the Record Date for the Interest Payment Date for<br \/>\nwhich interest has not been paid.<\/p>\n<p>Section 2.13.     Deposit of Moneys; Payments.<\/p>\n<p>                  Prior to 10:00  A.M.,  New York  City  time,  on the  relevant<br \/>\nInterest Payment Date, Stated Maturity date,  Redemption Date, Change of Control<br \/>\nPurchase Date and Excess Proceeds Payment Date, the Company shall have deposited<br \/>\nwith the Paying Agent in immediately  available  funds money  sufficient to make<br \/>\nall cash  payments due on such  Interest  Payment Date,  Stated  Maturity  date,<br \/>\nRedemption  Date,  Change of Control  Purchase Date and Excess Proceeds  Payment<br \/>\nDate,  as the case may be (or if any such date is not a Business  Day, the first<br \/>\npreceding  Business  Day).  The  principal and interest on Global Notes shall be<br \/>\npayable  to the  Depositary  or its  nominee,  as the case  may be,  as the sole<br \/>\nregistered  owner and the sole holder of the Global Notes  represented  thereby.<br \/>\nThe principal and interest on  Certificated  Notes,  if any, shall be payable at<br \/>\nthe office of the Paying  Agents.  The Paying  Agents  shall pay the Company any<br \/>\nexcess cash  remaining on deposit after all payments have been made with respect<br \/>\nto a given Interest Payment Date, Stated Maturity date,  Redemption Date, Change<br \/>\nof Control  Purchase Date or Excess  Proceeds  Payment Date, as the case may be.<br \/>\nAll payments made hereunder shall be in U.S. legal tender.<\/p>\n<p>Section 2.14.     &#8220;CUSIP&#8221; Number.<\/p>\n<p>                  The Company in issuing the Notes may use &#8220;CUSIP&#8221; number(s) and<br \/>\nthe  Trustee  shall use the  &#8220;CUSIP&#8221;  numbers(s)  in  notices of  redemption  or<br \/>\nexchange as a convenience to Holders;  provided that neither the Company nor the<br \/>\nTrustee shall have any  responsibility for any defect in the &#8220;CUSIP&#8221; number that<br \/>\nappears on any Note, check, advice or payment or redemption notice, and any such<br \/>\nnotice  may  state  that no  representation  is made  as to the  correctness  or<br \/>\naccuracy of the  &#8220;CUSIP&#8221;  number(s)  printed in the notice or on the Notes,  and<br \/>\nthat reliance may be placed only on the other identification  numbers printed on<br \/>\nthe Notes and any such  redemption  or  exchange  shall not be  affected  by any<br \/>\ndefect in or omission of such  number(s).  The Company shall promptly notify the<br \/>\nTrustee of any changes in &#8220;CUSIP&#8221; numbers.<\/p>\n<p>Section 2.15.     Depositary.<\/p>\n<p>                  (a) The Company  hereby  appoints DTC to act as depositary (in<br \/>\nsuch capacity,  together with its successors in such capacity, the &#8220;Depositary&#8221;)<br \/>\nwith  respect to the Global  Notes.  The Trustee  shall act as  custodian of the<br \/>\nGlobal Notes for the Depositary.  So long as the Depositary or its nominee, Cede<br \/>\n&amp; Co., is the registered  owner of the Global Notes,  it shall be considered the<br \/>\nHolder of the Notes represented thereby for all purposes hereunder and under the<br \/>\nGlobal Notes,  and neither any members of, or  participants  in, the  Depositary<br \/>\n(&#8220;Agent  Members&#8221;)  nor any other  Persons on whose behalf Agent Members may act<br \/>\nshall have any rights  hereunder  with  respect to the Global Notes or under the<br \/>\nGlobal Notes.  Notwithstanding  the foregoing,  nothing herein shall prevent the<br \/>\nCompany,  the  Trustee or any agent of the  Company or the  Trustee  from giving<br \/>\neffect to any written certification,  proxy or other authorization  furnished by<br \/>\nthe  Depositary  or its nominee,  as the case may be, or impair,  as between the<\/p>\n<p>                                       21<\/p>\n<p>Depositary,  its Agent  Members  and any other  Person on whose  behalf an Agent<br \/>\nMember may act, the operation of customary  practices of such Persons  governing<br \/>\nthe exercise of the rights of a Holder of any Note.<\/p>\n<p>                  (b) The Company may remove or replace DTC or any  successor as<br \/>\nDepositary  for  any  reason  upon  thirty  (30)  days&#8217;  notice  to DTC or  such<br \/>\nsuccessor. The Holders shall have no right to a depositary for the Notes.<\/p>\n<p>                  (c)  Notwithstanding  any other provision of this Indenture or<br \/>\nthe Notes, so long as DTC or its nominee is the registered owner of the Notes:<\/p>\n<p>                         (i) the provisions of the DTC Letter of Representations<br \/>\n                    shall  control over the  provisions of this  Indenture  with<br \/>\n                    respect to the matters covered thereby;<\/p>\n<p>                         (ii) presentation of Notes to the Trustee at redemption<br \/>\n                    or at maturity  shall be deemed made to the Trustee when the<br \/>\n                    right to exercise  ownership rights in the Notes through DTC<br \/>\n                    or Agent Members is transferred by DTC on its books; and<\/p>\n<p>                         (iii) DTC may present  notices,  approvals,  waivers or<br \/>\n                    other  communications  required or  permitted  to be made by<br \/>\n                    Holders under this  Indenture on a  fractionalized  basis on<br \/>\n                    behalf of some or all of those Persons  entitled to exercise<br \/>\n                    ownership rights in the Notes through DTC or Agent Members.<\/p>\n<p>Section 2.16.     Registration of Transfers and Exchanges.<\/p>\n<p>                  (a)  Transfer  and  Exchange  Generally.  (i)  The  Notes  are<br \/>\n         transferable  only  upon the  surrender  thereof  for  registration  of<br \/>\n         transfer.  When a  Note  is  presented  to  the  Registrar  with a duly<br \/>\n         executed  instrument of assignment  and transfer  substantially  in the<br \/>\n         form of  assignment  attached  to  Exhibit A or B, as  applicable,  the<br \/>\n         Registrar  shall  register the  transfer as requested if such  transfer<br \/>\n         complies with the provisions hereof.  Prior to the due presentation for<br \/>\n         registration  of  transfer  of any Note,  the Person in whose name such<br \/>\n         Note is registered  shall be treated as the absolute owner of such Note<br \/>\n         for the purpose of receiving payment of principal of, make-whole amount<br \/>\n         (if any) and  interest  on such Note  (whether  or not such  payment is<br \/>\n         overdue) and for all other  purposes  whatsoever,  notwithstanding  any<br \/>\n         notice to the  contrary.  Registration  of  transfer of any Note by the<br \/>\n         Registrar shall be deemed to be an  acknowledgment  of such transfer by<br \/>\n         the Company.<\/p>\n<p>                           (ii) When Notes are presented to the Registrar with a<br \/>\n         written  request to  exchange  such  Notes for Notes of any  authorized<br \/>\n         denominations and of a like aggregate  principal amount,  the Registrar<br \/>\n         shall make the exchange as requested if such exchange complies with the<br \/>\n         provisions of this Section 2.16(a).<\/p>\n<p>                           (iii)  Following any request for transfer or exchange<br \/>\n         of one or more Notes made in  compliance  with clauses (i) or (ii),  as<br \/>\n         the case may be, of this Section  2.16(a),  the Company shall  execute,<br \/>\n         and the Trustee shall  authenticate and deliver,  one or more new Notes<br \/>\n         of a like principal amount and in such authorized  denominations as may<br \/>\n         be requested.  Any exchange or transfer shall be without charge, except<br \/>\n         that the Company may require  payment by the Holder of a sum sufficient<br \/>\n         to cover any tax or other  governmental  charge  that may be<\/p>\n<p>                                       22<\/p>\n<p>          imposed in relation to a transfer or exchange  other than any exchange<br \/>\n          pursuant to Sections 2.10, 3.06, 4.12, 4.15 or 8.05 hereof.<\/p>\n<p>               (iv)  Transfers or  exchanges of the Global Notes and  beneficial<br \/>\n          interests  therein  shall be  subject  to the  provisions  of  Section<br \/>\n          2.16(b) and the rules of the  Depositary.  Transfers  or  exchanges of<br \/>\n          Certificated  Notes  shall be  subject  to the  provisions  of Section<br \/>\n          2.16(c).<\/p>\n<p>               (v) Except as  otherwise  provided  herein,  the Global Notes and<br \/>\n          each  Certificated Note shall bear the Private Placement Legend as set<br \/>\n          forth in Section  2.17.  By its  acceptance  of any Note  bearing  the<br \/>\n          Private Placement Legend, whether upon original issuance or subsequent<br \/>\n          transfer,  each Holder of such a Note acknowledges the restrictions on<br \/>\n          transfer of such Note set forth in this  Indenture  and in the Private<br \/>\n          Placement  Legend and agrees that it will  transfer  such Note only as<br \/>\n          provided in this  Indenture.  Upon the specific  written  request of a<br \/>\n          Holder to remove the Private  Placement  Legend,  the Registrar  shall<br \/>\n          authenticate  and deliver a Note with an equivalent  principal  amount<br \/>\n          not bearing the Private  Placement  Legend if there is provided to the<br \/>\n          Company evidence reasonably satisfactory to the Company (which may, at<br \/>\n          the Company&#8217;s request, include an Opinion of Counsel) that neither the<br \/>\n          Private  Placement  Legend nor the  restrictions on transfer set forth<br \/>\n          therein are required to ensure  compliance  with the  Securities  Act.<br \/>\n          Upon a written request for the registration of transfer or exchange of<br \/>\n          a Note bearing the Private  Placement  Legend pursuant to an effective<br \/>\n          registration statement under the Securities Act and in accordance with<br \/>\n          any applicable  securities laws of any state of the United States, the<br \/>\n          Registrar  shall  authenticate  and deliver a Note with an  equivalent<br \/>\n          principal  amount not  bearing the Private  Placement  Legend.  If the<br \/>\n          Private  Placement  Legend has been removed from a Note as provided in<br \/>\n          this clause (v), the transfer of such Note shall not be subject to the<br \/>\n          restrictions  on transfer set forth in the Private  Placement  Legend,<br \/>\n          and no other Note issued in exchange  for all or any part of such Note<br \/>\n          shall  bear the  Private  Placement  Legend  unless  the  Company  has<br \/>\n          reasonable  cause to  believe  that such  other  Note is a  Restricted<br \/>\n          Security and  instructs  the Registrar in writing to cause the Private<br \/>\n          Placement Legend to appear thereon.<\/p>\n<p>               (vi) None of the Company or the Trustee or the Registrar shall be<br \/>\n          liable for any delay by the Depositary in  identifying  the beneficial<br \/>\n          owners of the Notes,  and each such Person may  conclusively  rely on,<br \/>\n          and shall be protected in relying on, instructions from the Depositary<br \/>\n          for all  purposes  (including  with  respect to the  registration  and<br \/>\n          delivery,  and the respective  principal  amounts,  of any Notes to be<br \/>\n          issued).<\/p>\n<p>               (vii) Prior to the due  presentation for registration of transfer<br \/>\n          of any Note, the Company, the Trustee, the Paying Agent, the Registrar<br \/>\n          or any co-Registrar may deem and treat the Person in whose name a Note<br \/>\n          is  registered  as the absolute  owner of such Note for the purpose of<br \/>\n          receiving  payment of principal  of,  make-whole  amount,  if any, and<br \/>\n          interest,  if any, on such Note and for all other purposes whatsoever,<br \/>\n          whether  or not such Note is  overdue,  and none of the  Company,  the<br \/>\n          Trustee,  the Paying Agent, the Registrar or any co-Registrar shall be<br \/>\n          affected by notice to the contrary.  So long as the  Depositary or its<br \/>\n          nominee  is the  Holder  of a  Global  Note,  the  Depositary  or such<br \/>\n          nominee,  as the case may be,  will be  considered  the sole  owner or<br \/>\n          Holder of the Notes  represented  by such Global Note for all purposes<br \/>\n          hereunder and under the Notes.  Any Holder of a Global Note,  and each<br \/>\n          Person with an interest in such Global Note,  shall,  by acceptance of<br \/>\n          such  Global  Note or  such  interest,  agree  that  transfers  of the<br \/>\n          beneficial  interests in such Global Note may be effected only through<br \/>\n          a book-entry  system<\/p>\n<p>                                       23<\/p>\n<p>          maintained  by the Holder of such  Global Note (or its agent) and that<br \/>\n          ownership  of a  beneficial  interest  in such  Global  Note  shall be<br \/>\n          required to be reflected in a book entry.<\/p>\n<p>               (viii) Any Note issued upon any transfer or exchange  pursuant to<br \/>\n          this Section 2.16 will  evidence the same debt and will be entitled to<br \/>\n          the  same  benefits  and,  unless  otherwise   provided  for  in  this<br \/>\n          Indenture,  subject to the same  restrictions  under this Indenture as<br \/>\n          the Note or Notes surrendered upon such transfer or exchange.<\/p>\n<p>               (ix) The Registrar shall not be required to register the transfer<br \/>\n          of or exchange  any Note (A) selected  for  redemption  in whole or in<br \/>\n          part pursuant to Article 3, except the unredeemed  portion of any Note<br \/>\n          being redeemed in part, (B) for a period  beginning  fifteen (15) days<br \/>\n          before the  mailing of a notice of  redemption  of Notes and ending on<br \/>\n          the date of such  mailing  or (C)  between a Record  Date and the next<br \/>\n          succeeding Interest Payment Date.<\/p>\n<p>            (b)    Transfers  and  Exchanges of the Global Notes and  Beneficial<br \/>\n          Interests Therein.<br \/>\n               (i)  Subject  to  clauses  (ii)  through  (viii) of this  Section<br \/>\n          2.16(b),  transfers  of the Global Notes shall be limited to transfers<br \/>\n          in whole, but not in part, to the Depositary,  its successors or their<br \/>\n          respective  nominees.  So long as the Global Notes remain  outstanding<br \/>\n          and  are  held  by or on  behalf  of  the  Depositary,  transfers  and<br \/>\n          exchanges of beneficial interests in the Global Notes shall be made in<br \/>\n          accordance  with  the  provisions  of  this  Section  2.16(b)  and  in<br \/>\n          accordance  with the rules and  procedures  of the  Depositary  to the<br \/>\n          extent applicable (the &#8220;Applicable Procedures&#8221;).<\/p>\n<p>               (ii) No restrictions  shall apply with respect to the transfer or<br \/>\n          registration  of  transfer  of  (x)  a  beneficial   interest  in  the<br \/>\n          Restricted Global Note to a transferee that takes delivery in the form<br \/>\n          of a  beneficial  interest  in the  Restricted  Global  Note  or (y) a<br \/>\n          beneficial  interest in the  Regulation  S Global Note to a transferee<br \/>\n          that  takes  delivery  in the  form of a  beneficial  interest  in the<br \/>\n          Regulation S Global Note; provided that any transfer described in this<br \/>\n          clause  (ii)  shall  be  made  in  accordance   with  the   Applicable<br \/>\n          Procedures.<\/p>\n<p>               (iii) Any  transfer of a  beneficial  interest in the  Restricted<br \/>\n          Global Note to a transferee  that will take  delivery in the form of a<br \/>\n          beneficial  interest  in the  Regulation  S Global  Note  prior to the<br \/>\n          termination of the Regulation S Restricted Period shall be registered,<br \/>\n          subject to the  Applicable  Procedures,  only in accordance  with this<br \/>\n          clause (iii). At any time prior to the termination of the Regulation S<br \/>\n          Restricted   Period,   upon  (x)  receipt  by  the  Registrar  of  (A)<br \/>\n          instructions  given in accordance with the Applicable  Procedures from<br \/>\n          the  Depositary  or its nominee on behalf of an owner of a  beneficial<br \/>\n          interest in the  Restricted  Global Note to transfer  such  beneficial<br \/>\n          interest  to a  Person  that  will  take  delivery  in the  form  of a<br \/>\n          beneficial  interest in the  Regulation S Global  Note,  (B) a written<br \/>\n          order of the  Depositary or its nominee  given in accordance  with the<br \/>\n          Applicable  Procedures  containing  account and other information with<br \/>\n          respect to such  transfer and (C) a certificate  of the  transferor of<br \/>\n          the beneficial interest in the Restricted Global Note substantially in<br \/>\n          the form of  Exhibit D and (y)  satisfaction  of all other  applicable<br \/>\n          conditions  imposed by this Indenture and the  Applicable  Procedures,<br \/>\n          the  Registrar  shall  (1)  reflect  in the  register  for the Notes a<br \/>\n          decrease in the principal amount of the Restricted  Global Note and an<br \/>\n          increase in the principal amount of the Regulation S Global Note, each<br \/>\n          such  adjustment to be equal to the  beneficial  interest  transferred<br \/>\n          pursuant to this clause (iii) and (2) instruct the  Depositary to make<br \/>\n          the corresponding adjustment to its records<\/p>\n<p>                                       24<\/p>\n<p>          and debit the account of the  appropriate  Agent Members in accordance<br \/>\n          with the Applicable Procedures.<\/p>\n<p>               (iv) Any  transfer of a  beneficial  interest  in the  Restricted<br \/>\n          Global Note to a transferee  that will take  delivery in the form of a<br \/>\n          beneficial  interest in the Regulation S Global Note subsequent to the<br \/>\n          termination of the Regulation S Restricted Period shall be registered,<br \/>\n          subject to the  Applicable  Procedures,  only in accordance  with this<br \/>\n          clause  (iv).  At  any  time  subsequent  to  the  termination  of the<br \/>\n          Regulation S Restricted  Period,  upon (x) receipt by the Registrar of<br \/>\n          (A)  instructions  given in accordance with the Applicable  Procedures<br \/>\n          from  the  Depositary  or its  nominee  on  behalf  of an  owner  of a<br \/>\n          beneficial  interest in the  Restricted  Global Note to transfer  such<br \/>\n          beneficial interest to a Person that will take delivery in the form of<br \/>\n          a beneficial  interest in the  Regulation S Global Note, (B) a written<br \/>\n          order of the  Depositary or its nominee  given in accordance  with the<br \/>\n          Applicable  Procedures  containing  account and other information with<br \/>\n          respect to such  transfer and (C) a certificate  of the  transferor of<br \/>\n          the beneficial interest in the Restricted Global Note substantially in<br \/>\n          the form of Exhibit D (if  transfer is made in reliance on  Regulation<br \/>\n          S) or Exhibit E (if  transfer is made in reliance on Rule 144) and (y)<br \/>\n          satisfaction  of  all  other  conditions  imposed  by  the  Applicable<br \/>\n          Procedures,  the  Registrar  shall (1) reflect in the register for the<br \/>\n          Notes a decrease in the principal amount of the Restricted Global Note<br \/>\n          and an increase in the  principal  amount of the  Regulation  S Global<br \/>\n          Note,  each  such  adjustment  to equal  the  principal  amount of the<br \/>\n          beneficial interest  transferred pursuant to this clause (iv), and (2)<br \/>\n          instruct the  Depositary to make the  corresponding  adjustment to its<br \/>\n          records  and debit and credit the  accounts of the  appropriate  Agent<br \/>\n          Members in accordance with the Applicable Procedures.<\/p>\n<p>               (v) Any  transfer of a  beneficial  interest in the  Regulation S<br \/>\n          Global Note to a transferee  that will take  delivery in the form of a<br \/>\n          beneficial  interest in the  Restricted  Global Note,  either prior or<br \/>\n          subsequent to the  termination of the Regulation S Restricted  Period,<br \/>\n          shall be  registered,  subject to the Applicable  Procedures,  only in<br \/>\n          accordance  with this  clause (v). At any time upon (x) receipt by the<br \/>\n          Registrar of (A) instructions  given in accordance with the Applicable<br \/>\n          Procedures from the Depositary or its nominee on behalf of an owner of<br \/>\n          a beneficial interest in the Regulation S Global Note to transfer such<br \/>\n          beneficial interest to a Person that will take delivery in the form of<br \/>\n          a beneficial  interest in the  Restricted  Global Note,  (B) a written<br \/>\n          order of the  Depositary or its nominee  given in accordance  with the<br \/>\n          Applicable  Procedures  containing  account and other information with<br \/>\n          respect to such  transfer and (C) a certificate  of the  transferor of<br \/>\n          the beneficial  interest in the Regulation S Global Note substantially<br \/>\n          in the form of Exhibit C and (y)  satisfaction of all other conditions<br \/>\n          imposed by and the  Applicable  Procedures,  the  Registrar  shall (1)<br \/>\n          reflect  in the  register  for the Notes a decrease  in the  principal<br \/>\n          amount  of  the  Regulation  S  Global  Note  and an  increase  in the<br \/>\n          principal  amount of the Restricted  Global Note, each such adjustment<br \/>\n          to equal the principal amount of the beneficial  interest  transferred<br \/>\n          pursuant to this clause (v), and (2) instruct the  Depositary  to make<br \/>\n          the  corresponding  adjustment to its records and debit and credit the<br \/>\n          accounts  of the  appropriate  Agent  Members in  accordance  with the<br \/>\n          Applicable Procedures.<\/p>\n<p>               (vi) Any  transfer of a  beneficial  interest  in the  Restricted<br \/>\n          Global Note to a transferee that will take delivery in the form of one<br \/>\n          or  more  Certificated  Notes  shall  be  registered,  subject  to the<br \/>\n          Applicable  Procedures,  only in accordance  with this clause (vi). At<br \/>\n          any time upon (x) receipt by the Registrar of (A)  instructions  given<br \/>\n          in accordance  with the Applicable  Procedures  from the Depositary or<br \/>\n          its  nominee  on behalf of an owner of a<\/p>\n<p>                                       25<\/p>\n<p>          beneficial  interest in  the Restricted  Global Note  to transfer such<br \/>\n          beneficial interest to a Person that will take delivery in the form of<br \/>\n          one or more Certificated  Notes, (B) a written order of the Depositary<br \/>\n          or its nominee  given in  accordance  with the  Applicable  Procedures<br \/>\n          containing   account  and  other  information  with  respect  to  such<br \/>\n          transfer,  (C) a certificate of such Person  substantially in the form<br \/>\n          of Exhibit F and (D) unless the Restricted Global Note does not bear a<br \/>\n          Private  Placement  Legend,  an Opinion of Counsel to the effect  that<br \/>\n          such  transfer  is in  compliance  with the  Securities  Act,  and (y)<br \/>\n          satisfaction  of all  other  applicable  conditions  imposed  by  this<br \/>\n          Indenture and the Applicable  Procedures,  (1) the Registrar shall (A)<br \/>\n          reflect  in the  register  for the Notes a decrease  in the  principal<br \/>\n          amount  of the  Restricted  Global  Note  in an  amount  equal  to the<br \/>\n          beneficial interest  transferred  pursuant to this clause (vi) and (B)<br \/>\n          instruct the  Depositary to make the  corresponding  adjustment to its<br \/>\n          records  and debit the  account  of the  appropriate  Agent  Member in<br \/>\n          accordance with the Applicable  Procedures,  and (2) the Company shall<br \/>\n          execute and the Trustee shall authenticate and deliver to or on behalf<br \/>\n          of such Person one or more Certificated Notes of like tenor and amount<br \/>\n          and,  unless  the  Restricted  Global  Note  does not  bear a  Private<br \/>\n          Placement Legend, bearing the Private Placement Legend.<\/p>\n<p>               (vii) Any transfer of a beneficial  interest in the  Regulation S<br \/>\n          Global Note to a transferee that will take delivery in the form of one<br \/>\n          or more Certificated  Notes prior to the termination of the Regulation<br \/>\n          S Restricted  Period shall be  registered,  subject to the  Applicable<br \/>\n          Procedures,  only in accordance  with this clause  (vii).  At any time<br \/>\n          prior to the termination of the Regulation S Restricted  Period,  upon<br \/>\n          (x) receipt by the Registrar of (A)  instructions  given in accordance<br \/>\n          with the Applicable  Procedures  from the Depositary or its nominee on<br \/>\n          behalf of an owner of a beneficial interest in the Regulation S Global<br \/>\n          Note to transfer such  beneficial  interest to a Person that will take<br \/>\n          delivery in the form of one or more Certificated  Notes, (B) a written<br \/>\n          order of the  Depositary or its nominee  given in accordance  with the<br \/>\n          Applicable  Procedures  containing  account and other information with<br \/>\n          respect  to  such   transfer,   (C)  a  certificate   of  such  Person<br \/>\n          substantially  in the form of  Exhibit F and (D) an Opinion of Counsel<br \/>\n          to the effect that such transfer is in compliance  with the Securities<br \/>\n          Act  and (y)  satisfaction  of all  other  conditions  imposed  by the<br \/>\n          Applicable  Procedures,  (1) the  Registrar  shall (A)  reflect in the<br \/>\n          register  for the  Notes a  decrease  in the  principal  amount of the<br \/>\n          Regulation S Global Note in an amount equal to the beneficial interest<br \/>\n          transferred  pursuant  to  this  clause  (vii)  and (B)  instruct  the<br \/>\n          Depositary  to make the  corresponding  adjustment  to its records and<br \/>\n          debit the account of the  appropriate  Agent Member in accordance with<br \/>\n          the Applicable  Procedures,  and (2) the Company shall execute and the<br \/>\n          Trustee shall  authenticate and deliver to or on behalf of such Person<br \/>\n          one or more  Certificated  Notes of like tenor and amount  bearing the<br \/>\n          Private Placement Legend.<\/p>\n<p>               (viii)  Notwithstanding  any contrary provision contained herein,<br \/>\n          Certificated  Notes  shall be issued in  exchange  for the  beneficial<br \/>\n          interests in a Global Note if at any time: (x) the Company advises the<br \/>\n          Trustee in  writing  that the  Depositary  is  unwilling  or unable to<br \/>\n          continue as depositary  for such Global Note or is no longer  eligible<br \/>\n          to act as  such  and  in  each  case  a  successor  depositary  is not<br \/>\n          appointed  by the  Company  within  ninety (90) days of receipt by the<br \/>\n          Company of notice of such inability;  (y) the Company,  at its option,<br \/>\n          elects to terminate the book-entry  system through the Depositary with<br \/>\n          respect to such Global Note;  or (z) after the  occurrence of an Event<br \/>\n          of  Default,   beneficial  owners  holding  interests  representing  a<br \/>\n          majority of the aggregate  principal  amount of Notes  represented  by<br \/>\n          such Global Note advise the Trustee in writing  through the Depositary<br \/>\n          that the continuation of a book-entry system through the Depositary is<br \/>\n          no  longer  in  such  beneficial  owners&#8217;  best  interests.  Upon  the<br \/>\n          occurrence  of any<\/p>\n<p>                                       26<\/p>\n<p>          of the events set forth in clauses (x), (y) and (z) immediately above,<br \/>\n          the Trustee,  upon receipt of written notice thereof and a list of all<br \/>\n          Persons  that hold a beneficial  interest in such Global  Note,  shall<br \/>\n          notify,  through the  appropriate  Agent Members at the expense of the<br \/>\n          Company,  all Persons that hold a  beneficial  interest in such Global<br \/>\n          Note of the  issuance of  Certificated  Notes.  Upon  surrender by the<br \/>\n          Trustee,  as  custodian  for the  Depositary,  of such Global Note and<br \/>\n          receipt from the Depositary of instructions for  re-registration,  the<br \/>\n          Company shall execute and the Trustee,  upon the written  instructions<br \/>\n          of the Company,  shall authenticate and deliver  Certificated Notes of<br \/>\n          like tenor and amount  and,  unless  such  Global Note does not bear a<br \/>\n          Private  Placement  Legend,  bearing  the  Private  Placement  Legend.<br \/>\n          Certificated Notes issued in exchange for beneficial interests in such<br \/>\n          Global Note pursuant to this clause (viii) shall be registered in such<br \/>\n          names and in such authorized denominations as the Depositary, pursuant<br \/>\n          to  instructions  from Agent Members or otherwise,  shall instruct the<br \/>\n          Trustee.<\/p>\n<p>                  (c)  Transfers and Exchanges of  Certificated  Notes.  (i) Any<br \/>\n         transfer of a Certificated Note bearing the Private Placement Legend to<br \/>\n         a  transferee   that  takes  delivery  in  the  form  of  one  or  more<br \/>\n         Certificated  Notes shall be registered  only in  accordance  with this<br \/>\n         clause (i).  Upon (x)  surrender of any  Certificated  Note bearing the<br \/>\n         Private Placement Legend at the office of the Registrar,  together with<br \/>\n         (A) an executed  instrument  of assignment  of such  Certificated  Note<br \/>\n         substantially in the form of assignment  attached to such  Certificated<br \/>\n         Note,  (B) a certificate of the  transferee of such  Certificated  Note<br \/>\n         substantially in the form of Exhibit F and (C) an Opinion of Counsel to<br \/>\n         the effect that such transfer is in compliance  with the Securities Act<br \/>\n         and (y) satisfaction of all other applicable conditions imposed by this<br \/>\n         Indenture,  (1) the Trustee  shall  register  such transfer and (2) the<br \/>\n         Company shall execute and the Trustee shall authenticate and deliver in<br \/>\n         the  name of the  transferee  one or  more  Certificated  Notes  of any<br \/>\n         authorized  denomination in the same aggregate  principal amount and of<br \/>\n         the same maturity as the transferred  Certificated  Note, each such new<br \/>\n         Certificated  Note  bearing the  Private  Placement  Legend;  provided,<br \/>\n         however,  that Certificated Notes so delivered shall not be required to<br \/>\n         bear the Private  Placement  Legend if there is provided to the Company<br \/>\n         evidence  reasonably  satisfactory  to the  Company  (which may, at the<br \/>\n         Company&#8217;s  request,  include an Opinion of  Counsel)  that  neither the<br \/>\n         Private  Placement  Legend nor the  restrictions  on transfer set forth<br \/>\n         therein are required to ensure compliance with the Securities Act.<\/p>\n<p>                           (ii) Any transfer of a Certificated  Note not bearing<br \/>\n         the Private Placement Legend to a transferee that takes delivery in the<br \/>\n         form of one or more  Certificated  Notes  shall be  registered  only in<br \/>\n         accordance   with  this  clause  (ii).   Upon  (x)   surrender  of  any<br \/>\n         Certificated  Note not  bearing  the  Private  Placement  Legend at the<br \/>\n         office  of the  Registrar,  together  with an  executed  instrument  of<br \/>\n         assignment  of such  Certificated  Note  substantially  in the  form of<br \/>\n         assignment  attached to such Certificated Note, and (y) satisfaction of<br \/>\n         all other  applicable  conditions  imposed by this  Indenture,  (A) the<br \/>\n         Trustee shall  register such transfer and (B) the Company shall execute<br \/>\n         and the  Trustee  shall  authenticate  and  deliver  in the name of the<br \/>\n         transferee   one  or  more   Certificated   Notes  of  any   authorized<br \/>\n         denomination  in the same  aggregate  principal  amount and of the same<br \/>\n         maturity  as  the   transferred   Certificated   Note.  Each  such  new<br \/>\n         Certificated  Note may at the request of the transferee,  but shall not<br \/>\n         be required to, bear the Private Placement Legend.<\/p>\n<p>                           (iii) Any transfer of a Certificated Note bearing the<br \/>\n         Private  Placement  Legend to a transferee  that takes  delivery in the<br \/>\n         form of a beneficial interest in a Global Note shall be registered only<br \/>\n         in  accordance  with  this  clause  (iii).  Upon (x)  surrender  of any<\/p>\n<p>                                       27<\/p>\n<p>         Certificated Note bearing the Private Placement Legend at the office of<br \/>\n         the Registrar,  together with (A) an executed  instrument of assignment<br \/>\n         of such  Certificated  Note  substantially  in the  form of  assignment<br \/>\n         attached to such Certificated  Note, (B) written  instructions from the<br \/>\n         transferor that such  Certificated Note shall be registered in the name<br \/>\n         of  the  Depositary  or  its  nominee  and  (C) a  certificate  of  the<br \/>\n         transferor  of such  Certificated  Note  substantially  in the  form of<br \/>\n         Exhibit  D (if the  transferee  will  take  delivery  in the  form of a<br \/>\n         beneficial  interest in the  Regulation S Global Note) or Exhibit C (if<br \/>\n         the transferee will take delivery in the form of a beneficial  interest<br \/>\n         in the  Restricted  Global  Note),  and (y)  satisfaction  of all other<br \/>\n         applicable  conditions  imposed by this  Indenture  and the  Applicable<br \/>\n         Procedures,  the Registrar  shall (1) register such transfer and cancel<br \/>\n         such  Certificated  Note,  (2) reflect in the register for the Notes an<br \/>\n         increase  in the  appropriate  Global  Note in an  amount  equal to the<br \/>\n         Certificated  Note  transferred  pursuant to this clause  (iii) and (3)<br \/>\n         instruct the  Depositary  to make the  corresponding  adjustment to its<br \/>\n         records  and credit  the  account of the  appropriate  Agent  Member in<br \/>\n         accordance with the Applicable Procedures.<\/p>\n<p>                           (iv) Any transfer of a Certificated  Note not bearing<br \/>\n         the Private Placement Legend to a transferee that takes delivery in the<br \/>\n         form of a beneficial interest in a Global Note shall be registered only<br \/>\n         in  accordance   with  this  clause  (iv).  Upon  (x)  surrender  of  a<br \/>\n         Certificated  Note not  bearing  the  Private  Placement  Legend at the<br \/>\n         office of the  Registrar,  together with (A) an executed  instrument of<br \/>\n         assignment  of such  Certificated  Note  substantially  in the  form of<br \/>\n         assignment   attached  to  such   Certificated  Note  and  (B)  written<br \/>\n         instructions  from the transferor that such  Certificated Note shall be<br \/>\n         registered  in the  name  of the  Depositary  or its  nominee,  and (y)<br \/>\n         satisfaction  of  all  other  applicable  conditions  imposed  by  this<br \/>\n         Indenture  and the  Applicable  Procedures,  the  Registrar  shall  (1)<br \/>\n         register such transfer and cancel such  Certificated  Note, (2) reflect<br \/>\n         in the  register  for the Notes an  increase  in the Global  Note in an<br \/>\n         amount  equal to the  Certificated  Note  transferred  pursuant to this<br \/>\n         clause (iv) and (3) instruct the  Depositary to make the  corresponding<br \/>\n         adjustment  to it&#8217;s  records and credit the account of the  appropriate<br \/>\n         Agent Member in accordance with the Applicable Procedures.<\/p>\n<p>                           (v) Any  exchange of a  Certificated  Note for one or<br \/>\n         more Certificated Notes in different authorized  denominations shall be<br \/>\n         registered  only in accordance with this clause (v). Upon (x) surrender<br \/>\n         of a Certificated Note at the office of the Registrar,  together with a<br \/>\n         written  request to  exchange  such  Certificated  Note for one or more<br \/>\n         Certificated  Notes  in  different  authorized  denominations,  and (y)<br \/>\n         satisfaction  of  all  other  applicable  conditions  imposed  by  this<br \/>\n         Indenture,  (A) the Registrar  shall register such exchange and (B) the<br \/>\n         Company shall execute and the Trustee shall authenticate and deliver in<br \/>\n         the name of the registered owner one or more Certificated  Notes in any<br \/>\n         authorized  denomination  with the same aggregate  principal amount and<br \/>\n         maturity date.<\/p>\n<p>                           (vi)  Any  exchange  of a  Certificated  Note  for  a<br \/>\n         beneficial  interest  in a  Global  Note  shall be  registered  only in<br \/>\n         accordance  with this clause (vi). Upon (x) surrender of a Certificated<br \/>\n         Note at the  office  of the  Registrar,  together  with  (A) a  written<br \/>\n         request to exchange such Certificated Note for a beneficial interest in<br \/>\n         a Global Note, (B) written  instructions from the registered owner that<br \/>\n         such  Certificated  Note  shall  be  registered  in  the  name  of  the<br \/>\n         Depositary or its nominee and (C) a certificate of the registered owner<br \/>\n         of such  Certificated  Note  substantially in the form of Exhibit D (if<br \/>\n         the Certificated  Note is being exchanged for a beneficial  interest in<br \/>\n         the Regulation S Global Note) or Exhibit C (if the Certificated Note is<br \/>\n         being  exchanged  for a beneficial  interest in the  Restricted  Global<br \/>\n         Note)<\/p>\n<p>                                       28<\/p>\n<p>          and (y)  satisfaction of all other  applicable  conditions  imposed by<br \/>\n          this Indenture and the Applicable Procedures,  the Registrar shall (1)<br \/>\n          register such exchange and cancel such Certificated  Note, (2) reflect<br \/>\n          in the  register  for the Notes an increase in the  Restricted  Global<br \/>\n          Note in an amount equal to the Certificated Note exchanged pursuant to<br \/>\n          this  clause  (vi)  and  (3)  instruct  the  Depositary  to  make  the<br \/>\n          corresponding  adjustment to its records and credit the account of the<br \/>\n          appropriate Agent Member in accordance with the Applicable Procedures.<\/p>\n<p>Section 2.17.     Restrictive Legends.<\/p>\n<p>                  Each Note that  constitutes a Restricted  Security  shall bear<br \/>\nthe following legend (the &#8220;Private  Placement Legend&#8221;) on the face thereof until<br \/>\nFebruary  1, 2003,  unless  otherwise  agreed to by the  Company  and the Holder<br \/>\nthereof:<\/p>\n<p>                   THE  NOTE  (OR  ITS   PREDECESSORS)   EVIDENCED   HEREBY  WAS<br \/>\n         ORIGINALLY  ISSUED IN A  TRANSACTION  EXEMPT  FROM,  OR NOT SUBJECT TO,<br \/>\n         REGISTRATION  UNDER  SECTION 5 OF THE UNITED STATES  SECURITIES  ACT OF<br \/>\n         1933, AS AMENDED (THE &#8220;SECURITIES  ACT&#8221;), AND THE NOTE EVIDENCED HEREBY<br \/>\n         MAY NOT BE OFFERED,  SOLD OR  OTHERWISE  TRANSFERRED  IN THE ABSENCE OF<br \/>\n         SUCH  REGISTRATION  OR  AN  APPLICABLE  EXEMPTION  THEREFROM  OR  IN  A<br \/>\n         TRANSACTION NOT SUBJECT  THERETO.  EACH PURCHASER OF THE NOTE EVIDENCED<br \/>\n         HEREBY  IS  HEREBY  NOTIFIED  THAT THE  SELLER  MAY BE  RELYING  ON THE<br \/>\n         EXEMPTION  FROM THE  PROVISIONS  OF  SECTION  5 OF THE  SECURITIES  ACT<br \/>\n         PROVIDED  BY RULE  144A  THEREUNDER  OR  ANOTHER  EXEMPTION  UNDER  THE<br \/>\n         SECURITIES ACT. THE HOLDER OF THE NOTE EVIDENCED  HEREBY AGREES FOR THE<br \/>\n         BENEFIT OF THE  COMPANY  THAT (A) SUCH NOTE MAY BE  RESOLD,  PLEDGED OR<br \/>\n         OTHERWISE  TRANSFERRED  ONLY  (i)(a) TO A PERSON THE SELLER  REASONABLY<br \/>\n         BELIEVES  IS A QUALIFIED  INSTITUTIONAL  BUYER (AS DEFINED IN RULE 144A<br \/>\n         UNDER THE SECURITIES ACT) THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE<br \/>\n         ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT<br \/>\n         THE RESALE,  PLEDGE OR TRANSFER IS BEING MADE IN A TRANSACTION  MEETING<br \/>\n         THE  REQUIREMENTS  OF RULE 144A  UNDER  THE  SECURITIES  ACT,  (b) IN A<br \/>\n         TRANSACTION  MEETING THE  REQUIREMENTS OF RULE 144 UNDER THE SECURITIES<br \/>\n         ACT, (c) OUTSIDE THE UNITED STATES TO A FOREIGN PERSON IN A TRANSACTION<br \/>\n         MEETING  THE  REQUIREMENTS  OF  RULE  904 OF  REGULATION  S  UNDER  THE<br \/>\n         SECURITIES  ACT OR (d) IN ACCORDANCE  WITH ANOTHER  EXEMPTION  FROM THE<br \/>\n         REGISTRATION  REQUIREMENTS OF THE SECURITIES ACT,  PROVIDED THAT IN THE<br \/>\n         CASE OF A  TRANSFER,  PLEDGE OR SALE  PURSUANT  TO THIS CLAUSE (d) SUCH<br \/>\n         TRANSFER IS SUBJECT TO THE RECEIPT BY THE  REGISTRAR  (AND THE COMPANY,<br \/>\n         IF IT SO REQUESTS) OF A CERTIFICATION  OF THE TRANSFEROR AND AN OPINION<br \/>\n         OF COUNSEL TO THE EFFECT THAT SUCH TRANSFER IS IN  COMPLIANCE  WITH THE<br \/>\n         SECURITIES ACT, (ii) TO THE COMPANY OR ITS AFFILIATES OR (iii) PURSUANT<br \/>\n         TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT<\/p>\n<p>                                       29<\/p>\n<p>          AND, IN EACH CASE, IN ACCORDANCE  WITH ANY APPLICABLE  SECURITIES LAWS<br \/>\n          OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION<br \/>\n          AND THE  INDENTURE  GOVERNING  THE NOTES AND (B) THE HOLDER WILL,  AND<br \/>\n          EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER FROM IT OF<br \/>\n          THE NOTE EVIDENCED HEREBY OF THE RESALE  RESTRICTIONS SET FORTH IN (A)<br \/>\n          ABOVE.<\/p>\n<p>                  Each Global Note shall also bear the following legend:<\/p>\n<p>                  THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE<br \/>\n         HEREINAFTER  REFERRED TO AND IS  REGISTERED IN THE NAME OF A DEPOSITARY<br \/>\n         OR A NOMINEE OF A DEPOSITARY  OR A SUCCESSOR  DEPOSITARY.  THIS NOTE IS<br \/>\n         NOT  EXCHANGEABLE  FOR NOTES  REGISTERED  IN THE NAME OF A PERSON OTHER<br \/>\n         THAN THE DEPOSITARY OR ITS NOMINEE EXCEPT IN THE LIMITED  CIRCUMSTANCES<br \/>\n         DESCRIBED IN THE INDENTURE,  AND NO TRANSFER OF THIS NOTE (OTHER THAN A<br \/>\n         TRANSFER OF THIS NOTE AS A WHOLE BY THE  DEPOSITARY TO A NOMINEE OF THE<br \/>\n         DEPOSITARY  OR BY A NOMINEE  OF THE  DEPOSITARY  TO THE  DEPOSITARY  OR<br \/>\n         ANOTHER  NOMINEE OF THE  DEPOSITARY)  MAY BE  REGISTERED  EXCEPT IN THE<br \/>\n         LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE.<\/p>\n<p>                  TRANSFERS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS IN<br \/>\n         WHOLE,  BUT NOT IN PART, AND TRANSFERS OF INTERESTS IN THIS GLOBAL NOTE<br \/>\n         SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE  RESTRICTIONS<br \/>\n         SET FORTH IN SECTION 2.16 OF THE INDENTURE.<\/p>\n<p>                                    ARTICLE 3<\/p>\n<p>                                   REDEMPTION<\/p>\n<p>Section 3.01.     Notices to Trustee.<\/p>\n<p>                  If the Company  elects to redeem Notes pursuant to paragraph 6<br \/>\nof the Notes, at least 60 days prior to the Redemption Date or during such other<br \/>\nperiod as the  Trustee  may agree to, the  Company  shall  notify the Trustee in<br \/>\nwriting of the Redemption Date, the principal amount of Notes to be redeemed and<br \/>\nthe  Redemption  Price,  and  deliver to the  Trustee an  Officers&#8217;  Certificate<br \/>\nstating that such  redemption will comply with the conditions  contained  herein<br \/>\nand in the Notes, as appropriate.<\/p>\n<p>Section 3.02.     Selection of Notes To Be Redeemed.<\/p>\n<p>                  (a)      In  the event  that less than all of the Notes are to<br \/>\nbe redeemed at any time,  selection of the Notes to be redeemed shall be made by<br \/>\nthe Trustee on a pro rata basis,  by lot or by such method as the Trustee  shall<br \/>\ndeem fair and equitable;  provided, however, that no Notes of a principal amount<br \/>\nof  $1,000 or less  shall be  redeemed  in part;  provided,  further,  that if a<br \/>\npartial  redemption is made with the proceeds of any Equity Offering,  selection<br \/>\nof the Notes or  portions  thereof<\/p>\n<p>                                       30<\/p>\n<p>for  redemption  shall be made by the Trustee  only on a pro rata basis or on as<br \/>\nnearly a pro rata basis as is  practicable  (subject  to the  procedures  of the<br \/>\nDepositary),  unless such method is otherwise prohibited. The Trustee shall make<br \/>\nthe selection from the outstanding  Notes not previously  called for redemption.<br \/>\nThe Trustee shall  promptly  notify the Company in writing of the Notes selected<br \/>\nfor redemption  and, in the case of any Notes  selected for partial  redemption,<br \/>\nthe  principal  amount  of the Notes to be  redeemed.  In the event of a partial<br \/>\nredemption by lot, the Trustee shall select the particular  Notes to be redeemed<br \/>\nnot less than 30 nor more than 60 days  prior to the  relevant  Redemption  Date<br \/>\nfrom the Outstanding Notes not previously called for redemption. The Company may<br \/>\nredeem Notes in  denominations  of $1,000 only in whole.  The Trustee may select<br \/>\nfor redemption  portions (equal to $1,000 or any integral multiple of $1,000) of<br \/>\nthe principal of Notes that have denominations larger than $1,000. A new Note in<br \/>\na principal amount equal to the unredeemed portion thereof will be issued in the<br \/>\nname of the Holder  thereof  upon  delivery of the  original  Note to the Paying<br \/>\nAgent and  cancellation of the original Note. On and after the Redemption  Date,<br \/>\ninterest will cease to accrue on Notes or portions thereof called for redemption<br \/>\nas long as the Company has made a deposit  with the Paying  Agent in U.S.  legal<br \/>\ntender in  satisfaction  of the  applicable  Redemption  Price  pursuant to this<br \/>\nIndenture.<\/p>\n<p>                  (b)      For  all  purposes  of  this  Indenture,  unless  the<br \/>\ncontext otherwise requires, all provisions relating to redemption of Notes shall<br \/>\nrelate,  in the case of any Note redeemed or to be redeemed only in part, to the<br \/>\nportion  of the  principal  amount  of  that  Note  which  has  been or is to be<br \/>\nredeemed.<\/p>\n<p>Section 3.03.     Notice of Redemption.<\/p>\n<p>                  Notice of  redemption  shall be mailed by first  class mail at<br \/>\nleast 30 but not more than 60 calendar days before the  Redemption  Date to each<br \/>\nHolder of Notes to be redeemed at the registered  address of such Holder. If any<br \/>\nNote is to be redeemed in part only,  the notice of  redemption  that relates to<br \/>\nsuch  Note  shall  state the  portion  of the  principal  amount  thereof  to be<br \/>\nredeemed.  If the Company  elects to have the Trustee give notice of redemption,<br \/>\nthe Trustee  shall give  notice in the name of the Company and at the  Company&#8217;s<br \/>\nexpense;  provided,  however,  that the  Company  shall  furnish the Trustee all<br \/>\ninformation required to be contained in the notice.<\/p>\n<p>                    The notice shall identify the Notes to be redeemed and shall<br \/>\n               state:<\/p>\n<p>                    (1) the Redemption Date;<\/p>\n<p>                    (2) the Redemption Price and the amount of accrued interest,<br \/>\n               if any, to be paid;<\/p>\n<p>                    (3) whether or not the Company is redeeming all  outstanding<br \/>\n               Notes and if any Note is being  redeemed in part,  the portion of<br \/>\n               the principal  amount (equal to $1,000 in principal amount or any<br \/>\n               integral  multiple thereof) of such Note to be redeemed and that,<br \/>\n               on and after the Redemption  Date, upon surrender of such Note, a<br \/>\n               new Note or Notes in  principal  amount  equal to the  unredeemed<br \/>\n               portion thereof will be issued;<\/p>\n<p>                    (4) the name,  address  and  telephone  number of the Paying<br \/>\n               Agent;<\/p>\n<p>                    (5) that Notes called for redemption  must be surrendered to<br \/>\n               the  Paying  Agent at the  address  specified  in such  notice to<br \/>\n               collect the Redemption Price plus accrued interest, if any;<\/p>\n<p>                                       31<\/p>\n<p>                    (6)  that,   unless  the  Company  defaults  in  making  the<br \/>\n               redemption  payment,  interest  on Notes  called  for  redemption<br \/>\n               ceases to accrue  on and after the  Redemption  Date and the only<br \/>\n               remaining  right of the  Holders  is to  receive  payment  of the<br \/>\n               Redemption  Price plus accrued  interest to the  Redemption  Date<br \/>\n               upon surrender of the Notes to the Paying Agent;<\/p>\n<p>                    (7) the  subparagraph  of the  Notes  pursuant  to which the<br \/>\n               Notes called for redemption are being redeemed;<\/p>\n<p>                    (8) if fewer  than all the  Notes  are to be  redeemed,  the<br \/>\n               identification of the particular Notes (or portion thereof) to be<br \/>\n               redeemed,  as well as the aggregate  principal amount of Notes to<br \/>\n               be redeemed  and the  aggregate  principal  amount of Notes to be<br \/>\n               outstanding after such partial redemption; and<\/p>\n<p>                    (9) the CUSIP or ISIN number,  if any,  listed in the notice<br \/>\n               or printed on the Notes, and that no representation is made as to<br \/>\n               the accuracy or correctness of such CUSIP or ISIN number.<\/p>\n<p>Section 3.04.     Effect of Notice of Redemption.<\/p>\n<p>                  Once the notice of redemption described in Section 3.03 hereof<br \/>\nis mailed,  Notes called for redemption become due and payable on the Redemption<br \/>\nDate and at the Redemption Price,  including any make-whole amount, plus accrued<br \/>\ninterest to the  Redemption  Date, if any.  Upon  surrender to the Paying Agent,<br \/>\nsuch Notes  shall be paid at the  Redemption  Price,  including  any  make-whole<br \/>\namount,  plus accrued interest to the Redemption Date, if any;  provided that if<br \/>\nthe  Redemption  Date is  after a Record  Date  and on or prior to the  Interest<br \/>\nPayment  Date,  the  accrued  interest  shall be  payable  to the  Holder of the<br \/>\nredeemed Notes registered on the relevant Record Date.<\/p>\n<p>Section 3.05.     Deposit of Redemption Price.<\/p>\n<p>                  On or prior to 10:00 a.m., New York City time, on the relevant<br \/>\nRedemption  Date,  the Company  shall have  deposited  with the Paying  Agent in<br \/>\nimmediately  available funds U.S. legal tender  sufficient to pay the Redemption<br \/>\nPrice of and accrued interest, if any, on all Notes to be redeemed on that date.<br \/>\nThe Paying Agent shall return to the Company any money deposited with the Paying<br \/>\nAgent by the  Company in excess of the amount  necessary  to pay the  Redemption<br \/>\nPrice of and accrued interest, if any, on all Notes to be redeemed.<\/p>\n<p>                  On and  after  any  Redemption  Date,  if  U.S.  legal  tender<br \/>\nsufficient to pay the Redemption Price of and accrued interest, if any, on Notes<br \/>\ncalled for  redemption  shall have been made  available in  accordance  with the<br \/>\npreceding  paragraph,  the Notes  called  for  redemption  will  cease to accrue<br \/>\ninterest  and the only  right of the  Holders  of such  Notes will be to receive<br \/>\npayment of the Redemption  Price of and,  subject to the proviso in Section 3.04<br \/>\nhereof,  accrued and unpaid  interest on such Notes to the  Redemption  Date, if<br \/>\nany.  If any Note  called for  redemption  shall not be so paid,  interest  will<br \/>\ncontinue to accrue and be paid,  from the Redemption  Date until such redemption<br \/>\npayment is made,  on the unpaid  principal of the Note and any interest not paid<br \/>\non such unpaid  principal,  in each case, at the rate and in the manner provided<br \/>\nfor in Section 2.12 hereof.<\/p>\n<p>                                       32<\/p>\n<p>Section 3.06.     Notes Redeemed in Part.<\/p>\n<p>                  Upon surrender of a Note that is redeemed in part, the Company<br \/>\nshall execute and the Trustee shall authenticate, at the expense of the Company,<br \/>\nfor a Holder a new Note equal in principal  amount to the unredeemed  portion of<br \/>\nthe Note surrendered;  provided that each new Note will be in a principal amount<br \/>\nof $1,000 or an integral multiple of $1,000.<\/p>\n<p>                                    ARTICLE 4<\/p>\n<p>                                    COVENANTS<\/p>\n<p>Section 4.01.     Payment of Notes.<\/p>\n<p>                  The Company shall pay the principal of and interest (including<br \/>\nall Additional Interest as provided in the Registration Rights Agreement) on the<br \/>\nNotes on the dates and in the manner  provided in the Notes and this  Indenture.<br \/>\nAn installment of principal or interest shall be considered  paid on the date it<br \/>\nis due if the Trustee or Paying Agent holds, for the benefit of the Holders,  on<br \/>\nthat date money  designated for and  sufficient to pay such  installment in full<br \/>\nand is not  prohibited  from paying  such money to the  Holders  pursuant to the<br \/>\nterms of this Indenture.<\/p>\n<p>                  The  Company  shall pay  interest  on  overdue  principal  and<br \/>\ninterest on overdue  interest,  to the extent  lawful as provided for in Section<br \/>\n2.12 hereof.<\/p>\n<p>Section 4.02.     Reports.<\/p>\n<p>                  Whether or not  required by the rules and  regulations  of the<br \/>\nCommission,  so long as any Notes are  outstanding,  the Company shall file with<br \/>\nthe Commission,  to the extent such filings are accepted by the Commission,  and<br \/>\nshall  furnish  (within  15 days after such  filing) to the  Trustee  and to the<br \/>\nHolders all quarterly and annual  reports and other  information,  documents and<br \/>\nreports  that would be  required  to be filed with the  Commission  pursuant  to<br \/>\nSection 13 of the Exchange  Act if the Company were  required to file under such<br \/>\nsection.  In  addition,  the Company  shall make such  information  available to<br \/>\nprospective purchasers of the Notes,  securities analysts and broker-dealers who<br \/>\nrequest it in writing.  Delivery of such reports,  information  and documents to<br \/>\nthe Trustee is for informational purposes only and the Trustee&#8217;s receipt of such<br \/>\nshall not constitute constructive notice of any information contained therein or<br \/>\ndeterminable  from  information  contained  therein,   including  the  Company&#8217;s<br \/>\ncompliance  with any of its  covenants  hereunder  (as to which the  Trustee  is<br \/>\nentitled to rely exclusively on Officers&#8217; Certificates).<\/p>\n<p>Section 4.03.     Waiver of Stay, Extension or Usury Laws.<\/p>\n<p>                  The Company  covenants  (to the extent that it may lawfully do<br \/>\nso)  that it will  not at any time  insist  upon,  or  plead  (as a  defense  or<br \/>\notherwise)  or in any manner  whatsoever  claim or take the benefit or advantage<br \/>\nof, any stay or extension law or any usury law or other law which would prohibit<br \/>\nor forgive the  Company  from  paying all or any  portion of the  principal  of,<br \/>\nmake-whole amount, if any, and\/or interest on the Notes as contemplated  herein,<br \/>\nwherever enacted, now or at any time hereafter in force, or which may affect the<br \/>\ncovenants or the performance of this Indenture; and the Company<\/p>\n<p>                                       33<\/p>\n<p>hereby  expressly waives all benefit or advantage of any such law, and covenants<br \/>\nthat it will not  hinder,  delay or impede  the  execution  of any power  herein<br \/>\ngranted to the Trustee,  but will suffer and permit the  execution of every such<br \/>\npower as though no such law had been enacted.<\/p>\n<p>Section 4.04.     Compliance Certificate; Notice of Default; Tax Information.<\/p>\n<p>                  (a)      The  Company shall deliver to the Trustee,  within 90<br \/>\ndays after the end of the Company&#8217;s  fiscal year commencing with the fiscal year<br \/>\nending December 31, 2000, an Officers&#8217;  Certificate (one of the signers of which<br \/>\nshall  be the  principal  executive  officer,  principal  financial  officer  or<br \/>\nprincipal  accounting officer of the Company) stating that to the best of his or<br \/>\nher  knowledge  no  Default  or Event  of  Default  has  occurred,  listing  all<br \/>\nRestricted  Payments for such year,  and if a Default or Event of Default  shall<br \/>\nhave occurred,  describing all of such Defaults or Events of Default of which he<br \/>\nor she may have  knowledge  and what action the Company is taking or proposes to<br \/>\ntake with  respect  thereto.  The  Officers&#8217;  Certificate  shall also notify the<br \/>\nTrustee  should  the  Company  elect to change  the manner in which it fixes its<br \/>\nfiscal year end.<\/p>\n<p>                  (b)      The annual financial statements delivered pursuant to<br \/>\nSection 4.02 shall be accompanied  by a written report  addressed to the Trustee<br \/>\nof the Company&#8217;s  independent  accountants  (who shall be a firm of  established<br \/>\nnational reputation) that in conducting their audit of such financial statements<br \/>\nnothing  has come to their  attention  that would  lead them to  believe  that a<br \/>\nDefault or Event of Default has occurred  under this  Indenture  insofar as they<br \/>\nrelate to accounting matters or, if any such violation has occurred,  specifying<br \/>\nthe  nature and  period of  existence  thereof,  it being  understood  that such<br \/>\naccountants  shall not be liable  directly or  indirectly  to any Person for any<br \/>\nfailure to obtain knowledge of any such violation.<\/p>\n<p>                  (c)      If  (i) any Default or Event of Default has  occurred<br \/>\nand is continuing or (ii) any Holder seeks to exercise any remedy hereunder with<br \/>\nrespect to a claimed  default  under this  Indenture  or the Notes,  the Company<br \/>\nshall deliver to the Trustee,  at its address set forth in Section 11.02 hereof,<br \/>\nby  registered  or  certified  mail or by  telegram  or  facsimile  transmission<br \/>\nfollowed by hard copy by registered or certified  mail an Officers&#8217;  Certificate<br \/>\nspecifying such Default or Event of Default,  notice or other action, the status<br \/>\nthereof  and what  action  the  Company  is taking or  proposes  to take,  which<br \/>\nOfficers&#8217; Certificate shall be so delivered within five (5) Business Days of its<br \/>\nbecoming aware of such occurrence.<\/p>\n<p>Section 4.05.     Payment of Taxes and Other Claims.<\/p>\n<p>                  The  Company  shall  pay or  discharge  or cause to be paid or<br \/>\ndischarged,  before the same shall become  delinquent,  (i) all material  taxes,<br \/>\nassessments  and  governmental  charges  (including  withholding  taxes  and any<br \/>\npenalties,  interest and additions to taxes) levied or imposed upon it or any of<br \/>\nits  Subsidiaries  or properties of it or any of its  Subsidiaries  and (ii) all<br \/>\nlawful claims for labor,  materials and supplies  that, if unpaid,  might by law<br \/>\nbecome a Lien  upon the  property  of it or any of its  Subsidiaries;  provided,<br \/>\nhowever,  that the Company shall not be required to pay or discharge or cause to<br \/>\nbe paid or discharged  any such tax,  assessment,  charge or claim whose amount,<br \/>\napplicability  or  validity  is being  contested  in good  faith by  appropriate<br \/>\nproceedings  properly  instituted  and  diligently  conducted for which adequate<br \/>\nreserves, to the extent required under GAAP, have been taken.<\/p>\n<p>                                       34<\/p>\n<p>Section 4.06.     Corporate Existence.<\/p>\n<p>                  Subject to Article 5 hereof,  the Company shall do or cause to<br \/>\nbe done all things  necessary  to preserve and keep in full force and effect (i)<br \/>\nits corporate  existence,  and the corporate,  partnership or limited  liability<br \/>\ncompany or other existence of each Subsidiary, in accordance with the respective<br \/>\norganizational  documents (as the same may be amended from time to time) of each<br \/>\nSubsidiary  and the  material  rights  (charter  and  statutory),  licenses  and<br \/>\nfranchises  of the  Company  and its  Subsidiaries  except  where the failure to<br \/>\npreserve  and keep in full  force  and  effect  any such  rights,  licenses  and<br \/>\nfranchises shall not have a material adverse effect on the financial  condition,<br \/>\nbusiness, operations or prospects of the Company and its Subsidiaries taken as a<br \/>\nwhole;  and provided that the Company shall not be required to preserve any such<br \/>\nright,  license or  franchise,  or the  corporate,  limited  liability  company,<br \/>\npartnership  or other  existence  of any of the  Subsidiaries,  if the  Board of<br \/>\nDirectors of the Company shall  determine  that the  preservation  thereof is no<br \/>\nlonger  desirable  in  the  conduct  of the  business  of the  Company  and  its<br \/>\nSubsidiaries, taken as a whole.<\/p>\n<p>Section 4.07.     Maintenance of Office or Agency.<\/p>\n<p>                  The Company shall  maintain an office or agency in the Borough<br \/>\nof  Manhattan,  The  City  of New  York,  where  Notes  may be  surrendered  for<br \/>\nregistration of transfer or exchange or for  presentation  for payment and where<br \/>\nnotices  and  demands  to or upon the  Company  in respect of the Notes and this<br \/>\nIndenture  may be served.  The Company shall give prompt  written  notice to the<br \/>\nTrustee of the  location,  and any  change in the  location,  of such  office or<br \/>\nagency.  If at any time the  Company  shall fail to maintain  any such  required<br \/>\noffice or agency or shall fail to furnish the Trustee with the address  thereof,<br \/>\nsuch presentations, surrenders, notices and demands may be made or served at the<br \/>\naddress of the Trustee as set forth in Section 11.02 hereof.<\/p>\n<p>                  The Company may also from time to time  designate  one or more<br \/>\nother offices or agencies  where the Notes may be presented or  surrendered  for<br \/>\nany or all such  purposes and may from time to time  rescind such  designations.<br \/>\nThe Company shall give prompt written notice to the Trustee of such  designation<br \/>\nor  rescission  and of any change in the  location  of any such other  office or<br \/>\nagency.<\/p>\n<p>                  The Company hereby  initially  designates the Corporate  Trust<br \/>\nOffice of the  Trustee set forth in Section  11.02  hereof as such office of the<br \/>\nCompany in the Borough of Manhattan, The City of New York.<\/p>\n<p>Section 4.08.     Compliance with Laws.<\/p>\n<p>                  The  Company  shall  comply,  and  shall  cause  each  of  its<br \/>\nSubsidiaries to comply, with all applicable statutes, rules, regulations, orders<br \/>\nand  restrictions  of the  United  States of  America  and all  other  sovereign<br \/>\nnations,  all  states  and  municipalities  thereof,  and  of  any  governmental<br \/>\ndepartment,   commission,   board,  regulatory  authority,  bureau,  agency  and<br \/>\ninstrumentality of the foregoing,  in respect of the conduct of their respective<br \/>\nbusinesses  and the ownership of their  respective  properties,  except for such<br \/>\nnoncompliances  as would not in the aggregate have a material  adverse effect on<br \/>\nthe  financial  condition  or  results  of  operations  of the  Company  and its<br \/>\nSubsidiaries taken as a whole.<\/p>\n<p>                                       35<\/p>\n<p>Section 4.09.     Maintenance of Properties and Insurance.<\/p>\n<p>                  (a)      The Company shall cause all material properties owned<br \/>\nby or leased by it or any of its  Subsidiaries  used or useful to the conduct of<br \/>\nthe  Company&#8217;s  business  or the  business  of any  of  its  Subsidiaries  to be<br \/>\nmaintained and kept in normal  condition,  repair and working order and supplied<br \/>\nwith all necessary  equipment and shall cause to be made all necessary  repairs,<br \/>\nrenewals,  replacements,  betterments and  improvements  thereof,  all as in its<br \/>\njudgment  may be  necessary,  so that  the  business  carried  on in  connection<br \/>\ntherewith may be properly and advantageously  conducted at all times;  provided,<br \/>\nhowever,  that nothing in this Section 4.09 shall  prevent the Company or any of<br \/>\nits Subsidiaries from  discontinuing the use, operation or maintenance of any of<br \/>\nsuch properties, or disposing of any of them, if such discontinuance or disposal<br \/>\nis, in the  judgment of the Board of Directors of the Company or of the Board of<br \/>\nDirectors of the Subsidiary of the Company  concerned,  desirable in the conduct<br \/>\nof the business of the Company or any Subsidiary of the Company.<\/p>\n<p>                  (b)      The  Company  shall  maintain,  and  shall  cause the<br \/>\nSubsidiaries to maintain, insurance with responsible carriers against such risks<br \/>\nand in such amounts, and with such deductibles, retentions, self-insured amounts<br \/>\nand co-insurance provisions,  as, in the reasonable judgment of the Company, may<br \/>\nbe necessary.<\/p>\n<p>Section 4.10.     Limitation on Restricted Payments.<\/p>\n<p>                  The  Company  shall  not,  and  shall  not  permit  any of its<br \/>\nSubsidiaries,  directly or indirectly,  to make any Restricted Payment if at the<br \/>\ntime of such  Restricted  Payment:  (i) a Default or Event of Default shall have<br \/>\noccurred and be continuing or shall occur as a consequence  thereof;  (ii) after<br \/>\ngiving effect to the proposed Restricted Payment,  the amount of such Restricted<br \/>\nPayment,  when added to the  aggregate  amount of all  Restricted  Payments made<br \/>\nafter  September  25,  2000,  exceeds  the  sum  of:  (a)  50% of the  Company&#8217;s<br \/>\nConsolidated  Net Income  accrued  during the period (taken as a single  period)<br \/>\ncommencing on July 1, 1997 to and including the fiscal quarter ended immediately<br \/>\nprior to the date of such Restricted Payment (or, if such aggregate Consolidated<br \/>\nNet Income shall be a deficit,  minus 100% of such aggregate  deficit);  (b) the<br \/>\nnet cash  proceeds  from the issuance and sale of the  Company&#8217;s  Capital  Stock<br \/>\n(other than to a  Subsidiary  of the  Company)  that is not  Disqualified  Stock<br \/>\nduring the period (taken as a single period) commencing with the Issue Date; and<br \/>\n(c)  $50,000,000;  or (iii) the Company would not be able to incur an additional<br \/>\n$1.00 of Indebtedness pursuant to Section 4.11 hereof.<\/p>\n<p>                  Notwithstanding  the  foregoing,  the Company may: (w) pay any<br \/>\ndividend  within 60 days after the date of  declaration  thereof if the  payment<br \/>\nthereof  would have complied  with the  limitations  of this Section 4.10 on the<br \/>\ndate of  declaration;  (x) retire shares of the  Company&#8217;s  Capital Stock or the<br \/>\nCompany&#8217;s or a Subsidiary of the Company&#8217;s Indebtedness out of the proceeds of a<br \/>\nsubstantially  concurrent  sale (other than to a  Subsidiary  of the Company) of<br \/>\nshares of the Company&#8217;s Capital Stock (other than Disqualified  Stock); (y) make<br \/>\nInvestments in Joint  Ventures,  when added to the aggregate  amount of all such<br \/>\nother Investments made pursuant to this clause (y) (or such other Investments as<br \/>\nwould have been made pursuant to this clause (y) had such clause been in effect)<br \/>\nafter September 25, 2000, not exceeding at any time 5% of Consolidated  Tangible<br \/>\nAssets (with each such  Investment  being valued as of the date made and without<br \/>\nregard to subsequent changes in value); and (z) make Investments,  when added to<br \/>\nthe aggregate amount of all such other  Investments made pursuant to this clause<br \/>\n(z) (or such other  Investments  as would have been made pursuant to this clause<br \/>\n(z) had such clause been in effect) after  September 25, 2000,  not exceeding at<br \/>\nany time 2.5% of<\/p>\n<p>                                       36<\/p>\n<p>Consolidated  Tangible Assets (with each such Investment  being valued as of the<br \/>\ndate made and without regard to subsequent changes in value); provided, however,<br \/>\nthat each  Restricted  Payment  described  in clauses (w) and (x) above shall be<br \/>\ntaken into  account  for  purposes  of  computing  the  aggregate  amount of all<br \/>\nRestricted  Payments  pursuant  to  clause  (ii)  of the  immediately  preceding<br \/>\nparagraph.<\/p>\n<p>Section  4.11.  Limitation  on Additional Indebtedness and Subsidiary  Preferred<br \/>\n                Stock.<\/p>\n<p>                  (a)      After  the Issue Date, (i) the Company shall not, and<br \/>\nshall not permit any of its  Subsidiaries  to,  directly or indirectly,  create,<br \/>\nincur,  issue,  assume,  guarantee,  extend the Stated Maturity of, or otherwise<br \/>\nbecome  liable  with  respect  to  (collectively,   &#8220;incur&#8221;),  any  Indebtedness<br \/>\n(including,  without  limitation,  Acquired  Indebtedness)  and (ii) the Company<br \/>\nshall not permit any of its  Subsidiaries to issue (except to the Company or any<br \/>\nof its Wholly Owned  Subsidiaries)  or create any Preferred  Stock or permit any<br \/>\nPerson (other than the Company or a Wholly Owned  Subsidiary) to own or hold any<br \/>\ninterest in any Preferred Stock of any such Subsidiary;  provided, however, that<br \/>\nthe Company may incur  Indebtedness  and the Company may permit its Subsidiaries<br \/>\nto issue or  create  Preferred  Stock  if,  after  giving  effect  thereto,  the<br \/>\nCompany&#8217;s  EBITDA Coverage Ratio on the date thereof would be at least 2.5 to 1,<br \/>\ndetermined  on a pro  forma  basis  as if  the  incurrence  of  such  additional<br \/>\nIndebtedness  or the  issuance  of such  Preferred  Stock  (declared  to have an<br \/>\naggregate  principal  amount equal to the  aggregate  liquidation  value of such<br \/>\nPreferred  Stock),  as the case may be, and the  application of the net proceeds<br \/>\ntherefrom,  had  occurred at the  beginning of the  four-quarter  period used to<br \/>\ncalculate the Company&#8217;s EBITDA Coverage Ratio.<\/p>\n<p>                  (b)      Notwithstanding  the foregoing,  and  irrespective of<br \/>\nthe EBITDA Coverage Ratio, in addition to Existing Indebtedness: (i) the Company<br \/>\nmay incur  Indebtedness  pursuant to the Notes  issued on the Issue Date and the<br \/>\nExchange  Notes  issued in exchange  for such Notes;  (ii) the Company may incur<br \/>\nIndebtedness under the 2000 Credit Agreement in an aggregate principal amount at<br \/>\nany time not to exceed $400,000,000;  (iii) the Company and its Subsidiaries may<br \/>\nincur Refinancing  Indebtedness;  (iv) the Company may incur any Indebtedness to<br \/>\nany Subsidiary or any Subsidiary may incur any Indebtedness to the Company or to<br \/>\nany Subsidiary;  (v) the Company and its Subsidiaries may incur any Indebtedness<br \/>\nevidenced by letters of credit which are used in the ordinary course of business<br \/>\nof the Company and its  Subsidiaries to secure workers&#8217;  compensation  and other<br \/>\ninsurance coverages; (vi) the Company and its Subsidiaries may incur Capitalized<br \/>\nLease Obligations and Attributable Indebtedness, in each case excluding Existing<br \/>\nIndebtedness,  in an aggregate  principal amount at any one time outstanding not<br \/>\nto exceed 10% of Consolidated Tangible Assets; and (vii) the Subsidiaries of the<br \/>\nCompany may incur Indebtedness, excluding Existing Indebtedness, in an aggregate<br \/>\nprincipal amount at any time outstanding not to exceed $250,000,000, in addition<br \/>\nto  Indebtedness  permitted  to be  incurred  by  Subsidiaries  pursuant  to the<br \/>\nforegoing clauses (iii) &#8211; (vi).<\/p>\n<p>                  (c       Notwithstanding the foregoing, the Company may permit<br \/>\nany  Subsidiary  which is a  partnership  formed to operate a single  healthcare<br \/>\nfacility to issue or create Preferred Stock,  provided that the aggregate amount<br \/>\nof all such Preferred Stock  outstanding after giving effect to such issuance or<br \/>\ncreation shall not exceed 1% of  Consolidated  Tangible Assets as of the date of<br \/>\nsuch issuance or creation.<\/p>\n<p>                                       37<\/p>\n<p>Section 4.12.     Limitation on Asset Sales.<\/p>\n<p>                  (a)      The  Company  shall not,  and shall not permit any of<br \/>\nits  Subsidiaries  to,  consummate any Asset Sale unless (i) the Company or such<br \/>\nSubsidiary receives  consideration at the time of such Asset Sale at least equal<br \/>\nto the Fair  Market  Value of the  assets  included  in such  Asset  Sale,  (ii)<br \/>\nimmediately  before and  immediately  after giving effect to such Asset Sale, no<br \/>\nDefault or Event of Default shall have  occurred and be continuing  and (iii) at<br \/>\nleast  75% of the  consideration  received  by the  Company  or such  Subsidiary<br \/>\ntherefor is in the form of cash paid at the closing thereof, provided,  however,<br \/>\nthat this clause  (iii) shall not apply if,  after  giving  effect to such Asset<br \/>\nSale, the aggregate  principal  amount of all notes or similar debt  obligations<br \/>\nand Fair Market Value of all equity securities  received by the Company from all<br \/>\nAsset Sales  since  September  25,  2000 (other than such notes or similar  debt<br \/>\nobligations and such equity securities  converted into or otherwise  disposed of<br \/>\nfor cash and applied in accordance  with the second  succeeding  sentence) would<br \/>\nnot  exceed  2.5%  of  Consolidated   Tangible   Assets.   The  amount  (without<br \/>\nduplication) of any (x) Indebtedness  (other than Subordinated  Indebtedness) of<br \/>\nthe Company or such  Subsidiary  that is expressly  assumed by the transferee in<br \/>\nsuch Asset Sale and with respect to which the Company or such Subsidiary, as the<br \/>\ncase may be, is unconditionally  released by the holder of such Indebtedness and<br \/>\n(y) any notes,  securities or similar  obligations or items of property received<br \/>\nfrom such transferee that are  immediately  converted,  sold or exchanged by the<br \/>\nCompany  or such  Subsidiary  for cash (to the  extent of the cash  actually  so<br \/>\nreceived),  shall be deemed to be cash for purposes of this Section  4.12. If at<br \/>\nany time any non-cash  consideration received by the Company or such Subsidiary,<br \/>\nas the case may be, in connection  with any Asset Sale is converted into or sold<br \/>\nor otherwise  disposed of for cash (other than interest received with respect to<br \/>\nany  such  non-cash  consideration),   then  the  date  of  such  conversion  or<br \/>\ndisposition  shall be deemed to constitute  the date of an Asset Sale  hereunder<br \/>\nand the Net Proceeds  thereof shall be applied in  accordance  with this Section<br \/>\n4.12. A transfer of assets by the Company to a Wholly Owned  Subsidiary  or by a<br \/>\nWholly Owned  Subsidiary  to the Company or to another  Wholly Owned  Subsidiary<br \/>\nwill  not  be  deemed  to be an  Asset  Sale,  and a  transfer  of  assets  that<br \/>\nconstitutes a Restricted Payment and that is permitted under Section 4.10 hereof<br \/>\nwill not be deemed to be an Asset Sale.<\/p>\n<p>                  (b)      If the Company or any Subsidiary  engages in an Asset<br \/>\nSale, the Company or such  Subsidiary  shall,  no later than 360 days after such<br \/>\nAsset  Sale,  (i)  apply  all or any of the  Net  Proceeds  therefrom  to  repay<br \/>\nIndebtedness  that  ranks pari passu with the Notes and is secured by the assets<br \/>\ndisposed  of in the  Asset  Sale or to repay  Bank Debt in  accordance  with the<br \/>\napplicable  provisions thereof,  (ii) invest all or any part of the Net Proceeds<br \/>\ntherefrom  in the lines of business  of the  Company or any of its  Subsidiaries<br \/>\nimmediately prior to such investment or (iii) any combination of clauses (i) and<br \/>\n(ii) above.  The amount of such Net Proceeds not applied or invested as provided<br \/>\nin this paragraph (b) will constitute &#8220;Excess Proceeds.&#8221;<\/p>\n<p>                  (c)      When  the aggregate  amount of Excess Proceeds equals<br \/>\nor  exceeds  $5,000,000,  the  Company  shall  be  required  to make an offer to<br \/>\npurchase (an &#8220;Asset Sale Offer&#8221;) from all Holders, an aggregate principal amount<br \/>\nof Notes equal to the amount of such Excess Proceeds as follows:<\/p>\n<p>                  (i) The Company  shall make an Asset Sale Offer to all Holders<br \/>\n         in  accordance  with the  procedures  set forth in this Section 4.12 to<br \/>\n         purchase  the  maximum  principal  amount  (expressed  as a multiple of<br \/>\n         $1,000) of Notes that may be  purchased  out of the amount  (the &#8220;Asset<br \/>\n         Sale Payment Amount&#8221;) of such Excess Proceeds.<\/p>\n<p>                                       38<\/p>\n<p>                  (ii) The offer price for the Notes shall be payable in cash in<br \/>\n         an amount equal to 100% of the principal  amount of the Notes  tendered<br \/>\n         pursuant to such Asset Sale Offer, plus accrued and unpaid interest and<br \/>\n         Additional  Interest,  if any,  to the date such  Asset  Sale  Offer is<br \/>\n         consummated (the &#8220;Asset Sale Purchase  Price&#8221;),  in accordance with the<br \/>\n         procedures  set forth in this  Section  4.12.  To the  extent  that the<br \/>\n         aggregate  Asset Sale Purchase Price of Notes  tendered  pursuant to an<br \/>\n         Asset Sale Offer is less than the Asset Sale  Payment  Amount  relating<br \/>\n         thereto (such shortfall constituting a &#8220;Net Proceeds Deficiency&#8221;),  the<br \/>\n         Company may use such Net Proceeds Deficiency, or a portion thereof, for<br \/>\n         general corporate purposes.<\/p>\n<p>                  (iii) If the  aggregate  Asset  Sale  Purchase  Price of Notes<br \/>\n         validly tendered and not withdrawn by holders thereof exceeds the Asset<br \/>\n         Sale Payment  Amount,  Notes to be purchased shall be selected on a pro<br \/>\n         rata basis.<\/p>\n<p>                  (iv) Upon  completion  of such Asset Sale Offer in  accordance<br \/>\n         with the  foregoing  provisions,  the  amount of Excess  Proceeds  with<br \/>\n         respect  to which  such Asset Sale Offer was made shall be deemed to be<br \/>\n         zero.<\/p>\n<p>                  In the event that any other  Indebtedness of the Company which<br \/>\nranks pari passu with the Notes (&#8220;Other Debt&#8221;)  requires an offer to purchase to<br \/>\nbe made to repurchase  such Other Debt upon the  consummation  of an Asset Sale,<br \/>\nthe Company may apply the Excess  Proceeds to both  purchase such Other Debt and<br \/>\nto make an Asset Sale Offer,  provided,  that the  purchase  price of such Other<br \/>\nDebt does not exceed 100% of the aggregate  principal  amount or accreted  value<br \/>\nthereof plus interest thereon. With respect to any Excess Proceeds,  the Company<br \/>\nshall  make the Asset  Sale  Offer in  respect  thereof  at the same time as the<br \/>\nanalogous  offer to purchase is made pursuant to any Other Debt and the purchase<br \/>\ndate in  respect  thereof  shall be the  same as the  purchase  date in  respect<br \/>\nthereof pursuant to any Other Debt.<\/p>\n<p>                  With respect to any Asset Sale Offer effected pursuant to this<br \/>\nSection 4.12, to the extent the  aggregate  principal  amount of Notes and Other<br \/>\nDebt,  if any,  tendered  pursuant  to such Asset Sale Offer and the  concurrent<br \/>\noffer to purchase  with respect to such Other Debt exceeds the Excess  Proceeds,<br \/>\nsuch Notes and Other  Debt,  if any,  shall be  purchased  pro rata based on the<br \/>\naggregate  principal  amount of such Notes and such Other Debt  tendered by each<br \/>\nholder thereof.<\/p>\n<p>                  (d) If the  Company is  required  to make an Asset Sale Offer,<br \/>\nthe Company  shall,  within 30 days  following the date  specified in clause (c)<br \/>\nabove,  notify the Trustee  thereof and give  written  notice of such Asset Sale<br \/>\nOffer to each Holder by first-class  mail,  postage  prepaid,  at the address of<br \/>\nsuch Holder appearing in the register maintained by the Registrar, stating:<\/p>\n<p>                  (1)    that an Asset Sale Offer is being made pursuant to this<br \/>\n         Section 4.12;<\/p>\n<p>                  (2) that such Holders have the right to require the Company to<br \/>\n         apply the Excess  Proceeds to repurchase  the Notes at a purchase price<br \/>\n         in cash equal to 100% of the principal  amount thereof plus accrued and<br \/>\n         unpaid interest, if any, to the purchase date which shall be no earlier<br \/>\n         than 30 days and not later  than 60 days  from the date such  notice is<br \/>\n         mailed (the &#8220;Excess Proceeds Payment Date&#8221;);<\/p>\n<p>                  (3)    that any Note not tendered or accepted for payment will<br \/>\n         continue to accrue interest;<\/p>\n<p>                                       39<\/p>\n<p>                  (4) that any Notes accepted for payment  pursuant to the Asset<br \/>\n         Sale Offer shall  cease to accrue  interest  after the Excess  Proceeds<br \/>\n         Payment Date;<\/p>\n<p>                  (5) that  Holders  accepting  the  offer to have  their  Notes<br \/>\n         purchased  pursuant  to the  Asset  Sale  Offer  will  be  required  to<br \/>\n         surrender the Notes,  with the form entitled &#8220;Option of Holder to Elect<br \/>\n         Purchase&#8221; on the reverse of the Note completed,  to the Paying Agent at<br \/>\n         the address  specified  in the notice prior to the close of business on<br \/>\n         the Business Day preceding the Excess Proceeds Payment Date;<\/p>\n<p>                  (6) that Holders will be entitled to withdraw their acceptance<br \/>\n         of the Asset Sale Offer if the Paying  Agent  receives,  not later than<br \/>\n         the close of business on the third  Business Day  preceding  the Excess<br \/>\n         Proceeds  Payment Date, a telegram,  facsimile  transmission  or letter<br \/>\n         setting forth the name of the Holder, the principal amount of the Notes<br \/>\n         delivered for purchase and a statement  that such Holder is withdrawing<br \/>\n         his or her election to have such Notes purchased;<\/p>\n<p>                  (7)  that  if  the   aggregate   principal   amount  of  Notes<br \/>\n         surrendered by Holders exceeds the amount of Excess  Proceeds,  Company<br \/>\n         shall  select the Notes to be purchased on a pro rata basis so that the<br \/>\n         aggregate  amount of Notes so  purchased  equals  the  amount of Excess<br \/>\n         Proceeds  (with such  adjustments  as may be deemed  appropriate by the<br \/>\n         Company  so that only  Notes in  denominations  of  $1,000 or  integral<br \/>\n         multiples thereof shall be purchased);<\/p>\n<p>                  (8) that Holders whose Notes are being  purchased only in part<br \/>\n         will be issued new Notes equal in principal  amount to the  unpurchased<br \/>\n         portion of the Notes surrendered; provided that each Note purchased and<br \/>\n         each such new Note issued shall be in an original  principal  amount in<br \/>\n         denominations of $1,000 or integral multiples thereof;<\/p>\n<p>                  (9)  the calculations used in determining the amount of Excess<br \/>\n         Proceeds to be applied to the purchase of such Notes;<\/p>\n<p>                  (10) any other  procedures that a Holder must follow to accept<br \/>\n         an Asset Sale Offer or effect withdrawal of such acceptance; and<\/p>\n<p>                  (11)   the name and address of the Paying Agent.<\/p>\n<p>                  On the Excess Proceeds Payment Date, the Company shall, to the<br \/>\nextent  lawful,  (1)  accept  for  payment,  on a pro rata  basis to the  extent<br \/>\nnecessary,  Notes or portions thereof tendered pursuant to the Asset Sale Offer,<br \/>\n(2) deposit with the Paying Agent US legal tender sufficient to pay the purchase<br \/>\nprice plus accrued and unpaid interest,  if any, on the Notes to be purchased or<br \/>\nportions  thereof,  (3) deliver or cause to be delivered to the Trustee Notes so<br \/>\naccepted  together  with an  Officers&#8217;  Certificate  stating  that such Notes or<br \/>\nportions thereof were accepted for payment by the Company in accordance with the<br \/>\nterms of this Section 4.12.  The Paying Agent shall promptly mail to each Holder<br \/>\nso accepted payment in an amount equal to the purchase price for such Notes, and<br \/>\nthe Company shall execute and issue, and the Trustee shall promptly authenticate<br \/>\nand make  available  for delivery to such Holder,  a new Note equal in principal<br \/>\namount to any unpurchased  portion of the Notes surrendered;  provided that each<br \/>\nNote  purchased and each such new Note issued shall be in an original  principal<br \/>\namount in denominations of $1,000 or integral multiples thereof.<\/p>\n<p>                                       40<\/p>\n<p>                  (e) The Company  shall  comply with the  requirements  of Rule<br \/>\n14e-1  under  the  Exchange  Act  and  other  securities  laws  and  regulations<br \/>\nthereunder to the extent such laws and  regulations are applicable in connection<br \/>\nwith the repurchase of Notes pursuant to an Asset Sale Offer. To the extent that<br \/>\nthe provisions of any securities laws or regulations  conflict with this Section<br \/>\n4.12,  the  Company  shall  comply  with  the  applicable  securities  laws  and<br \/>\nregulations and shall not be deemed to have breached its obligations  under this<br \/>\nSection 4.12 by virtue thereof.<\/p>\n<p>Section 4.13.     Limitation on Transactions with Affiliates.<\/p>\n<p>                  Neither  the  Company  nor  any  of  its  Subsidiaries  shall,<br \/>\ndirectly or indirectly, in one transaction or a series of transactions, make any<br \/>\nloan, advance,  guarantee or capital  contribution to, or for the benefit of, or<br \/>\nsell,  lease,  transfer or otherwise  dispose of any of its properties or assets<br \/>\nto, or for the benefit of, or purchase or lease any property or assets from,  or<br \/>\nenter into or amend any contract,  agreement or  understanding  with, or for the<br \/>\nbenefit  of, any  Affiliate  of the  Company or any of its  Subsidiaries  or any<br \/>\nPerson  (or any  Affiliate  of such  Person)  holding  10% or more of the Common<br \/>\nEquity of the Company or any of its Subsidiaries, other than transactions in the<br \/>\nordinary course between the Company and its  Subsidiaries or among  Subsidiaries<br \/>\nof the  Company  (an  &#8220;Affiliate  Transaction&#8221;),  unless:  (i) the terms of such<br \/>\nAffiliate   Transactions  are  fair  and  reasonable  to  the  Company  or  such<br \/>\nSubsidiary, as the case may be, and are at least as favorable as the terms which<br \/>\ncould be obtained by the  Company or such  Subsidiary,  as the case may be, in a<br \/>\ncomparable  transaction  made  on an  arm&#8217;s-length  basis  between  unaffiliated<br \/>\nparties; (ii) with respect to any such Affiliate Transaction involving aggregate<br \/>\npayments in excess of $5,000,000,  the Company delivers an Officers&#8217; Certificate<br \/>\nto the Trustee certifying that such Affiliate  Transaction  complies with clause<br \/>\n(i) above and a Secretary&#8217;s  Certificate  which sets forth and  authenticates  a<br \/>\nresolution  that has been  adopted by a vote of a majority of the  disinterested<br \/>\nmembers of the Board of Directors  approving  such  Affiliate  Transaction;  and<br \/>\n(iii)  with  respect  to any  such  Affiliate  Transaction  involving  aggregate<br \/>\npayments  in excess of  $25,000,000,  the  Company  delivers  to the Trustee the<br \/>\ncertificates  specified  in clause  (ii) above and an opinion of an  independent<br \/>\ninvestment banking firm of national standing in the United States,  stating that<br \/>\nsuch Affiliate Transaction is fair from a financial point of view to the Company<br \/>\nor such Subsidiary,  as the case may be; provided,  however,  that the foregoing<br \/>\nclauses  (ii) and (iii) shall not apply to  transactions  between the Company or<br \/>\nany of its Subsidiaries and MedCenterDirect.com, Inc. or any entity to which the<br \/>\nCompany  transfers  all or  substantially  all of the rights to its  HEALTHSOUTH<br \/>\nClinical Automation Program.<\/p>\n<p>Section 4.14.     Limitation on Liens.<\/p>\n<p>                  The Company will not create or suffer to exist any Lien (other<br \/>\nthan Permitted Liens) on any of its assets, unless contemporaneously therewith:<\/p>\n<p>                  (i) in the case of any Lien securing an obligation  that ranks<br \/>\n         pari passu with the Notes,  effective  provision  is made to secure the<br \/>\n         Notes at least  equally  and ratably  with or prior to such  obligation<br \/>\n         with a Lien on the same collateral; and<\/p>\n<p>                  (ii) in the case of any Lien  securing an  obligation  that is<br \/>\n         subordinated in right of payment to the Notes,  effective  provision is<br \/>\n         made to secure  the Notes  with a Lien on the same  collateral  that is<br \/>\n         prior to the Lien securing such subordinated obligation.<\/p>\n<p>                                       41<\/p>\n<p>                  Notwithstanding  the above,  the Company may, without securing<br \/>\nthe Notes,  create or assume any  Indebtedness  which is secured by a Lien which<br \/>\nwould  otherwise be subject to the foregoing  restrictions,  provided that after<br \/>\ngiving effect thereto, the Exempted Debt then outstanding does not exceed 10% of<br \/>\nthe total  Consolidated  Tangible Assets of the Company and its  Subsidiaries at<br \/>\nsuch time.<\/p>\n<p>Section 4.15.     Purchase of Notes upon a Change of Control.<\/p>\n<p>                  (a) Upon the  occurrence  of a Change of Control,  the Company<br \/>\nshall be obligated to make an offer to purchase (the &#8220;Change of Control  Offer&#8221;)<br \/>\nthe outstanding  Notes of each Holder in whole or in part in integral  multiples<br \/>\nof $1,000,  at a purchase price (the &#8220;Change of Control Purchase Price&#8221;) in cash<br \/>\nin an  amount  equal  to 101% of the  principal  amount  thereof,  plus  accrued<br \/>\ninterest,  if any,  to the date of  purchase  (the  &#8220;Change of Control  Purchase<br \/>\nDate&#8221;), pursuant to the procedures set forth below.<\/p>\n<p>                  (b)  Within  30 days  following  any  Change of  Control,  the<br \/>\nCompany shall notify the Trustee  thereof and give written notice of such Change<br \/>\nof Control to each Holder by first-class mail,  postage prepaid,  at the address<br \/>\nof such Holder appearing in the register  maintained by the Registrar,  stating,<br \/>\namong other things:<\/p>\n<p>                    (1) that the Change of Control  Offer is being made pursuant<br \/>\n               to this Section 4.15;<\/p>\n<p>                    (2) that such  Holders have the right to require the Company<br \/>\n               to repurchase such Notes at the Change of Control  Purchase Price<br \/>\n               on the Change of Control  Purchase Date which shall be no earlier<br \/>\n               than 30 days and not later than 60 days from the date such notice<br \/>\n               is mailed;<\/p>\n<p>                    (3) that any Note not  tendered or accepted for payment will<br \/>\n               continue to accrue interest;<\/p>\n<p>                    (4) that,  unless the Company defaults in its payment of the<br \/>\n               Change of Control  Purchase Price,  any Note accepted for payment<br \/>\n               pursuant  to the Change of Control  Offer  shall  cease to accrue<br \/>\n               interest after the Change of Control Purchase Date;<\/p>\n<p>                    (5) that  Holders  accepting  the offer to have their  Notes<br \/>\n               purchased  pursuant to a Change of Control Offer will be required<br \/>\n               to surrender the Notes,  with the form entitled &#8220;Option of Holder<br \/>\n               to Elect Purchase&#8221; on the reverse of the Note  completed,  to the<br \/>\n               Paying Agent at the address  specified in the notice prior to the<br \/>\n               close of business on the  Business  Day  preceding  the Change of<br \/>\n               Control Purchase Date;<\/p>\n<p>                    (6)  that  Holders  will  be  entitled  to  withdraw   their<br \/>\n               acceptance  of the  Change of Control  Offer if the Paying  Agent<br \/>\n               receives,  not  later  than the  close of  business  on the third<br \/>\n               Business Day  preceding  the Change of Control  Purchase  Date, a<br \/>\n               telegram, facsimile transmission or letter setting forth the name<br \/>\n               of the Holder,  the principal  amount of the Notes  delivered for<br \/>\n               purchase and a statement that such Holder is  withdrawing  his or<br \/>\n               her election to have such Notes purchased;<\/p>\n<p>                    (7) any other procedures that a Holder must follow to accept<br \/>\n               an  Change  of  Control  Offer  or  effect   withdrawal  of  such<br \/>\n               acceptance; and<\/p>\n<p>                                       42<\/p>\n<p>                    (8) the name and address of the Paying Agent.<\/p>\n<p>                  On the Change of Control  Payment Date, the Company shall,  to<br \/>\nthe extent  lawful,  (1) accept for payment Notes or portions  thereof  tendered<br \/>\npursuant to the Change of Control Offer,  (2) deposit with the Paying Agent U.S.<br \/>\nlegal  tender  sufficient  to pay the  purchase  price of all Notes or  portions<br \/>\nthereof so  tendered  and (3)  deliver or cause to be  delivered  to the Trustee<br \/>\nNotes so accepted together with an Officers&#8217; Certificate stating that such Notes<br \/>\nor portions  thereof were  accepted for payment by the Company  pursuant to this<br \/>\nSection  4.15.  The Paying Agent shall  promptly mail to each Holder so accepted<br \/>\npayment in an amount equal to the purchase price for such Notes, and the Company<br \/>\nshall execute and issue, and the Trustee shall promptly authenticate and mail to<br \/>\nsuch Holder, a new Note equal in principal amount to any unpurchased  portion of<br \/>\nthe Notes  surrendered;  provided  that each such new Note shall be issued in an<br \/>\noriginal amount in denominations of $1,000 and integral multiples thereof.<\/p>\n<p>                  (c) The Company  shall  comply with the  requirements  of Rule<br \/>\n14e-1  under  the  Exchange  Act  and  other  securities  laws  and  regulations<br \/>\nthereunder to the extent such laws and  regulations are applicable in connection<br \/>\nwith the  repurchase  of Notes  pursuant  to a Change of Control  Offer.  To the<br \/>\nextent that the provisions of any securities  laws or regulations  conflict with<br \/>\nthis Section 4.15, the Company shall comply with the applicable  securities laws<br \/>\nand regulations  and shall not be deemed to have breached its obligations  under<br \/>\nthis Section 4.15 by virtue thereof.<\/p>\n<p>Section 4.16.     Limitation on Restrictions on Distributions from Subsidiaries.<\/p>\n<p>                  The  Company  shall  not,  and  shall  not  permit  any of its<br \/>\nSubsidiaries  to,  create  or  otherwise  cause or  suffer  to  exist or  become<br \/>\neffective any consensual  encumbrance or restriction (other than encumbrances or<br \/>\nrestrictions imposed by law or by judicial or regulatory action or by provisions<br \/>\nin leases or other  agreements that restrict the  assignability  thereof) on the<br \/>\nability of any  Subsidiary of the Company to (i) pay dividends or make any other<br \/>\ndistributions on its Capital Stock or any other interest or participation in, or<br \/>\nmeasured by, its profits, owned by the Company or any of its other Subsidiaries,<br \/>\nor pay interest on or principal of any  Indebtedness  owed to the Company or any<br \/>\nof its other Subsidiaries,  (ii) make loans or advances to the Company or any of<br \/>\nits other  Subsidiaries or (iii) transfer any of its properties or assets to the<br \/>\nCompany or any of its other  Subsidiaries,  in each case except for encumbrances<br \/>\nor  restrictions  existing  under or by reason of (a)  applicable  law,  (b) the<br \/>\nCredit  Agreements,  (c) Existing  Indebtedness,  (d) any restrictions under any<br \/>\nagreement evidencing any Acquired Indebtedness that was permitted to be incurred<br \/>\npursuant  to this  Indenture  and  which was not  incurred  in  anticipation  or<br \/>\ncontemplation of the related  acquisition,  provided that such  restrictions and<br \/>\nencumbrances  only apply to assets that were  subject to such  restrictions  and<br \/>\nencumbrances  prior to the  acquisition  of such  assets by the  Company  or its<br \/>\nSubsidiaries,  (e)  restrictions  or  encumbrances  replacing those permitted by<br \/>\nclause (b), (c) or (d) above which,  taken as a whole,  are not materially  more<br \/>\nrestrictive,  (f) this Indenture,  (g) any restrictions and encumbrances arising<br \/>\nin  connection  with  Refinancing  Indebtedness;  provided,  however,  that  any<br \/>\nrestrictions or encumbrances of the type described in this clause (g) that arise<br \/>\nunder such Refinancing  Indebtedness are not, taken as a whole,  materially more<br \/>\nrestrictive   than  those  under  the  agreement   creating  or  evidencing  the<br \/>\nIndebtedness being refunded or refinanced,  (h) any restrictions with respect to<br \/>\na  Subsidiary  of the Company  imposed  pursuant to an  agreement  that has been<br \/>\nentered into for the sale or other  disposition of all or  substantially  all of<br \/>\nthe Capital Stock or assets of such  Subsidiary,  (i) any agreement  restricting<br \/>\nthe  sale  or  other  disposition  of  property  securing  Indebtedness  if such<br \/>\nagreement does not expressly restrict the<\/p>\n<p>                                     43<\/p>\n<p>ability  of a  Subsidiary  of the  Company  to pay  dividends  or make  loans or<br \/>\nadvances  and (j)  customary  restrictions  in  purchase  money  debt or  leases<br \/>\nrelating to the property covered thereby.<\/p>\n<p>Section 4.17.     Limitations on Layering Indebtedness.<\/p>\n<p>                  The  Company  will  not,  and  will  not  permit  any  of  its<br \/>\nSubsidiaries to, directly or indirectly, incur any Indebtedness that purports to<br \/>\nbe by its terms  subordinated  to any other  Indebtedness of the Company or such<br \/>\nSubsidiary,  as the case may be,  unless  such  Indebtedness  is also  expressly<br \/>\nsubordinated  to the  Notes to the same  extent  and in the same  manner as such<br \/>\nIndebtedness is subordinated to such other Indebtedness.<\/p>\n<p>                                    ARTICLE 5<\/p>\n<p>                                SURVIVING ENTITY<\/p>\n<p>Section 5.01.     Limitations on Mergers and Consolidations.<\/p>\n<p>                  The Company  shall not  consolidate  or merge with or into, or<br \/>\nsell,  lease,  convey or otherwise  dispose of all or  substantially  all of its<br \/>\nassets, or assign any of its obligations  under the Notes or this Indenture,  to<br \/>\nany Person unless:  (i) the Person formed by or surviving such  consolidation or<br \/>\nmerger (if other than the Company), or to which such sale, lease,  conveyance or<br \/>\nother disposition or assignment shall be made  (collectively,  the &#8220;Successor&#8221;),<br \/>\nis a corporation  organized and existing  under the laws of the United States or<br \/>\nany State  thereof or the District of  Columbia,  and the  Successor  assumes by<br \/>\nsupplemental  indenture  in a  form  satisfactory  to  the  Trustee  all  of the<br \/>\nobligations of the Company under the Notes and this Indenture;  (ii) immediately<br \/>\nafter giving effect to such consolidation,  merger,  sale, lease,  conveyance or<br \/>\nother  disposition or assignment and the use of any net proceeds  therefrom on a<br \/>\npro forma  basis,  no  Default or Event of Default  shall have  occurred  and be<br \/>\ncontinuing; (iii) immediately after giving effect to such consolidation, merger,<br \/>\nsale,  lease,  conveyance or other  disposition or assignment and the use of any<br \/>\nnet proceeds  therefrom on a pro forma basis,  the Consolidated Net Worth of the<br \/>\nCompany or the  Successor,  as the case may be,  would be at least  equal to the<br \/>\nConsolidated  Net Worth of the Company  immediately  prior to such  transaction;<br \/>\n(iv) immediately after giving effect to such consolidation, merger, sale, lease,<br \/>\nconveyance or other  disposition  or assignment  and the use of any net proceeds<br \/>\ntherefrom on a pro forma basis,  the EBITDA Coverage Ratio of the Company or the<br \/>\nSuccessor,  as the case may be, would be such that the Company or the Successor,<br \/>\nas the case may be,  would be  entitled  to incur at least  $1.00 of  additional<br \/>\nIndebtedness  under the EBITDA  Coverage Ratio test in Section 4.11 hereof;  and<br \/>\n(v) the Company shall have delivered to the Trustee an Officers&#8217; Certificate and<br \/>\nan Opinion of Counsel,  each  stating  that such  consolidation,  merger,  sale,<br \/>\nlease,   conveyance  or  other  disposition  or  assignment  complies  with  the<br \/>\nprovisions of this Indenture.<\/p>\n<p>Section 5.02.     Successor Substituted.<\/p>\n<p>                  Upon any consolidation,  merger, conveyance or any transfer of<br \/>\nall or substantially all of the assets of the Company in accordance with Section<br \/>\n5.01 hereof, the surviving entity formed by such consolidation or into which the<br \/>\nCompany or any such Subsidiary is merged or to which such transfer is made shall<br \/>\nsucceed to, and be  substituted  for, and may exercise every right and power of,<br \/>\nthe<br \/>\n                                       44<\/p>\n<p>Company or such  Subsidiary,  as the case may be, under this  Indenture with the<br \/>\nsame  effect as if such  surviving  entity had been named as the Company or such<br \/>\nSubsidiary,  as the case may be herein,  and thereafter the  predecessor  entity<br \/>\nshall be relieved of all  obligations and covenants under this Indenture and the<br \/>\nNotes.<\/p>\n<p>                                    ARTICLE 6<\/p>\n<p>                              DEFAULTS AND REMEDIES<\/p>\n<p>Section 6.01.     Events of Default.<\/p>\n<p>                  An &#8220;Event of Default&#8221;  means each one of the following  events<br \/>\nwhich shall have occurred and be continuing  (whatever the reason for such Event<br \/>\nof Default and whether it shall be  voluntary or  involuntary  or be effected by<br \/>\noperation  of law or pursuant to any  judgment,  decree or order of any court or<br \/>\nany order, rule or regulation of any administrative or governmental body):<\/p>\n<p>                  (a) default in the payment of any installment of interest upon<br \/>\n         any of the Notes as and when the same shall become due and payable, and<br \/>\n         continuance of such default for a period of 30 days;<\/p>\n<p>                  (b)  default  in  the  payment  of  all  or  any  part  of the<br \/>\n         principal,  or  make-whole  amount,  if any, on any of the Notes as and<br \/>\n         when the  same  shall  become  due and  payable  either  at its  Stated<br \/>\n         Maturity, upon any redemption, by declaration or otherwise;<\/p>\n<p>                  (c)      failure by the Company to comply with its obligations<br \/>\n         or covenants  described under Section 4.12,  Section 4.15 or  Article 5<br \/>\n         hereof;<\/p>\n<p>                  (d)  failure  on the part of the  Company  duly to  observe or<br \/>\n         perform any other of the  covenants  or  agreements  on the part of the<br \/>\n         Company  in the  Notes or this  Indenture  (other  than  the  covenants<br \/>\n         referred to in clauses  (a), (b) and (c) above) for a period of 60 days<br \/>\n         after the date on which written notice specifying such failure, stating<br \/>\n         that such  notice is a &#8220;Notice of  Default&#8221;  under this  Indenture  and<br \/>\n         demanding  that the Company  remedy the same,  shall have been given by<br \/>\n         registered or certified mail, return receipt requested,  to the Company<br \/>\n         by the Trustee,  or to the Company and the Trustee by the holders of at<br \/>\n         least 25% in aggregate principal amount of the outstanding Notes;<\/p>\n<p>                  (e) default under any bond, debenture,  note or other evidence<br \/>\n         of indebtedness  for money borrowed by the Company or any Subsidiary of<br \/>\n         the Company or under any mortgage,  indenture or instrument under which<br \/>\n         there may be issued or by which there may be secured or  evidenced  any<br \/>\n         indebtedness for money borrowed by the Company or any Subsidiary of the<br \/>\n         Company,  whether such  indebtedness  now exists or shall  hereafter be<br \/>\n         created,  if (i) such default results in such indebtedness  becoming or<br \/>\n         being  declared  due and  payable  prior  to the date on which it would<br \/>\n         otherwise  become due and payable,  (ii) the  principal  amount of such<br \/>\n         indebtedness,  together  with the  principal  amount of any other  such<br \/>\n         indebtedness which has been so accelerated,  aggregates  $25,000,000 or<br \/>\n         more at any one time  outstanding  and (iii) such  indebtedness  is not<br \/>\n         discharged, or such acceleration is not rescinded or annulled, within a<\/p>\n<p>                                       45<\/p>\n<p>         period of 10 days after  there  shall have been given to the Company by<br \/>\n         the  Trustee or to the  Company  and the  Trustee by the  holders of at<br \/>\n         least 25% in  aggregate  principal  amount of the  outstanding  Notes a<br \/>\n         written  notice  specifying  such default and  requiring the Company to<br \/>\n         cause such  Indebtedness to be discharged or cause such acceleration to<br \/>\n         be rescinded or annulled;<\/p>\n<p>                  (f) a court having  jurisdiction in the premises shall enter a<br \/>\n         decree or order for relief in respect of the Company or any Significant<br \/>\n         Subsidiary  in an  involuntary  case under any  applicable  bankruptcy,<br \/>\n         insolvency  or  other  similar  law  now or  hereafter  in  effect,  or<br \/>\n         appointing  a  receiver,  liquidator,   assignee,  custodian,  trustee,<br \/>\n         sequestrator  or similar  official  of the  Company or any  Significant<br \/>\n         Subsidiary  for  any  substantial  part  of its or  their  property  or<br \/>\n         ordering the winding up or  liquidation  of its or their  affairs,  and<br \/>\n         such decree or order shall  remain  unstayed and in effect for a period<br \/>\n         of 60 consecutive days; or<\/p>\n<p>                  (g) the Company or any Significant Subsidiary shall commence a<br \/>\n         voluntary  case under any  applicable  bankruptcy,  insolvency or other<br \/>\n         similar law now or hereafter  in effect,  or consent to the entry of an<br \/>\n         order for relief in an involuntary  case under any such law, or consent<br \/>\n         to the  appointment  or taking  possession  by a receiver,  liquidator,<br \/>\n         assignee, custodian, trustee, sequestrator (or similar official) of the<br \/>\n         Company or any Significant Subsidiary or for any substantial part of it<br \/>\n         or their  property,  or make any general  assignment for the benefit of<br \/>\n         creditors.<\/p>\n<p>Section 6.02.     Acceleration.<\/p>\n<p>                  If an  Event  of  Default  (other  than an  Event  of  Default<br \/>\nspecified in Section  6.01(f) or 6.01(g)  hereof  relating to the Company) shall<br \/>\nhave occurred and be continuing  under this Indenture,  the Trustee,  by written<br \/>\nnotice to the  Company,  or the Holders of at least 25% in  aggregate  principal<br \/>\namount of the Notes then  outstanding  by written  notice to the Company and the<br \/>\nTrustee,  may declare all amounts  owing under the Notes to be due and  payable.<br \/>\nUpon effectiveness of such acceleration,  the aggregate principal of, make-whole<br \/>\namount, if any, and interest on the outstanding  Notes shall immediately  become<br \/>\ndue and payable.  At any time after such  acceleration  but before a judgment or<br \/>\ndecree based on such acceleration is obtained by the Trustee, or any Holder, the<br \/>\nHolders of a majority in aggregate  principal  amount of outstanding  Notes,  by<br \/>\nwritten  notice to the  Company  and the  Trustee,  may  rescind  and annul such<br \/>\nacceleration if:<\/p>\n<p>               (a) the  Company  has paid or  deposited  with the  Trustee a sum<br \/>\n          sufficient to pay:<\/p>\n<p>                    (1) all overdue interest on the Notes;<\/p>\n<p>                    (2) all unpaid principal of and make-whole  amount,  if any,<br \/>\n               on any of the  outstanding  Notes that has  become due  otherwise<br \/>\n               than by such  declaration of acceleration and interest thereon at<br \/>\n               the rate borne by the Notes;<\/p>\n<p>                    (3) to the extent that  payment of such  interest is lawful,<br \/>\n               interest upon overdue interest and overdue  principal at the rate<br \/>\n               borne by the Notes;<\/p>\n<p>                    (4) all sums paid or  advanced  by the  Trustee  under  this<br \/>\n               Indenture   and   the    reasonable    compensation,    expenses,<br \/>\n               disbursements  and  advances  of  the  Trustee,  its  agents  and<br \/>\n               counsel;<\/p>\n<p>                                       46<\/p>\n<p>               (b) all Events of Default,  other than the non-payment of amounts<br \/>\n          of principal of,  make-whole  amount, if any, or interest on the Notes<br \/>\n          that has become due solely by such declaration of  acceleration,  have<br \/>\n          been cured or waived; and<\/p>\n<p>               (c) in the  event of the cure or  waiver  of an Event of  Default<br \/>\n          with respect to the Company of the type  described in Section  6.01(f)<br \/>\n          or 6.01(g)  hereof,  the  Trustee  shall have  received  an  Officers&#8217;<br \/>\n          Certificate  and an Opinion of Counsel  that such Event of Default has<br \/>\n          been cured or waived.<\/p>\n<p>                  No such  rescission  shall  affect any  subsequent  Default or<br \/>\nimpair any right consequent thereto.<\/p>\n<p>                  In case an Event of Default with respect to the Company of the<br \/>\ntype described in Section  6.01(f) or 6.01(g) hereof shall occur,  the aggregate<br \/>\nprincipal of,  make-whole  amount, if any, and interest on the outstanding Notes<br \/>\nshall immediately become due and payable without any declaration or other act on<br \/>\nthe part of the Trustee or the Holders.<\/p>\n<p>Section 6.03.     Other Remedies.<\/p>\n<p>                  If an Event of Default occurs and is  continuing,  the Trustee<br \/>\nmay pursue any available remedy by proceeding at law or in equity to collect the<br \/>\npayment of principal of, or make-whole amount, if any, and interest on the Notes<br \/>\nor to enforce the  performance  of any provision of the Notes or this  Indenture<br \/>\nand may  take  any  necessary  action  requested  of it as  Trustee  to  settle,<br \/>\ncompromise, adjust or otherwise conclude any proceedings to which it is a party.<\/p>\n<p>                  The  Trustee  may  maintain a  proceeding  even if it does not<br \/>\npossess any of the Notes or does not produce  any of them in the  proceeding.  A<br \/>\ndelay or omission by the Trustee or any Holder in exercising any right or remedy<br \/>\naccruing  upon an Event of  Default  shall  not  impair  the  right or remedy or<br \/>\nconstitute  a waiver of or  acquiescence  in the Event of Default.  No remedy is<br \/>\nexclusive of any other  remedy.  All  available  remedies are  cumulative to the<br \/>\nextent permitted by law.<\/p>\n<p>Section 6.04.     Waiver of Existing Defaults and Events of Default.<\/p>\n<p>                  Subject to Sections  2.09,  6.02,  6.07 and 8.02  hereof,  the<br \/>\nHolders of a majority in principal amount of the Notes then outstanding have the<br \/>\nright to waive existing  Defaults  under or in compliance  with any provision of<br \/>\nthis  Indenture or the Notes  except a continuing  Default in the payment of the<br \/>\nprincipal of, or interest or make-whole amount, if any, on any Note as specified<br \/>\nin clauses  (a) and (b) of Section  6.01 hereof or in respect of a covenant or a<br \/>\nprovision which cannot be modified or amended without the consent of all Holders<br \/>\nas provided for in Section 8.02 hereof. The Company shall deliver to the Trustee<br \/>\nan Officers&#8217;  Certificate stating that the requisite  percentage of Holders have<br \/>\nconsented to such waiver and attach copies of such consents. In case of any such<br \/>\nwaiver,  the  Company,  the Trustee  and the Holders  shall be restored to their<br \/>\nformer  positions and rights hereunder and under the Notes,  respectively.  This<br \/>\nparagraph of this Section 6.04 shall be in lieu of ss.  316(a)(1)(B)  of the TIA<br \/>\nand such ss.  316(a)(1)(B)  of the TIA is hereby  expressly  excluded  from this<br \/>\nIndenture and the Notes, as permitted by the TIA.<\/p>\n<p>                  Upon any such waiver, such Default shall cease to exist and be<br \/>\ndeemed to have been  cured and not to have  occurred,  and any Event of  Default<br \/>\narising  therefrom  shall be deemed to have<\/p>\n<p>                                       47<\/p>\n<p>been cured and not to have occurred for every purpose of this Indenture,  but no<br \/>\nsuch waiver shall extend to any  subsequent or other Default or Event of Default<br \/>\nor impair any right consequent thereto.<\/p>\n<p>Section 6.05.     Control by Majority.<\/p>\n<p>                  Subject to Section 2.09  hereof,  the Holders of a majority in<br \/>\nprincipal  amount of the then  outstanding  Notes shall have the right to direct<br \/>\nthe time,  method and place of conducting  any  proceeding  for  exercising  any<br \/>\nremedy  available to the Trustee or exercising  any trust or power  conferred on<br \/>\nthe Trustee by this Indenture.  The Trustee,  however,  may refuse to follow any<br \/>\ndirection  that  conflicts  with  law or  this  Indenture  or that  the  Trustee<br \/>\ndetermines in its reasonable judgment may be unduly prejudicial to the rights of<br \/>\nanother Holder not taking part in such direction, and the Trustee shall have the<br \/>\nright to decline to follow any such  direction if the Trustee,  being advised by<br \/>\ncounsel,  determines that the action so directed may not lawfully be taken or if<br \/>\nthe  Trustee  in good  faith  shall,  by a Trust  Officer,  determine  that  the<br \/>\nproceedings so directed may involve it in personal liability;  provided that the<br \/>\nTrustee may take any other  action  deemed  proper by the  Trustee  which is not<br \/>\ninconsistent  with such direction.  In the event the Trustee takes any action or<br \/>\nfollows any direction pursuant to this Indenture,  the Trustee shall be entitled<br \/>\nto indemnification satisfactory to it in its sole discretion against any loss or<br \/>\nexpense caused by taking such action or following such  direction.  This Section<br \/>\n6.05  shall be in lieu of  Section  316(a)(1)(A)  of the TIA,  and such  Section<br \/>\n316(a)(1)(A) of the TIA is hereby expressly excluded from this Indenture and the<br \/>\nNotes, as permitted by the TIA.<\/p>\n<p>Section 6.06.     Limitation on Suits.<\/p>\n<p>                  Subject to  Section  6.07  hereof,  no Holder has any right to<br \/>\ninstitute any proceeding with respect to this Indenture or any remedy  hereunder<br \/>\nunless:<\/p>\n<p>                    (1)  the  Holder  gives  the  Trustee  written  notice  of a<br \/>\n               continuing Event of Default;<\/p>\n<p>                    (2) the  Holders  of at  least  25% in  aggregate  principal<br \/>\n               amount of the  outstanding  Notes  make a written  request to the<br \/>\n               Trustee to pursue the remedy;<\/p>\n<p>                    (3) such Holder or Holders  offer to the  Trustee  indemnity<br \/>\n               reasonably   satisfactory   to  the  Trustee  against  any  loss,<br \/>\n               liability  or expense  which may be incurred in  compliance  with<br \/>\n               such request;<\/p>\n<p>                    (4) the Trustee fails to institute such proceeding within 60<br \/>\n               calendar  days  after  receipt  of such  notice  and the offer of<br \/>\n               indemnity; and<\/p>\n<p>                    (5) the Trustee  has not  received  directions  inconsistent<br \/>\n               with  such  written  request  during  such  60-day  period by the<br \/>\n               Holders  of a  majority  in  aggregate  principal  amount of then<br \/>\n               outstanding Notes.<\/p>\n<p>                  A Holder may not use this Indenture to prejudice the rights of<br \/>\nanother Holder or to obtain a preference or priority over another Holder.<\/p>\n<p>                                       48<\/p>\n<p>Section 6.07.     Rights of Holders To Receive Payment.<\/p>\n<p>                  Notwithstanding  any other  provision of this  Indenture,  the<br \/>\nright of any Holder to receive payment of principal of, or make-whole amount, if<br \/>\nany,  or  accrued  interest  on any Note  held by such  Holder  on or after  the<br \/>\nrespective  due  dates  expressed  in  such  Note,  or to  bring  suit  for  the<br \/>\nenforcement of any such payment on or after such  respective  dates, is absolute<br \/>\nand  unconditional  (subject  to the terms of this  Indenture)  and shall not be<br \/>\nimpaired or affected without the consent of such Holder.<\/p>\n<p>Section 6.08.     Collection Suit by Trustee.<\/p>\n<p>                  If an Event of Default occurs and is  continuing,  the Trustee<br \/>\nmay recover  judgment in its own name and as trustee of an express trust against<br \/>\nthe Company for the whole amount of unpaid principal, make-whole amount, if any,<br \/>\nand accrued interest remaining unpaid, together with, to the extent that payment<br \/>\nof such  interest  is lawful,  interest  on overdue  principal  and  interest on<br \/>\noverdue installments of interest,  in each case at the rate set forth in Section<br \/>\n4.01 hereof,  and such further amounts as shall be sufficient to cover the costs<br \/>\nand expenses of  collection,  including the reasonable  compensation,  expenses,<br \/>\ndisbursements and advances of the Trustee, its agents and counsel.<\/p>\n<p>Section 6.09.     Trustee May File Proofs of Claim.<\/p>\n<p>                  The Trustee may file such proofs of claim and other  papers or<br \/>\ndocuments  as may be  necessary  or advisable in order to have the claims of the<br \/>\nTrustee  (including  any  claim  for  the  reasonable  compensation,   expenses,<br \/>\ndisbursements  and  advances of the  Trustee,  its agents and  counsel)  and the<br \/>\nHolders  allowed in any  judicial  proceedings  relative  to the Company (or any<br \/>\nother  obligor  upon the Notes),  its  creditors  or its  property  and shall be<br \/>\nentitled  and  empowered  to collect and  receive  any monies or other  property<br \/>\npayable  or  deliverable  on any such  claims and to  distribute  the same after<br \/>\ndeduction  of its charges and  expenses to the extent that any such  charges and<br \/>\nexpenses  are  not  paid  out of the  estate  in any  such  proceedings  and any<br \/>\ncustodian in any such judicial proceeding is hereby authorized by each Holder to<br \/>\nmake such  payments  to the  Trustee,  and in the event that the  Trustee  shall<br \/>\nconsent to the making of such  payments  directly to the Holders,  to pay to the<br \/>\nTrustee  any  amount  due  to it  for  the  reasonable  compensation,  expenses,<br \/>\ndisbursements and advances of the Trustee, its agents and counsel, and any other<br \/>\namounts due the Trustee under Section 7.07 hereof.<\/p>\n<p>                  Nothing  herein  contained  shall be deemed to  authorize  the<br \/>\nTrustee  to  authorize  or consent to or accept or adopt on behalf of any Holder<br \/>\nany plan or reorganization, arrangement, adjustment or composition affecting the<br \/>\nNotes or the rights of any Holder  thereof,  or to authorize the Trustee to vote<br \/>\nin respect of the claim of any Holder in any such proceedings.<\/p>\n<p>Section 6.10.     Priorities.<\/p>\n<p>                  If the Trustee  collects any money pursuant to this Article 6,<br \/>\nit shall pay out the money in the following order:<\/p>\n<p>                  FIRST:  to the  Trustee for  amounts  due under  Section  7.07<br \/>\nhereof;<\/p>\n<p>                  SECOND:  if the  Holders  are  forced to proceed  against  the<br \/>\nCompany directly without the Trustee, to Holders for their collection costs; and<\/p>\n<p>                                       49<\/p>\n<p>                  THIRD:  to Holders for amounts due and unpaid on the Notes for<br \/>\nprincipal,  make-whole amount, if any, and interest as to each, ratably, without<br \/>\npreference or priority of any kind,  according to the amounts due and payable on<br \/>\nthe Notes.<\/p>\n<p>                  The Trustee, upon prior written notice to the Company, may fix<br \/>\na Record  Date and  payment  date for any  payment to Holders  pursuant  to this<br \/>\nSection 6.10.<\/p>\n<p>Section 6.11.     Undertaking for Costs.<\/p>\n<p>                  In any suit for the  enforcement  of any right or remedy under<br \/>\nthis  Indenture  or in any suit  against  the  Trustee  for any action  taken or<br \/>\nomitted by it as Trustee,  a court in its  discretion  may require the filing by<br \/>\nany party  litigant in the suit of an  undertaking to pay the costs of the suit,<br \/>\nand  the  court  in  its  discretion  may  assess  reasonable  costs,  including<br \/>\nreasonable  attorneys&#8217; fees,  against any party litigant in the suit, having due<br \/>\nregard to the merits and good faith of the claims or defenses  made by the party<br \/>\nlitigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a<br \/>\nHolder  pursuant to Section 6.07 hereof or a suit by Holders of more than 10% in<br \/>\nprincipal amount of the Notes then outstanding.<\/p>\n<p>                                    ARTICLE 7<\/p>\n<p>                                     TRUSTEE<\/p>\n<p>Section 7.01.     Duties of Trustee.<\/p>\n<p>                  (a) If an Event of Default  actually  known to a Trust Officer<br \/>\nof the Trustee has occurred and is  continuing,  the Trustee shall exercise such<br \/>\nrights and powers vested in it by this Indenture and use the same degree of care<br \/>\nand  skill in their  exercise  as a  prudent  Person  would  exercise  under the<br \/>\ncircumstances in the conduct of such Person&#8217;s own affairs.<\/p>\n<p>                  (b) Except during the  continuance of a Default or an Event of<br \/>\nDefault:<\/p>\n<p>                  (1) The Trustee need perform only those duties and obligations<br \/>\nthat are specifically set forth in this Indenture.<\/p>\n<p>                  (2)   In the absence of bad faith on its part, the Trustee may<br \/>\n               conclusively  rely,  as to the  truth of the  statements  and the<br \/>\n               correctness of the opinions expressed therein,  upon certificates<br \/>\n               or  opinions  furnished  to the  Trustee  and  conforming  to the<br \/>\n               requirements  of this  Indenture  but,  in the  case of any  such<br \/>\n               certificates  or  opinions  which  by any  provision  hereof  are<br \/>\n               specifically required to be furnished to the Trustee, the Trustee<br \/>\n               shall be under a duty to examine the same to determine whether or<br \/>\n               not they conform to the requirements of this Indenture.<\/p>\n<p>                  (c) Notwithstanding anything to the contrary herein contained,<br \/>\nthe Trustee may not be relieved from liability for its own negligent action, its<br \/>\nown negligent failure to act, or its own willful misconduct, except that:<\/p>\n<p>                                       50<\/p>\n<p>                          (A)  This  paragraph  does not  limit  the  effect  of<br \/>\n          paragraph (b) of this Section 7.01.<\/p>\n<p>                          (B) The  Trustee  shall not be liable for any error of<br \/>\n          judgment made in good faith by a Trust Officer of the Trustee,  unless<br \/>\n          it is proved  that the  Trustee  was  negligent  in  ascertaining  the<br \/>\n          pertinent facts.<\/p>\n<p>                          (C) The Trustee  shall not be liable  with  respect to<br \/>\n          any action it takes or omits to take in good faith in accordance  with<br \/>\n          a direction  received by it pursuant to Sections  6.02,  6.04 and 6.05<br \/>\n          hereof.<\/p>\n<p>                  (d) No provision of this  Indenture  shall require the Trustee<br \/>\nto expend or risk its own funds or otherwise  incur any  financial  liability in<br \/>\nthe  performance  of any of its duties  hereunder or to take or omit to take any<br \/>\naction  under this  Indenture  or take any action at the request or direction of<br \/>\nHolders if it shall have reasonable grounds for believing that repayment of such<br \/>\nfunds is not assured to it or it does not receive from such Holders an indemnity<br \/>\nreasonably satisfactory to it against such risk, liability, loss, fee or expense<br \/>\nwhich might be incurred by it in compliance with such request or direction.<\/p>\n<p>                  (e) Whether or not  expressly so provided,  the  provisions of<br \/>\nthe TIA and  paragraphs  (a), (b), (c) and (d) of this Section 7.01 shall govern<br \/>\nevery provision of this Indenture that in any way relates to the Trustee.<\/p>\n<p>                  (f) The Trustee  shall not be liable for interest on any money<br \/>\nreceived  by it except as the  Trustee  may agree in writing  with the  Company.<br \/>\nMoney held in trust by the  Trustee  need not be  segregated  from  other  funds<br \/>\nexcept to the extent required by the law or as otherwise agreed to in writing by<br \/>\nthe Trustee and the Company.<\/p>\n<p>                  (g) Unless otherwise  specifically provided in this Indenture,<br \/>\nany demand,  request direction or notice from the Company shall be sufficient if<br \/>\nsigned by an Officer of the Company.<\/p>\n<p>Section 7.02.     Rights of Trustee.<\/p>\n<p>                  Subject to Section 7.01 hereof:<\/p>\n<p>                  (1) The Trustee may conclusively rely on any document believed<br \/>\nby it in good faith to be genuine  and to have been signed or  presented  by the<br \/>\nproper Person. The Trustee need not investigate any fact or matter stated in the<br \/>\ndocument.<\/p>\n<p>                  (2) Before the  Trustee  acts or  refrains  from  acting  with<br \/>\nrespect  to any  matters  contemplated  by this  Indenture  or the  Notes it may<br \/>\nrequire an Officers&#8217;  Certificate or an Opinion of Counsel, or both, which shall<br \/>\nconform to the  provisions of Section  11.05 hereof.  The Trustee shall be fully<br \/>\nprotected  and shall not be liable  for any  action it takes or omits to take in<br \/>\ngood faith in reliance on such Officers&#8217; Certificate or Opinion of Counsel.<\/p>\n<p>                  (3) The Trustee may act through agents, attorneys,  custodians<br \/>\nor nominees and shall not be responsible for the misconduct or negligence of any<br \/>\nagent, attorney, custodian or nominee appointed with due care by it hereunder.<\/p>\n<p>                                       51<\/p>\n<p>                  (4) The Trustee shall not be liable for any action it takes or<br \/>\nomits to take in good faith which it  reasonably  believes to be  authorized  or<br \/>\nwithin its rights or powers under this Indenture.<\/p>\n<p>                  (5) Before the  Trustee  acts or  refrains  from  acting  with<br \/>\nrespect to any matters  contemplated by this Indenture or the Notes, the Trustee<br \/>\nmay consult  with  counsel of its  selection,  and the advice or opinion of such<br \/>\ncounsel,  accountant,  appraiser or other  expert  adviser  whether  retained or<br \/>\nemployed by the Company or the Trustee shall be full and complete  authorization<br \/>\nand  protection  from  liability  in  respect of any  action  taken,  omitted or<br \/>\nsuffered by it hereunder in good faith and in reliance thereon.<\/p>\n<p>                  (6) The Trustee  shall not be bound to make any  investigation<br \/>\ninto the facts or  matters  stated in any  resolution,  certificate,  statement,<br \/>\ninstrument,  opinion, report, notice, request, direction,  consent, order, bond,<br \/>\ndebenture or other paper or document,  but the Trustee,  in its discretion,  may<br \/>\nmake such further inquiry or investigation  into such facts or matters as it may<br \/>\nsee fit, and if the Trustee  shall  determine in good faith to make such further<br \/>\ninquiry or investigation, it shall be entitled to examine the books, records and<br \/>\npremises of the Company,  personally or by agent or attorney at the sole cost of<br \/>\nthe Company and shall incur no liability or additional  liability of any kind by<br \/>\nreason of such inquiry or investigation.<\/p>\n<p>                  (7) In no event shall the Trustee be liable for the  selection<br \/>\nof investments or for investment losses incurred thereon. The Trustee shall have<br \/>\nno liability in respect of losses incurred as a result of the liquidation of any<br \/>\nsuch  investment  prior to its  Stated  Maturity  or the  failure  of the  party<br \/>\ndirecting such investment to provide timely written  investment  direction.  The<br \/>\nTrustee  shall  have no  obligation  to  invest or  reinvest  any  amounts  held<br \/>\nhereunder in the absence of specific written investment direction.<\/p>\n<p>                  (8)  The  rights,   privileges,   immunities  and  protections<br \/>\nafforded  to  the  Trustee  pursuant  to  this  Indenture  (including,   without<br \/>\nlimitation,  the right to be indemnified)  shall also be afforded to the Trustee<br \/>\nin  each  of  its  capacities  hereunder  and  each  Paying  Agent,   Registrar,<br \/>\nCo-Registrar,  Custodian, transfer agent or tender agent and each agent or other<br \/>\nPerson employed to act hereunder.<\/p>\n<p>                  (9) The  Trustee  shall not be  deemed  to have  notice of any<br \/>\nDefault or Event of Default  unless a Trust  Officer of the  Trustee  has actual<br \/>\nknowledge  thereof or unless written notice of any event which is in fact such a<br \/>\ndefault is received by the Trustee at the Corporate Trust Office of the Trustee,<br \/>\nand such notice references the Notes and this Indenture.<\/p>\n<p>                  (10) The  Trustee  may  request  that the  Company  deliver an<br \/>\nOfficers&#8217;  Certificate  setting forth the names of individuals  and\/or titles of<br \/>\nofficers  authorized  at such time to take  specified  actions  pursuant to this<br \/>\nIndenture, which Officers&#8217; Certificate may be signed by any person authorized to<br \/>\nsign an Officers&#8217;  Certificate,  including any person specified as so authorized<br \/>\nin any such certificate previously delivered and not superseded.<\/p>\n<p>Section 7.03.     Individual Rights of Trustee.<\/p>\n<p>                  The Trustee in its individual or any other capacity may become<br \/>\nthe owner or  pledgee  of Notes and may make  loans to,  accept  deposits  from,<br \/>\nperform  services for or  otherwise  deal with the  Company,  or any  Affiliates<br \/>\nthereof,  with the same rights it would have if it were not  Trustee.  Any<\/p>\n<p>                                       52<\/p>\n<p>Agent may do the same with like rights. The Trustee,  however,  shall be subject<br \/>\nto Sections 7.10 and 7.11 hereof.<\/p>\n<p>Section 7.04.     Trustee&#8217;s Disclaimer.<\/p>\n<p>                  The  Trustee  shall  not  be  responsible  for  and  makes  no<br \/>\nrepresentation  as to the validity or adequacy of this Indenture or the Notes or<br \/>\nany recitals  therein,  it shall not be accountable for the Company&#8217;s use of the<br \/>\nproceeds from the sale of Notes or any money paid to the Company pursuant to the<br \/>\nterms of this Indenture and it shall not be responsible for any statement in the<br \/>\nNotes other than its certificate of authentication.<\/p>\n<p>Section 7.05.     Notice of Defaults.<\/p>\n<p>                  If a Default or an Event of Default  occurs and is  continuing<br \/>\nand is known to a Trust  Officer of the Trustee,  the Trustee shall mail to each<br \/>\nHolder  notice of the  uncured  Default or Event of Default  within 5 days after<br \/>\nobtaining  knowledge  thereof.  Except in the case of a  Default  or an Event of<br \/>\nDefault in payment of principal of,  make-whole  amount, if any, or interest on,<br \/>\nany Note,  including an  accelerated  payment and the failure to make payment on<br \/>\nthe Change of Control  Payment Date  pursuant to a Change of Control Offer or on<br \/>\nthe Excess Proceeds  Payment Date pursuant to an Asset Sale Offer, and except in<br \/>\nthe case of a failure to comply with  Article 5 hereof the Trustee may  withhold<br \/>\nthe notice if and so long as a  committee  of its Trust  Officers  in good faith<br \/>\ndetermines  that  withholding the notice is in the best interest of the Holders.<br \/>\nThis Section 7.05 shall be in lieu of the proviso to Section  315(b) of the TIA,<br \/>\nand such proviso of Section 315(b) of the TIA is hereby expressly  excluded from<br \/>\nthis Indenture and the Notes, as permitted by the TIA.<\/p>\n<p>Section 7.06.     Reports by Trustee to Holders.<\/p>\n<p>                  If required by TIA Section 313(a), within 60 days after May 15<br \/>\nof any year,  commencing on May 15, 2001,  the Trustee shall transmit by mail to<br \/>\neach  Holder  a brief  report  dated as of such  May 15 that  complies  with TIA<br \/>\nSection 313(a). The Trustee also shall comply with the reporting requirements of<br \/>\nTIA Sections 313(b), (c) and (d).<\/p>\n<p>                  A copy of each  such  report  at the time of such  mailing  to<br \/>\nHolders  shall be mailed to the Company  and, if the Notes are listed on a stock<br \/>\nexchange,  filed with the  Commission and each stock exchange on which the Notes<br \/>\nare listed as provided by TIA Section 313(d).  The Company shall promptly notify<br \/>\nthe Trustee when the Notes are listed on any stock  exchange  and any  delisting<br \/>\nthereof.<\/p>\n<p>Section 7.07.     Compensation and Indemnity.<\/p>\n<p>                  The Company  shall pay to the  Trustee  from time to time such<br \/>\ncompensation  as may from time to time be agreed in writing  between the Company<br \/>\nand the Trustee for its  services  hereunder  (which  compensation  shall not be<br \/>\nlimited by any provision of law in regard to the compensation of a trustee of an<br \/>\nexpress trust). Except as otherwise provided herein, the Company shall reimburse<br \/>\nthe Trustee upon request for all reasonable disbursements, expenses and advances<br \/>\nincurred  or made by it in  connection  with its duties  under  this  Indenture,<br \/>\nincluding  the  reasonable  compensation,  disbursements  and  expenses  of  the<br \/>\nTrustee&#8217;s  agents,  counsel,  custodians  and  nominees,  except  for  any  such<br \/>\ndisbursement or expense as may be attributable to the Trustee&#8217;s negligence,  bad<br \/>\nfaith or willful misconduct.<\/p>\n<p>                                       53<\/p>\n<p>                  The  Company  shall  indemnify  each  of the  Trustee  and its<br \/>\nofficers,  directors,  employees and agents and any predecessor  Trustee and its<br \/>\nofficers,  directors,  employees  and agents for,  and hold it or them  harmless<br \/>\nagainst,  any and all loss,  damage,  claim,  liability or  reasonable  expense,<br \/>\nincluding taxes (other than franchise taxes and taxes based on the income of the<br \/>\nTrustee) incurred by it or them in connection with the acceptance or performance<br \/>\nof its duties under this Indenture and any other  documents and  transactions in<br \/>\nconnection  therewith  including the reasonable  costs and expenses of defending<br \/>\nitself against any claim (whether asserted by the Company,  or any Holder or any<br \/>\nother Person) or liability in connection with the exercise or performance of any<br \/>\nof its or their  powers  or duties  hereunder  (including,  without  limitation,<br \/>\nsettlement costs,  provided any settlement with respect to which indemnification<br \/>\nis sought shall have been consented to by the Company). The Trustee shall notify<br \/>\nthe Company in writing  promptly of any claim  asserted  against the Trustee for<br \/>\nwhich it may seek  indemnity.  However,  the failure by the Trustee to so notify<br \/>\nthe Company shall not relieve the Company of its obligations hereunder except to<br \/>\nthe extent the Company is  prejudiced  thereby.  This Section 7.07 shall survive<br \/>\nthe termination of this Indenture and the earlier  resignation or removal of the<br \/>\nTrustee.<\/p>\n<p>                  Notwithstanding the foregoing,  the Company need not reimburse<br \/>\nthe Trustee for any expense or indemnify it against any loss,  damage,  claim or<br \/>\nliability  incurred by the Trustee through its negligence,  bad faith or willful<br \/>\nmisconduct.  To secure the payment  obligations  of the Company in this  Section<br \/>\n7.07,  the Trustee shall have a lien prior to the Notes on all money or property<br \/>\nheld or collected by the Trustee  except such money or property held in trust to<br \/>\npay principal of and interest on particular Notes.<\/p>\n<p>                  When the Trustee incurs expenses or renders  services after an<br \/>\nEvent of Default  specified in Section  6.01(f) or 6.01(g)  hereof  occurs,  the<br \/>\nexpenses  (including the reasonable charges and expenses of its counsel) and the<br \/>\ncompensation   for  the  services  are  intended  to   constitute   expenses  of<br \/>\nadministration under any Federal or state bankruptcy, insolvency or similar law.<\/p>\n<p>                  The  obligation  of the Company  under this Section 7.07 shall<br \/>\nsurvive  the  resignation  or removal of the Trustee  and the  satisfaction  and<br \/>\ndischarge of this Indenture.<\/p>\n<p>Section 7.08.     Replacement of Trustee.<\/p>\n<p>                  The Trustee may resign by so notifying the Company in writing.<br \/>\nThe Holders of a majority in principal amount of the then outstanding  Notes may<br \/>\nremove the Trustee by notifying  the removed  Trustee and the Company in writing<br \/>\nand may appoint a successor  Trustee with the  Company&#8217;s  written  consent.  The<br \/>\nCompany may remove the Trustee at its election if:<\/p>\n<p>                    (1) the Trustee fails to comply with Section 7.10 hereof;<\/p>\n<p>                    (2) the Trustee is adjudged a bankrupt or an insolvent or an<br \/>\n               order for relief is entered with respect to the Trustee under any<br \/>\n               Bankruptcy Law;<\/p>\n<p>                    (3) a  receiver  or other  public  officer  takes  charge or<br \/>\n               control of the Trustee or its property or affairs; or<\/p>\n<p>                    (4) the Trustee otherwise becomes incapable of acting.<\/p>\n<p>                                       54<\/p>\n<p>                  If the Trustee resigns or is removed or if a vacancy exists in<br \/>\nthe office of Trustee  for any  reason,  the Company  shall  promptly  appoint a<br \/>\nsuccessor Trustee.<\/p>\n<p>                  No   resignation  or  removal  of  the  Trustee  shall  become<br \/>\neffective  until the acceptance of appointment  by the successor  Trustee.  If a<br \/>\nsuccessor Trustee does not take office within 30 days after the retiring Trustee<br \/>\nresigns or is removed,  the  retiring  Trustee,  the Company or the Holders of a<br \/>\nmajority in principal amount of the outstanding  Notes may petition any court of<br \/>\ncompetent  jurisdiction  at the expense of the Company for the  appointment of a<br \/>\nsuccessor Trustee.<\/p>\n<p>                  If the Trustee  fails to comply with Section 7.10 hereof,  any<br \/>\nHolder may petition any court of competent  jurisdiction  for the removal of the<br \/>\nTrustee and the  appointment  of a successor  Trustee if the Trustee fails after<br \/>\nwritten request thereof by such Holder to comply with such Section 7.10.<\/p>\n<p>                  A successor Trustee shall deliver a written  acceptance of its<br \/>\nappointment to the retiring  Trustee and to the Company.  Immediately  following<br \/>\nsuch delivery,  the resignation or removal of the retiring  Trustee shall become<br \/>\neffective and the retiring  Trustee  shall,  subject to its rights under Section<br \/>\n7.07  hereof,  transfer  all  property  held by it as Trustee  to the  successor<br \/>\nTrustee, and the successor Trustee, after any and all amounts then due and owing<br \/>\nthe Trustee hereunder have been paid in full, shall have all the rights,  powers<br \/>\nand duties of the Trustee under this Indenture.  A successor  Trustee shall mail<br \/>\nnotice of its  succession  to each Holder.  Notwithstanding  replacement  of the<br \/>\nTrustee pursuant to this Section 7.08, the Company&#8217;s  obligations  under Section<br \/>\n7.07 hereof shall continue for the benefit of the retiring Trustee.<\/p>\n<p>Section 7.09.     Successor Trustee by Consolidation, Merger or Conversion.<\/p>\n<p>                  If the Trustee  consolidates with, merges or converts into, or<br \/>\ntransfers all or  substantially  all of its corporate  trust assets to,  another<br \/>\ncorporation,  subject to Section 7.10 hereof, the successor  corporation without<br \/>\nany  further  act  shall be the  successor  Trustee.  In case at the  time  such<br \/>\nsuccessor or successors by merger,  conversion or  consolidation  to the Trustee<br \/>\nshall  succeed to the trusts  created by this  Indenture  any of the Notes shall<br \/>\nhave been authenticated but not delivered, any such successor to the Trustee may<br \/>\nadopt the certificate of authentication of any predecessor  trustee, and deliver<br \/>\nsuch Notes so authenticated; and in case at that time any of the Notes shall not<br \/>\nhave been authenticated, any such successor to the Trustee may authenticate such<br \/>\nNotes  either  in the name of any  predecessor  hereunder  or in the name of the<br \/>\nsuccessor to the Trustee; and in all such cases such certificates shall have the<br \/>\nfull force which it is anywhere in the Notes or in this Indenture  provided that<br \/>\nthe certificate of the Trustee shall have.<\/p>\n<p>Section 7.10.     Eligibility; Disqualification.<\/p>\n<p>                  This  Indenture  shall  always  have a Trustee  which shall be<br \/>\neligible to act as Trustee  under TIA  Sections  310(a)(1)  and  310(a)(2).  The<br \/>\nTrustee shall have a combined capital and surplus of at least $50,000,000 as set<br \/>\nforth in its most recent  published  annual report of condition.  If the Trustee<br \/>\nhas or shall  acquire  any  &#8220;conflicting  interest&#8221;  within  the  meaning of TIA<br \/>\nSection 310(b),  the Trustee and the Company shall comply with the provisions of<br \/>\nTIA Section  310(b);  provided,  however,  that there shall be excluded from the<br \/>\noperation of TIA Section 310(b)(1) any indenture or indentures under which other<br \/>\nsecurities or certificates of interest or  participation  in other securities of<br \/>\nthe Company are outstanding if the  requirements for such exclusion set forth in<br \/>\nTIA Section  310(b)(1)  are met.  If at any<\/p>\n<p>                                       55<\/p>\n<p>time the Trustee shall cease to be eligible in accordance with the provisions of<br \/>\nthis Section 7.10,  the Trustee shall resign  immediately in the manner and with<br \/>\nthe effect hereinbefore specified in this Article 7.<\/p>\n<p>Section 7.11.     Preferential Collection of Claims Against Company.<\/p>\n<p>                  The Trustee  shall comply with TIA Section  311(a),  excluding<br \/>\nany  creditor  relationship  listed in TIA  Section  311(b).  A Trustee  who has<br \/>\nresigned or been  removed  shall be subject to TIA Section  311(a) to the extent<br \/>\nindicated therein.<\/p>\n<p>                                    ARTICLE 8<\/p>\n<p>               MODIFICATIONS, AMENDMENTS, SUPPLEMENTS AND WAIVERS<\/p>\n<p>Section 8.01.     Without Consent of Holders.<\/p>\n<p>                  The Company,  when  authorized  by a Board  Resolution  of the<br \/>\nCompany,  and the Trustee may modify,  amend or supplement this Indenture or the<br \/>\nNotes without notice to or consent of any Holder:<\/p>\n<p>                    (1) to cure any  ambiguity,  or to correct or supplement any<br \/>\n               provision  in this  Indenture  or the  Notes  or make  any  other<br \/>\n               provisions  with  respect to matters or questions  arising  under<br \/>\n               this Indenture or the Notes;  provided  that, in each case,  such<br \/>\n               provisions  shall  not  adversely  affect  the  interest  of  the<br \/>\n               Holders;<\/p>\n<p>                    (2) to provide for uncertificated Notes in addition to or in<br \/>\n               place of certificated Notes;<\/p>\n<p>                    (3) to provide for the assumption by a successor corporation<br \/>\n               of the Company&#8217;s obligations under this Indenture;<\/p>\n<p>                    (4) to add guarantees with respect to the Notes;<\/p>\n<p>                    (5) to secure the Notes;<\/p>\n<p>                    (6) to add to the  covenants of the Company or the Events of<br \/>\n               Default for the benefit of Holders;<\/p>\n<p>                    (7)  to  surrender  any  right  or  power  conferred  on the<br \/>\n               Company; or<\/p>\n<p>                    (8) to make any other change that does not adversely  affect<br \/>\n               the rights of any Holder or to comply with any requirement of the<br \/>\n               Commission in connection with the qualification of this Indenture<br \/>\n               under the Trust Indenture Act.<\/p>\n<p>                                       56<\/p>\n<p>Section 8.02.     With Consent of Holders.<\/p>\n<p>                  Subject to Section  6.07  hereof,  the Company and the Trustee<br \/>\nmay modify,  amend or  supplement  this  Indenture or the Notes with the written<br \/>\nconsent of the Holders of a majority in principal amount of the then outstanding<br \/>\nNotes (including consents obtained in connection with a tender offer or exchange<br \/>\noffer for, or purchase of, the Notes). Subject to Sections 6.04 and 6.07 hereof,<br \/>\nthe Holders of a majority in principal amount of the then outstanding  Notes may<br \/>\nwaive  compliance  by the Company with any  provision  of this  Indenture or the<br \/>\nNotes. However,  without the consent of each Holder affected (including consents<br \/>\nobtained in  connection  with a tender offer or exchange  offer for, or purchase<br \/>\nof, the Notes),  a modification,  amendment,  supplement or waiver,  including a<br \/>\nwaiver pursuant to Section 6.04 hereof, may not:<\/p>\n<p>                  (1) change the Stated Maturity of the principal of, or<br \/>\n          any  installment  of  interest  on,  such Note or alter  the  optional<br \/>\n          redemption provisions thereof;<\/p>\n<p>                  (2) reduce the principal amount of, or make-whole  amount,  if<br \/>\n          any,  or interest  on, such Note or extend the time of payments  under<br \/>\n          the Notes;<\/p>\n<p>                  (3) modify the ranking of the Notes in a manner adverse to the<br \/>\n          Holder;<\/p>\n<p>                  (4) change the place or currency of payment of  principal  of,<br \/>\n          or make-whole amount, if any, or interest on, such Note;<\/p>\n<p>                  (5) alter the provisions with respect to the obligation of the<br \/>\n          Company to make a Change of Control Offer in  accordance  with Section<br \/>\n          4.15 hereof or to make an Asset Sale Offer in accordance  with Section<br \/>\n          4.12 hereof;<\/p>\n<p>                  (6) impair the right to institute suit for the  enforcement of<br \/>\n          any payment on or with respect to such Note; or<\/p>\n<p>                  (7) reduce the  percentage in principal  amount of outstanding<br \/>\n          Notes,  the consent of whose Holders is required for  modification  or<br \/>\n          amendment of this  Indenture or for waiver of compliance  with certain<br \/>\n          provisions  of this  Indenture  or for waiver of certain  Defaults  or<br \/>\n          Events of Default.<\/p>\n<p>                  After an  amendment,  supplement  or waiver under this Section<br \/>\n8.02 becomes  effective,  the Company shall mail to the Holders a notice briefly<br \/>\ndescribing  the amendment,  supplement or waiver.  Any failure of the Company to<br \/>\nmail such notice, or any defect therein,  shall not, however,  in any way impair<br \/>\nor affect the validity of any such supplemental indenture.<\/p>\n<p>                  Upon  the  request  of the  Company,  accompanied  by a  Board<br \/>\nResolution  authorizing the execution of any such  supplemental  indenture,  and<br \/>\nupon the  receipt by the  Trustee of  evidence  reasonably  satisfactory  to the<br \/>\nTrustee of the  consent  of the  Holders as  aforesaid  and upon  receipt by the<br \/>\nTrustee of the  documents  described in Section 8.06 hereof,  the Trustee  shall<br \/>\njoin with the Company in the  execution of such  supplemental  indenture  unless<br \/>\nsuch  supplemental  indenture  affects  the  Trustee&#8217;s  own  rights,  duties  or<br \/>\nimmunities  under  this  Indenture,  in which  case the  Trustee  may in its own<br \/>\ndiscretion,  but  shall  not be  obligated  to,  enter  into  such  supplemental<br \/>\nindenture.<\/p>\n<p>                                       57<\/p>\n<p>                  It shall not be necessary for the consent of the Holders under<br \/>\nthis Section  8.02 to approve the  particular  form of any  proposed  amendment,<br \/>\nsupplement or waiver,  but it shall be  sufficient if such consent  approves the<br \/>\nsubstance thereof.<\/p>\n<p>Section 8.03.     Compliance with TIA.<\/p>\n<p>                  Every  amendment  to or  supplement  of this  Indenture or the<br \/>\nNotes shall comply with the TIA as then in effect.<\/p>\n<p>Section 8.04.     Revocation and Effect of Consents.<\/p>\n<p>                  Until an amendment,  waiver or supplement becomes effective, a<br \/>\nconsent  to it by a Holder  is a  continuing  consent  by the  Holder  and every<br \/>\nsubsequent Holder of a Note or portion of a Note that evidences the same debt as<br \/>\nthe consenting Holder&#8217;s Note, even if notation of the consent is not made on any<br \/>\nNote. Subject to the following  paragraph,  any such Holder or subsequent Holder<br \/>\nmay  revoke  the  consent  as to such  Holder&#8217;s  Note or portion of such Note by<br \/>\nnotice to the  Trustee  or the  Company  received  before  the date on which the<br \/>\nTrustee  receives an Officers&#8217;  Certificate  certifying  that the Holders of the<br \/>\nrequisite  principal amount of Notes have consented (and not theretofore revoked<br \/>\nsuch consent) to the amendment, supplement or waiver.<\/p>\n<p>                  The Company may,  but shall not be obligated  to, fix a Record<br \/>\nDate for the  purpose of  determining  the  Holders  entitled  to consent to any<br \/>\namendment, supplement or waiver. If a Record Date is fixed, then notwithstanding<br \/>\nthe last sentence of the immediately preceding paragraph, those Persons who were<br \/>\nHolders at such Record Date (or their duly designated  proxies),  and only those<br \/>\nPersons,  shall be entitled to revoke any consent  previously given,  whether or<br \/>\nnot such Persons  shall  continue to be Holders  after such Record Date. No such<br \/>\nconsent  shall be valid or  effective  for more than 90 days after  such  Record<br \/>\nDate.<\/p>\n<p>                  After an amendment, supplement or waiver becomes effective, it<br \/>\nshall bind every  Holder,  unless it makes a change  described in any of clauses<br \/>\n(1) through (7) of Section 8.02 hereof, in which case, the amendment, supplement<br \/>\nor waiver  shall  bind only each  Holder of a Note who has  consented  to it and<br \/>\nevery  subsequent  Holder of a Note or portion of a Note that evidences the same<br \/>\ndebt as the consenting  Holder&#8217;s  Note;  provided that any such waiver shall not<br \/>\nimpair or affect the right of any Holder to receive  payment of principal of and<br \/>\ninterest on a Note, on or after the respective due dates expressed in such Note,<br \/>\nor to  bring  suit for the  enforcement  of any such  payment  on or after  such<br \/>\nrespective dates without the consent of such Holder.<\/p>\n<p>Section 8.05.     Notation on or Exchange of Notes.<\/p>\n<p>                  If an amendment,  supplement, or waiver changes the terms of a<br \/>\nNote,  the Trustee may request the Holder to deliver it to the Trustee.  In such<br \/>\ncase,  the  Trustee  shall place an  appropriate  notation on the Note about the<br \/>\nchanged terms and return it to the Holder. Alternatively,  if the Company or the<br \/>\nTrustee so  determine,  in exchange for the Note the Company shall issue and the<br \/>\nTrustee shall  authenticate a new Note that reflects the changed terms.  Failure<br \/>\nto make the  appropriate  notation  or issue a new Note  shall  not  affect  the<br \/>\nvalidity and effect of such amendment, supplement or waiver.<\/p>\n<p>                                       58<\/p>\n<p>Section 8.06.     Trustee To Sign Amendments, etc.<\/p>\n<p>                  The Trustee  shall be entitled to receive,  and shall be fully<br \/>\nprotected in relying  upon, an Officers&#8217;  Certificate  and an Opinion of Counsel<br \/>\nstating that the execution of any  amendment,  supplement  or waiver  authorized<br \/>\npursuant to this Article 8 is authorized or permitted by this Indenture and that<br \/>\nsuch amendment,  supplement or waiver  constitutes the legal,  valid and binding<br \/>\nobligation of the Company,  enforceable in accordance with its terms (subject to<br \/>\ncustomary  exceptions).  The Trustee may, but shall not be obligated to, execute<br \/>\nany such amendment, supplement or waiver which affects the Trustee&#8217;s own rights,<br \/>\nduties or immunities under this Indenture or otherwise.<\/p>\n<p>                                    ARTICLE 9<\/p>\n<p>                       DISCHARGE OF INDENTURE; DEFEASANCE<\/p>\n<p>Section 9.01.     Satisfaction and Discharge of Indenture.<\/p>\n<p>                  This  Indenture  shall be discharged  and shall cease to be of<br \/>\nfurther  effect  (except  those  obligations  referred  to  in  the  penultimate<br \/>\nparagraph of this Section 9.01) and the Trustee, on written demand of and at the<br \/>\nexpense  of  the  Company,   shall  execute  proper  instruments   acknowledging<br \/>\nsatisfaction and discharge of this Indenture, when either:<\/p>\n<p>                  (a) all Notes  theretofore  authenticated and delivered (other<br \/>\n         than (i) Notes which have been destroyed, lost or stolen and which have<br \/>\n         been replaced or paid as provided in Section 2.07 hereof and (ii) Notes<br \/>\n         for whose  payment  money has  theretofore  been  deposited in trust or<br \/>\n         segregated  and held in trust by the Company and  thereafter  repaid to<br \/>\n         the Company or discharged  from such trust) have been  delivered to the<br \/>\n         Trustee for cancellation; or<\/p>\n<p>                  (b) (i) either (A)  pursuant to Article 3 hereof,  the Company<br \/>\n         shall  have  given  notice  to the  Trustee  and  mailed  a  notice  of<br \/>\n         redemption  to each Holder of the  redemption of all of the Notes under<br \/>\n         arrangements  satisfactory to the Trustee for the giving of such notice<br \/>\n         or  (B)  all  Notes  not  theretofore  delivered  to  the  Trustee  for<br \/>\n         cancellation  have  become  due  and  payable;  (ii)  the  Company  has<br \/>\n         irrevocably  deposited  or caused to be  deposited  with the Trustee in<br \/>\n         trust for the purpose an amount in U.S. legal tender  sufficient to pay<br \/>\n         and discharge  the entire  Indebtedness  on such Notes not  theretofore<br \/>\n         delivered  to the  Trustee  for  cancellation,  for the  principal  of,<br \/>\n         make-whole  amount,  if any, and interest to the date of such  deposit;<br \/>\n         (iii) no Default or Event of Default with respect to this  Indenture or<br \/>\n         the Notes shall have  occurred  and be  continuing  on the date of such<br \/>\n         deposit or shall  occur as a result of such  deposit  and such  deposit<br \/>\n         will not result in a breach or  violation  of, or  constitute a default<br \/>\n         under, any other material instrument to which the Company is a party or<br \/>\n         by  which it is  bound  (other  than a  Default  or  Event  of  Default<br \/>\n         resulting  from the  incurrence  of  Indebtedness,  all or a portion of<br \/>\n         which  will  be  used to  defease  the  Notes  concurrently  with  such<br \/>\n         incurrence);  (iv) the  Company has paid or caused to be paid all other<br \/>\n         sums  payable  hereunder  by the  Company;  and  (v)  the  Company  has<br \/>\n         delivered  to the Trustee  (A)  irrevocable  instructions  to apply the<br \/>\n         deposited  money  toward  payment of the Notes at the  Stated  Maturity<br \/>\n         thereof,  and (B) an  Officers&#8217;  Certificate  and an Opinion of Counsel<br \/>\n         each stating that all conditions precedent herein provided for relating<br \/>\n         to the  satisfaction and discharge of this Indenture have been complied<\/p>\n<p>                                       59<\/p>\n<p>         with and that such  satisfaction  and  discharge  does not  result in a<br \/>\n         default under any material  agreement or instrument  then known to such<br \/>\n         counsel which binds or affects the Company.<\/p>\n<p>                  Notwithstanding   the  foregoing   paragraph,   the  Company&#8217;s<br \/>\nobligations  in Article 2 and Sections  4.01,  4.07,  7.07 and 8.06 hereof shall<br \/>\nsurvive until the Notes are no longer outstanding pursuant to the last paragraph<br \/>\nof Section 2.08 hereof.  After the Notes are no longer  outstanding  pursuant to<br \/>\nSection 2.08 hereof, the Company&#8217;s obligations under Section 7.07 and 8.06 shall<br \/>\nsurvive.<\/p>\n<p>                  After such delivery or irrevocable  deposit,  the Trustee upon<br \/>\nrequest shall acknowledge in writing the discharge of the Company&#8217;s  obligations<br \/>\nunder the Notes  and this  Indenture  except  for  those  surviving  obligations<br \/>\nspecified above.<\/p>\n<p>Section 9.02.     Legal Defeasance.<\/p>\n<p>                  (a) The Company  may, at its option by a Board  Resolution  of<br \/>\nthe Board of Directors of the Company,  at any time,  elect to have this Section<br \/>\n9.02 be applied to all outstanding Notes upon compliance with the conditions set<br \/>\nforth in Section 9.04 hereof.<\/p>\n<p>                  (b) Upon the Company&#8217;s  exercise under paragraph (a) hereof of<br \/>\nthe option  applicable to this paragraph (b), the Company shall,  subject to the<br \/>\nsatisfaction  of the conditions  set forth in Section 9.04 hereof,  be deemed to<br \/>\nhave been discharged from its obligations with respect to all outstanding  Notes<br \/>\non the date the  conditions set forth below are satisfied  (hereinafter,  &#8220;Legal<br \/>\nDefeasance&#8221;). For this purpose, Legal Defeasance means that the Company shall be<br \/>\ndeemed to have paid and  discharged the entire  Indebtedness  represented by the<br \/>\noutstanding Notes, which shall thereafter be deemed to be &#8220;outstanding&#8221; only for<br \/>\nthe  purposes of Section  9.05 hereof and the other  Sections of this  Indenture<br \/>\nreferred to in clauses (i) and (ii) below,  and to have  satisfied all its other<br \/>\nobligations  under such Notes and this Indenture (and the Trustee,  on demand of<br \/>\nand  at  the  expense  of  the  Company,   shall  execute   proper   instruments<br \/>\nacknowledging  the  same),  except for the  following  provisions,  which  shall<br \/>\nsurvive until otherwise  terminated or discharged  hereunder:  (i) the rights of<br \/>\nHolders of outstanding Notes to receive, solely from the trust fund described in<br \/>\nSection  9.05  hereof and as more fully set forth in such  Section,  payments in<br \/>\nrespect of the principal  of,  make-whole  amount,  if any, and interest on such<br \/>\nNotes  when such  payments  are due on the Stated  Maturity  thereof  (or,  upon<br \/>\nredemption, if applicable),  (ii) the Company&#8217;s obligations with respect to such<br \/>\nNotes under Article 2 and Section 4.07 hereof, (iii) the rights, powers, trusts,<br \/>\nduties and immunities of the Trustee hereunder and the Company&#8217;s  obligations in<br \/>\nconnection  therewith and (iv) this Article 9. Subject to  compliance  with this<br \/>\nArticle  9, the  Company  may  exercise  its  option  under  this  Section  9.02<br \/>\nnotwithstanding  the prior  exercise of its option under Section 9.03 below with<br \/>\nrespect to the Notes.<\/p>\n<p>Section 9.03.     Covenant Defeasance.<\/p>\n<p>                  (a) The Company  may, at its option by a Board  Resolution  of<br \/>\nthe Board of Directors of the Company,  at any time,  elect to have this Section<br \/>\n9.03 be applied to all outstanding Notes upon compliance with the conditions set<br \/>\nforth in Section 9.04 hereof.<\/p>\n<p>                  (b) Upon the Company&#8217;s  exercise under paragraph (a) hereof of<br \/>\nthe option  applicable to this paragraph (b), the Company shall,  subject to the<br \/>\nsatisfaction  of the  conditions  set forth in Section 9.04 hereof,  be released<br \/>\nfrom its  obligations  under the covenants  contained in Sections 4.05, 4.08 and<br \/>\n4.09  through  4.17,  inclusive,  and  Article  5  hereof  with  respect  to the<br \/>\noutstanding  Notes<\/p>\n<p>                                       60<\/p>\n<p>on and after the date the conditions set forth below are satisfied (hereinafter,<br \/>\n&#8220;Covenant   Defeasance&#8221;),   and  the  Notes  shall   thereafter  be  deemed  not<br \/>\n&#8220;outstanding&#8221; for the purposes of any direction,  waiver, consent or declaration<br \/>\nor act of Holders (and the  consequences of any thereof) in connection with such<br \/>\ncovenants,  but shall continue to be deemed &#8220;outstanding&#8221; for all other purposes<br \/>\nhereunder.  For this purpose,  such Covenant Defeasance means that, with respect<br \/>\nto the outstanding  Notes, the Company may omit to comply with and shall have no<br \/>\nliability in respect of any term,  condition or limitation set forth in any such<br \/>\ncovenant,  whether directly or indirectly,  by reason of any reference elsewhere<br \/>\nherein to any such  covenant or by reason of any  reference in any such covenant<br \/>\nto any other  provision  herein or in any other  document  and such  omission to<br \/>\ncomply  shall not  constitute  a Default  or an Event or Default  under  Section<br \/>\n6.01(c) or 6.01(d) hereof, but, except as specified above, the remainder of this<br \/>\nIndenture,  and such Notes shall be unaffected  thereby.  In addition,  upon the<br \/>\nCompany&#8217;s  exercise under paragraph (a) hereof of the option  applicable to this<br \/>\nparagraph  (b),  subject  to the  satisfaction  of the  conditions  set forth in<br \/>\nSection 9.04 hereof, Sections 6.01(c),  6.01(d) and 6.01(e) shall not constitute<br \/>\nEvents of Default.<\/p>\n<p>Section 9.04.     Conditions to Legal Defeasance or Covenant Defeasance.<\/p>\n<p>                  The following  shall be the  conditions to the  application of<br \/>\neither Section 9.02 or 9.03 hereof to the outstanding Notes:<\/p>\n<p>                  In order to  exercise  either  Legal  Defeasance  or  Covenant<br \/>\nDefeasance:<\/p>\n<p>                  (a) the  Company  must  irrevocably  deposit  or  cause  to be<br \/>\n         deposited  with the  Trustee,  as trust  funds in  trust,  specifically<br \/>\n         pledged as security  for, and  dedicated  solely to, the benefit of the<br \/>\n         Holders,  cash in U.S. dollars, or U.S. Government  Obligations,  or in<br \/>\n         the case of Covenant Defeasance,  corporate  obligations rated at least<br \/>\n         &#8220;A&#8221; by  Standard  &amp; Poor&#8217;s  Ratings  Group or at least  &#8220;A&#8221; by  Moody&#8217;s<br \/>\n         Investors Service,  Inc. or a combination  thereof,  in such amounts as<br \/>\n         will be sufficient,  in the opinion of a nationally  recognized firm of<br \/>\n         independent public accountants,  to pay and discharge the principal of,<br \/>\n         make-whole amount, if any, and interest on the outstanding Notes on the<br \/>\n         Stated  Maturity  thereof (or upon  redemption,  if applicable) of such<br \/>\n         principal, make-whole amount, if any, or installment of interest;<\/p>\n<p>                  (b) no Default or Event of Default  with  respect to the Notes<br \/>\n         shall have  occurred and be  continuing on the date of such deposit or,<br \/>\n         insofar as an event of  bankruptcy  under clauses (f) or (g) of Section<br \/>\n         6.01 hereof is  concerned,  at any time during the period ending on the<br \/>\n         91st day after the date of such deposit;<\/p>\n<p>                  (c) such Legal  Defeasance  or Covenant  Defeasance  shall not<br \/>\n         result in a breach or violation of, or constitute a default under, this<br \/>\n         Indenture or any material  agreement or instrument to which the Company<br \/>\n         is a party or by which it is bound;<\/p>\n<p>                  (d) in the case of Legal  Defeasance,  the Company  shall have<br \/>\n         delivered to the Trustee an Opinion of Counsel stating that the Company<br \/>\n         has received from, or there has been published by, the Internal Revenue<br \/>\n         Service a ruling,  or since the Issue Date,  there has been a change in<br \/>\n         applicable  federal  income tax law, in either case to the effect that,<br \/>\n         and based thereon such opinion  shall confirm that,  the Holders of the<br \/>\n         outstanding  Notes of such series will not  recognize  income,  gain or<br \/>\n         loss for federal income tax purposes as a result of such defeasance and<br \/>\n         will be subject to federal income tax on the same amounts,  in the same<br \/>\n         manner  and at the  same  times  as  would  have  been the case if such<br \/>\n         defeasance had not occurred; and<\/p>\n<p>                                       61<\/p>\n<p>                  (e) in the case of Covenant Defeasance, the Company shall have<br \/>\n         delivered  to the  Trustee an Opinion of Counsel to the effect that the<br \/>\n         Holders of outstanding  Notes of such series will not recognize income,<br \/>\n         gain or loss for  federal  income  tax  purposes  as a  result  of such<br \/>\n         defeasance  and  will be  subject  to  federal  income  tax on the same<br \/>\n         amounts,  in the same  manner  and at the same times as would have been<br \/>\n         the case if such defeasance had not occurred; and<\/p>\n<p>                  (f)  the  Company  shall  have  delivered  to the  Trustee  an<br \/>\n         Officers&#8217;  Certificate and an Opinion of Counsel, each stating that all<br \/>\n         conditions   precedent  provided  for  relating  to  either  the  Legal<br \/>\n         Defeasance  or the Covenant  Defeasance,  as the case may be, have been<br \/>\n         complied with.<\/p>\n<p>Section 9.05.     Application of Trust Money.<\/p>\n<p>                  All money and U.S. Government  Obligations  deposited with the<br \/>\nTrustee  pursuant to Section  9.01 or 9.04 hereof in respect of the  outstanding<br \/>\nNotes shall be held in trust and applied by the Trustee,  in accordance with the<br \/>\nprovisions of such Notes and this Indenture,  to the payment, either directly or<br \/>\nthrough any Paying  Agent as the Trustee may  determine,  to the Holders of such<br \/>\nNotes,  of all sums due and to become  due  thereon  in  respect  of  principal,<br \/>\nmake-whole  amount,  if any,  and accrued  interest,  but such money need not be<br \/>\nsegregated from other funds except to the extent required by law.<\/p>\n<p>                  Anything in this  Article 9 to the  contrary  notwithstanding,<br \/>\nthe Trustee shall deliver or pay to the Company from time to time upon a written<br \/>\nrequest of the Company in the form of an Officers&#8217; Certificate any money or U.S.<br \/>\nGovernment  Obligations  held by it as provided  in Section  9.01 or 9.04 hereof<br \/>\nwhich,  in the opinion of a  nationally-recognized  firm of  independent  public<br \/>\naccountants  expressed  in a  written  certification  thereof  delivered  to the<br \/>\nTrustee,  are in excess of the amount thereof which would then be required to be<br \/>\ndeposited to effect an equivalent Legal Defeasance or Covenant Defeasance.<\/p>\n<p>Section 9.06.     Repayment to the Company.<\/p>\n<p>                  Subject to Sections 9.01,  9.,02,  9.03,  9.04, 9.05 and 9.07,<br \/>\nthe Trustee and the Paying Agent shall  promptly pay to the Company upon request<br \/>\nany excess U.S. legal tender or U.S. Government  Obligations held by them at any<br \/>\ntime and thereupon  shall be relieved  from all  liability  with respect to such<br \/>\nmoney.  The Trustee and the Paying  Agent shall pay to the Company  upon request<br \/>\nany money held by them for the payment of principal,  make-whole amount, if any,<br \/>\nor interest that remains  unclaimed for two years;  provided that the Trustee or<br \/>\nsuch Paying Agent, before being required to make any payment, may at the expense<br \/>\nof the Company cause to be published once in a newspaper of general  circulation<br \/>\nin the City of New York or mail to each  Holder  entitled  to such money  notice<br \/>\nthat such money remains unclaimed, and that after a date specified therein which<br \/>\nshall be at least 30 days  from the date of such  publication  or  mailing,  any<br \/>\nunclaimed  balance of such money then  remaining  will be repaid to the Company.<br \/>\nAfter  payment to the Company,  Holders  entitled to such money must look to the<br \/>\nCompany for payment as general  creditors  unless an applicable  law  designates<br \/>\nanother Person.<\/p>\n<p>                                       62<\/p>\n<p>Section 9.07.     Reinstatement.<\/p>\n<p>                  If the Trustee or Paying Agent is unable to apply any money or<br \/>\nU.S. Government Obligations in accordance with Section 9.01, 9.02 or 9.03 hereof<br \/>\nby reason of any legal  proceeding  or by reason of any order or judgment of any<br \/>\ncourt or governmental authority enjoining,  restraining or otherwise prohibiting<br \/>\nsuch application,  the Company&#8217;s  obligations under this Indenture and the Notes<br \/>\nshall be revived and  reinstated  as though no deposit had occurred  pursuant to<br \/>\nthis  Article 9 until such time as the Trustee or Paying  Agent is  permitted to<br \/>\napply all such money and U.S. Government  Obligations in accordance with Section<br \/>\n9.01  hereof;  provided,  however,  that if the  Company has made any payment of<br \/>\nprincipal  of,  make-whole  amount,  if any,  or accrued  interest  on any Notes<br \/>\nbecause  of the  reinstatement  of  their  obligations,  the  Company  shall  be<br \/>\nsubrogated  to the rights of the Holders of such Notes to receive  such  payment<br \/>\nfrom the money and U.S.  Government  Obligations  held by the  Trustee or Paying<br \/>\nAgent.<\/p>\n<p>                                   ARTICLE 10<\/p>\n<p>                             [INTENTIONALLY OMITTED]<\/p>\n<p>                                   ARTICLE 11<\/p>\n<p>                                  MISCELLANEOUS<\/p>\n<p>Section 11.01.    TIA Controls.<\/p>\n<p>                  If any  provision  of  this  Indenture  limits,  qualifies  or<br \/>\nconflicts  with  another  provision  which is  required  to be  included in this<br \/>\nIndenture by the TIA, the required provision shall control.<\/p>\n<p>Section 11.02.    Notices.<\/p>\n<p>                  Any  notices or other  communications  required  or  permitted<br \/>\nhereunder shall be in writing,  and shall be sufficiently  given if made by hand<br \/>\ndelivery, by telecopier or registered or certified mail, postage prepaid, return<br \/>\nreceipt requested, addressed as follows:<\/p>\n<p>                  If to the Company:<\/p>\n<p>                           HEALTHSOUTH Corporation<br \/>\n                           One HealthSouth Parkway<br \/>\n                           Birmingham, Alabama  35243<br \/>\n                           Telephone No.:  (205) 969-4977<br \/>\n                           Facsimile No.:  (205) 969-4730<br \/>\n                           Attention:  William W. Horton<\/p>\n<p>                                       63<\/p>\n<p>                  If to the Trustee:<\/p>\n<p>                           The Bank of New York<br \/>\n                           101 Barclay Street, Floor 21 West<br \/>\n                           New York, New York  10286<br \/>\n                           Telephone No.:  (212) 815-5287<br \/>\n                           Facsimile No.:  (212) 815-5915<br \/>\n                           Attention:  Corporate Trust Trustee Administration<\/p>\n<p>                  The Company or the Trustee by written notice to the others may<br \/>\ndesignate   additional  or  different   addresses  for  subsequent   notices  or<br \/>\ncommunications. Any notice or communication to the Company or the Trustee, shall<br \/>\nbe deemed to have been given or made when actually received.<\/p>\n<p>                  Any notice or communication mailed to a Holder shall be mailed<br \/>\nby first-class mail, postage prepaid,  at the address shown on the register kept<br \/>\nby the Registrar.<\/p>\n<p>                  Failure to mail a notice or  communication  to a Holder or any<br \/>\ndefect in it shall not affect its sufficiency with respect to other Holders.  If<br \/>\na notice or communication to a Holder is mailed in the manner provided above, it<br \/>\nshall be deemed duly given, whether or not the addressee receives it.<\/p>\n<p>                  In case by reason of the  suspension  of regular mail service,<br \/>\nor by reason of any other cause,  it shall be  impossible  to mail any notice as<br \/>\nrequired by this  Indenture,  then such method of  notification as shall be made<br \/>\nwith the approval of the Trustee shall  constitute a sufficient  mailing of such<br \/>\nnotice.<\/p>\n<p>Section 11.03.    Communications by Holders with Other Holders.<\/p>\n<p>                  Holders may  communicate  pursuant to TIA Section  312(b) with<br \/>\nother  Holders with  respect to their rights under this  Indenture or the Notes.<br \/>\nThe  Company,  the  Trustee,  the  Registrar  and  anyone  else  shall  have the<br \/>\nprotection of TIA Section 312(c).<\/p>\n<p>Section 11.04.    Certificate and Opinion as to Conditions Precedent.<\/p>\n<p>                  Upon any request or  application by the Company to the Trustee<br \/>\nto take any action  under  this  Indenture,  the  Company  shall  furnish to the<br \/>\nTrustee:<\/p>\n<p>                  (1)  an  Officers&#8217;   Certificate   (which  shall  include  the<br \/>\n          statements  set forth in Section  11.05  hereof)  stating that, in the<br \/>\n          opinion of the signers, all conditions precedent, if any, provided for<br \/>\n          in this Indenture  relating to the proposed  action have been complied<br \/>\n          with; and<\/p>\n<p>                  (2) an Opinion of Counsel  (which shall include the statements<br \/>\n          set forth in Section  11.05  hereof)  stating  that, in the opinion of<br \/>\n          such counsel, all such conditions  precedent,  if any, provided for in<br \/>\n          this  Indenture  relating to the  proposed  action have been  complied<br \/>\n          with.<br \/>\n                                       64<\/p>\n<p>Section 11.05.    Statements Required in Certificate and Opinion.<\/p>\n<p>                  Each certificate and opinion with respect to compliance with a<br \/>\ncondition or covenant provided for in this Indenture shall include:<\/p>\n<p>                  (1) a statement  that the person  making such  certificate  or<br \/>\n          opinion  has read  such  covenant  or  condition  and the  definitions<br \/>\n          relating thereto;<\/p>\n<p>                  (2) a  brief  statement  as to the  nature  and  scope  of the<br \/>\n          examination or investigation upon which the statements or opinions<br \/>\n         contained in such certificate or opinion are based;<\/p>\n<p>                  (3) a statement that, in the opinion of such person,  it or he<br \/>\n          has made such examination or investigation as is reasonably  necessary<br \/>\n          to enable such person to express an informed  opinion as to whether or<br \/>\n          not such covenant or condition has been complied with; and<\/p>\n<p>                  (4) a  statement  as to whether or not, in the opinion of such<br \/>\n          person,  such covenant or condition has been complied with;  provided,<br \/>\n          however,  that with respect to matters of fact,  an Opinion of Counsel<br \/>\n          may  rely  on an  Officers&#8217;  Certificate  or  certificates  of  public<br \/>\n          officials.<\/p>\n<p>Section 11.06.    Rules by Trustee and Agents.<\/p>\n<p>                  The  Trustee  may make  reasonable  rules for  action by or at<br \/>\nmeetings of Holders.  The Registrar and Paying Agent may make  reasonable  rules<br \/>\nfor their functions.<\/p>\n<p>Section 11.07.    Business Days; Legal Holidays.<\/p>\n<p>                  A  &#8220;Business  Day&#8221; is a day  that is not a  Legal  Holiday.  A<br \/>\n&#8220;Legal Holiday&#8221; is a Saturday, a Sunday, a federally-recognized holiday or a day<br \/>\non which  banking  institutions  are not required to be open in the State of New<br \/>\nYork. If a payment date is a Legal Holiday at a place of payment, payment may be<br \/>\nmade at that place on the next  succeeding day that is not a Legal Holiday,  and<br \/>\nno interest shall accrue for the intervening period.<\/p>\n<p>Section 11.08.    Governing Law.<\/p>\n<p>                  THIS  INDENTURE  AND  THE  NOTES  SHALL  BE  GOVERNED  BY  AND<br \/>\nCONSTRUED IN  ACCORDANCE  WITH THE LAWS OF THE STATE OF NEW YORK,  AS APPLIED TO<br \/>\nCONTRACTS  MADE AND PERFORMED  WITHIN THE STATE OF NEW YORK,  WITHOUT  REGARD TO<br \/>\nPRINCIPLES OF CONFLICTS OF LAW.  EACH OF THE PARTIES  HERETO AGREES TO SUBMIT TO<br \/>\nTHE  JURISDICTION  OF THE  COURTS  OF THE  STATE  OF NEW YORK IN ANY  ACTION  OR<br \/>\nPROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE OR THE NOTES.<\/p>\n<p>Section 11.09.    Waiver of Trial by Jury.<\/p>\n<p>                  The Company  hereby  irrevocably  waives any and all rights to<br \/>\ntrial  by  jury in any  legal  proceeding  arising  out of or  relating  to this<br \/>\nIndenture.<\/p>\n<p>                                       65<\/p>\n<p>Section 11.10.    Submission to Jurisdiction.<\/p>\n<p>                  The Company hereby consents to the non-exclusive  jurisdiction<br \/>\nof a state or federal  court  situated in New York City,  New York in connection<br \/>\nwith any  dispute  arising  hereunder  or under the Notes.  The  Company  hereby<br \/>\nirrevocably  waives,  to the fullest  extent  permitted by  applicable  law, any<br \/>\nobjection  which it may now or hereafter have to the laying of venue of any such<br \/>\nproceeding brought in such a court and any claim that such proceeding brought in<br \/>\nsuch a court has been brought in an inconvenient forum.<\/p>\n<p>Section 11.11.    No Adverse Interpretation of Other Agreements.<\/p>\n<p>                  This Indenture may not be used to interpret another indenture,<br \/>\nloan,  security or debt agreement of the Company or any Subsidiary  thereof.  No<br \/>\nsuch indenture,  loan,  security or debt agreement may be used to interpret this<br \/>\nIndenture.<\/p>\n<p>Section 11.12.    No Recourse Against Others.<\/p>\n<p>                  No incorporator,  director, officer, employee,  stockholder or<br \/>\ncontrolling  person,  as such,  of the Company  shall have any liability for any<br \/>\nobligations  of the Company  under the Notes or this  Indenture or for any claim<br \/>\nbased on, in respect of or by reason of such  obligations or their creation.  By<br \/>\naccepting a Note,  each Holder shall waive and release all such  liability.  The<br \/>\nwaiver  and  release  shall be part of the  consideration  for the  issue of the<br \/>\nNotes.<\/p>\n<p>Section 11.13.    Successors.<\/p>\n<p>                  All  agreements  of each of the Company in this  Indenture and<br \/>\nthe Notes shall bind their respective successors. All agreements of the Trustee,<br \/>\nany additional  trustee and any Paying Agents in this  Indenture  shall bind its<br \/>\nsuccessor.<\/p>\n<p>Section 11.14.    Multiple Counterparts.<\/p>\n<p>                  The parties may sign multiple  counterparts of this Indenture.<br \/>\nEach signed  counterpart  shall be deemed an original,  but all of them together<br \/>\nrepresent one and the same agreement.<\/p>\n<p>Section 11.15.    Table of Contents, Headings, etc.<\/p>\n<p>                  The table of contents,  cross-reference  sheet and headings of<br \/>\nthe Articles and Sections of this Indenture  have been inserted for  convenience<br \/>\nof reference  only, are not to be considered a part hereof,  and shall in no way<br \/>\nmodify or restrict any of the terms or provisions hereof.<\/p>\n<p>Section 11.16.    Separability.<\/p>\n<p>                  Each provision of this Indenture shall be considered separable<br \/>\nand if for any reason any provision shall be invalid,  illegal or unenforceable,<br \/>\nthe validity,  legality and enforceability of the remaining provisions shall not<br \/>\nin any way be affected or impaired thereby to the extent allowed by law.<\/p>\n<p>                                       66<\/p>\n<p>Section 11.17.    Translation.<\/p>\n<p>                  The original and controlling version of this Indenture and any<br \/>\nrelated  agreements shall be the English language  version.  All translations of<br \/>\nthis Indenture or any agreements  related hereto into other  languages  shall be<br \/>\nfor the  convenience  of the parties only,  and shall not control the meaning or<br \/>\napplication of this Indenture.  All notices and other communications required or<br \/>\npermitted by this  Indenture  or any other  transactional  agreement  must be in<br \/>\nEnglish or accompanied by an English  translation,  and the  interpretation  and<br \/>\napplication of such notices and other  communications shall be based solely upon<br \/>\nthe English language version thereof.<\/p>\n<p>                                       67<\/p>\n<p>                  IN WITNESS WHEREOF,  the parties have caused this Indenture to<br \/>\nbe duly executed all as of the date and year first written above.<\/p>\n<p>                                                     Company:<\/p>\n<p>                             HEALTHSOUTH CORPORATION<\/p>\n<p>                                     By:    \/s\/ William T. Owens<br \/>\n                                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                             Name:  William T. Owens<br \/>\n                                             Title: Executive Vice President and<br \/>\n                                                    Chief Financial Officer<\/p>\n<p>                                        Trustee:<\/p>\n<p>                                        THE BANK OF NEW YORK,<br \/>\n                                            as Trustee<\/p>\n<p>                                        By: \/s\/ Robert A. Massimillo<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                            Name:  Robert A. Massimillo<br \/>\n                                            Title: Assistant Vice President<\/p>\n<p>                                                                       EXHIBIT A<\/p>\n<p>                             [FORM OF SERIES A NOTE]<\/p>\n<p>                                                            CUSIP No.:<br \/>\n                             HEALTHSOUTH CORPORATION<\/p>\n<p>                           8 1\/2% SENIOR NOTE DUE 2008<\/p>\n<p>No.                                                                          $ <\/p>\n<p>                  HEALTHSOUTH   CORPORATION,   a  corporation   incorporated  in<br \/>\nDelaware (the &#8220;Company,&#8221;  which term includes any successor  entity),  for value<br \/>\nreceived  promises to pay to or  registered  assigns,  the principal sum of $ on<br \/>\nFebruary 1, 2008.<\/p>\n<p>                  Interest  Payment Dates:  February 1 and August 1,  commencing<br \/>\n          August 1, 2001.<\/p>\n<p>                  Record Dates:  January 15 and July 15.<\/p>\n<p>                  Reference  is  made to the  further  provisions  of this  Note<br \/>\ncontained  herein and the Indenture  (as  defined),  which will for all purposes<br \/>\nhave the same effect as if set forth at this place.<\/p>\n<p>                  IN WITNESS  WHEREOF,  the  Company  has caused this Note to be<br \/>\nsigned  manually or by facsimile by its duly authorized  directors,  officers or<br \/>\nother authorized signatories.<\/p>\n<p>                             HEALTHSOUTH CORPORATION<\/p>\n<p>                                      By:<br \/>\n                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:<br \/>\n                                            Title:<\/p>\n<p>                                      By:<br \/>\n                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                             Name:<br \/>\n                                             Title:<\/p>\n<p>CERTIFICATE OF AUTHENTICATION<\/p>\n<p>Date: February 1, 2001<\/p>\n<p>                  This is one of the 8 1\/2% Senior Notes due 2008 referred to in<br \/>\nthe within-mentioned Indenture.<\/p>\n<p>                                       THE BANK OF NEW YORK,<br \/>\n                                           as Trustee<\/p>\n<p>                                       By:<br \/>\n                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                          Authorized Signatory<br \/>\n                                      A-2<\/p>\n<p>                              (REVERSE OF SECURITY)<\/p>\n<p>                           8 1\/2% SENIOR NOTE DUE 2008<\/p>\n<p>                  1.   Interest.    HEALTHSOUTH   CORPORATION,   a   corporation<br \/>\nincorporated  in  Delaware  (the  &#8220;Company&#8221;),  promises  to pay  interest on the<br \/>\nprincipal amount of this Note at the rate per annum shown above. Interest on the<br \/>\nNotes will accrue from the most recent date on which  interest  has been paid or<br \/>\nduly  provided  for,  or if no  interest  has  been  paid,  from the date of the<br \/>\noriginal  issuance of the Notes. The Company will pay interest  semi-annually in<br \/>\narrears on each Interest Payment Date,  commencing August 1, 2001. Interest will<br \/>\nbe computed on the basis of a 360-day year comprised of twelve 30-day months.<\/p>\n<p>                  The Company  shall pay  interest on overdue  principal  and on<br \/>\noverdue  installments  of  interest  (without  regard  to any  applicable  grace<br \/>\nperiods)  to the extent  lawful from time to time on demand at the rate borne by<br \/>\nthe Notes.<\/p>\n<p>                  2. Method of Payment.  The Company  shall pay  interest on the<br \/>\nNotes (except defaulted  interest) to the Persons who are the registered Holders<br \/>\nat the close of  business  on January 15 or July 15  immediately  preceding  the<br \/>\nInterest  Payment Date  (whether or not such day is a Business  Day) even if the<br \/>\nNotes are canceled on registration of transfer or registration of exchange after<br \/>\nsuch Record  Date.  Holders  must  surrender  Notes to a Paying Agent to collect<br \/>\nprincipal payments. Payments of principal and make-whole amount, if any, will be<br \/>\nmade (on  presentation  of such  Notes if in  certificated  form) in U.S.  legal<br \/>\ntender;  provided,  however,  that the  Company  may pay  principal,  make-whole<br \/>\namount, if any, and interest by check payable in U.S. legal tender.  The Company<br \/>\nmay  deliver  any such  interest  payment by check  mailed to the address of the<br \/>\nPerson entitled thereto as such address will appear on the security register.<\/p>\n<p>                  3. Paying  Agents and  Registrar.  Initially,  The Bank of New<br \/>\nYork,  a  banking  organization  organized  under  the  laws  of New  York  (the<br \/>\n&#8220;Trustee&#8221;),  will act as Paying Agent and the Trustee will act as Registrar. The<br \/>\nCompany may change any Paying Agents,  Registrar or co-Registrar  without notice<br \/>\nto the Holders.  Neither the Company nor any of its  Subsidiaries  or Affiliates<br \/>\nmay act as Paying Agent but may act as Registrar or co-Registrar.<\/p>\n<p>                  4. Indenture. The Company issued this Note under an Indenture,<br \/>\ndated as of February 1, 2001 (the &#8220;Indenture&#8221;), by and among the Company and the<br \/>\nTrustee.  This Note is one of a duly  authorized  issue of Initial  Notes of the<br \/>\nCompany designated as its 8 1\/2% Senior Notes due 2008 (the &#8220;Notes&#8221;).  The Notes<br \/>\ninclude  the  Initial  Notes  and the  Exchange  Notes  issued  pursuant  to the<br \/>\nIndenture.  The  Initial  Notes and the  Exchange  Notes are treated as a single<br \/>\nclass of securities  under the Indenture.  Capitalized  terms herein are used as<br \/>\ndefined in the Indenture unless otherwise defined herein. The terms of the Notes<br \/>\ninclude  those stated in the  Indenture  and those made part of the Indenture by<br \/>\nreference to the Trust Indenture Act of 1939 (15 U.S. Code ss.ss.  77aaa-77bbbb)<br \/>\n(the &#8220;TIA&#8221;), as in effect on the date of the Indenture. Notwithstanding anything<br \/>\nto the contrary herein,  the Notes are subject to all such terms, and Holders of<br \/>\nNotes are referred to the  Indenture  and the TIA for a statement  of them.  The<br \/>\nNotes are general unsecured obligations of the Company.<\/p>\n<p>                                      A-3<\/p>\n<p>                  5.       [Intentionally Omitted.]<\/p>\n<p>                  6.       Redemption.<\/p>\n<p>                  The  Notes  will be  redeemable,  in whole or in part,  at the<br \/>\noption of the Company at any time at a redemption  price equal to the greater of<br \/>\n(i) 100% of the principal amount of the Notes,  plus accrued interest thereon to<br \/>\nthe date of redemption  and (ii) as determined by a Quotation  Agent (as defined<br \/>\nbelow),  the sum of the present  values of the remaining  scheduled  payments of<br \/>\nprincipal  and  interest  thereon  discounted,  to  the  redemption  date  on  a<br \/>\nsemi-annual  basis  (assuming a 360-day year consisting of twelve 30-day months)<br \/>\nat the Adjusted Treasury Rate, plus accrued interest on the Notes to the date of<br \/>\nredemption.  If a  redemption  date does not fall on an interest  payment  date,<br \/>\nthen, with respect to the interest payment immediately succeeding the redemption<br \/>\ndate, only the unaccrued  portion of such interest  payment as of the redemption<br \/>\ndate shall be included  in any  calculation  pursuant to clause (ii) above.  Any<br \/>\namount  payable in excess of 100% of the  principal  amount of the Notes  (other<br \/>\nthan accrued  interest  thereon) shall be referred to herein as the  &#8220;make-whole<br \/>\namount.&#8221;<\/p>\n<p>                  &#8220;Adjusted Treasury Rate&#8221; means, with respect to any redemption<br \/>\ndate, the rate per annum equal to the semi-annual  equivalent  yield to maturity<br \/>\nof the Comparable  Treasury Issue,  assuming a price for the Comparable Treasury<br \/>\nIssue  (expressed  as a  percentage  of  the  principal  amount)  equal  to  the<br \/>\nComparable Treasury Price for such redemption date, plus 0.50%.<\/p>\n<p>                  &#8220;Comparable  Treasury  Issue&#8221; means the United States Treasury<br \/>\nsecurity  selected by a Quotation  Agent as having a maturity  comparable to the<br \/>\nremaining  term of the Notes to be redeemed that would be utilized,  at the time<br \/>\nof selection and in accordance with customary financial practice, in pricing new<br \/>\nissues of corporate debt securities of comparable maturity to the remaining term<br \/>\nof such Notes.<\/p>\n<p>                  &#8220;Comparable   Treasury  Price&#8221;  means,  with  respect  to  any<br \/>\nredemption date, (i) the average of the Reference Treasury Dealer Quotations for<br \/>\nsuch redemption  date,  after excluding the highest and lowest of such Reference<br \/>\nTreasury Dealer  Quotations,  or (ii) if the Trustee obtains three or fewer such<br \/>\nReference Treasury Dealer Quotations, the average of all such quotations.<\/p>\n<p>                  &#8220;Quotation Agent&#8221; means one of the Reference  Treasury Dealers<br \/>\nappointed by the Trustee after consultation with the Company.<\/p>\n<p>                  &#8220;Reference Treasury Dealer&#8221; means (i) each of UBS Warburg LLC,<br \/>\nDeutsche Banc Alex.  Brown Inc. and Chase  Securities Inc. and their  respective<br \/>\nsuccessors;  provided, however, that if any of the foregoing shall cease to be a<br \/>\nprimary  U.S.  Government  securities  dealer in New York,  New York (a &#8220;Primary<br \/>\nTreasury  Dealer&#8221;),  the  Company  shall  substitute  therefor  another  Primary<br \/>\nTreasury  Dealer;  and (ii) any other Primary  Treasury  Dealer  selected by the<br \/>\nTrustee after consultation with the Company.<\/p>\n<p>                  &#8220;Reference  Treasury Dealer  Quotation&#8221; means, with respect to<br \/>\neach  Reference  Treasury  Dealer  and any  redemption  date,  the  average,  as<br \/>\ndetermined  by the  Trustee,  of the bid and  asked  prices  for the  Comparable<br \/>\nTreasury Issue (expressed in each case as a percentage of its principal  amount)<br \/>\nquoted in writing to the Trustee by such Reference  Treasury Dealer at 5:00 p.m.<br \/>\non the third business day preceding such redemption date.<\/p>\n<p>                                      A-4<\/p>\n<p>                  If less than all of the Notes are to be  redeemed at any time,<br \/>\nselection of the Notes to be redeemed will be made by the Trustee from among the<br \/>\noutstanding  Notes on a pro rata basis, by lot or by any other method  permitted<br \/>\nin the  Indenture.  On and after the  redemption  date,  interest  will cease to<br \/>\naccrue on the Notes or portions thereof called for redemption.<\/p>\n<p>                  The Notes will not be entitled to any sinking fund.<\/p>\n<p>                  7. Notice of Redemption.  Notice of redemption under paragraph<br \/>\n6 of this Note will be mailed at least 30 days but not more than 60 days  before<br \/>\nthe  Redemption  Date to each Holder of Notes to be  redeemed  at such  Holder&#8217;s<br \/>\nregistered address.<\/p>\n<p>                  Except  as set  forth  in the  Indenture,  if  monies  for the<br \/>\nredemption of the Notes called for redemption shall have been deposited with the<br \/>\nPaying Agent for redemption on such  Redemption  Date, then the Notes called for<br \/>\nredemption  will cease to bear interest from and after such  Redemption Date and<br \/>\nthe only right of the  Holders  of such Notes will be to receive  payment of the<br \/>\nRedemption Price plus interest accrued through the Redemption Date, if any.<\/p>\n<p>                  8. Offers to Purchase.  The  Indenture  provides  that,  after<br \/>\ncertain Asset Sales (as defined in the  Indenture)  and upon the occurrence of a<br \/>\nChange of  Control  (as  defined  in the  Indenture),  and  subject  to  further<br \/>\nlimitations  contained  therein,  the  Company  will  make an offer to  purchase<br \/>\ncertain  amounts of the Notes in accordance with the procedures set forth in the<br \/>\nIndenture.<\/p>\n<p>                  9. Registration  Rights.  Pursuant to the Registration  Rights<br \/>\nAgreement  by and between the  Company and the Initial  Purchasers,  the Company<br \/>\nwill be obligated to consummate an exchange  offer  pursuant to which the Holder<br \/>\nof this Note shall have the right to exchange this Note for the Company&#8217;s Series<br \/>\nB 8 1\/2%  Senior  Notes due 2008  (the  &#8220;Exchange  Notes&#8221;),  at such time as the<br \/>\nExchange  Notes shall have been  registered  under the  Securities  Act, in like<br \/>\nprincipal  amount and having terms  identical  in all  material  respects to the<br \/>\nInitial  Notes.  The Holders of the  Initial  Notes shall be entitled to receive<br \/>\ncertain  Additional  Interest  payments in the event such exchange  offer is not<br \/>\nconsummated and upon certain other conditions, all pursuant to and in accordance<br \/>\nwith the terms of the Registration Rights Agreement.<\/p>\n<p>                  10.  Denominations;  Transfer;  Exchange.  The  Notes  are  in<br \/>\ndefinitive,  fully registered form, without coupons, in minimum denominations of<br \/>\n[$1,000]  [$250,000] and in integral  multiples [of $1,000 in excess] thereof. A<br \/>\nHolder shall  register the transfer or exchange of Notes in accordance  with the<br \/>\nIndenture.  The Registrar may require a Holder,  among other things,  to furnish<br \/>\nappropriate  endorsements  and transfer  documents  and to pay certain  transfer<br \/>\ntaxes or  similar  governmental  charges  payable  in  connection  therewith  as<br \/>\npermitted by the  Indenture.  The Registrar need not register the transfer of or<br \/>\nexchange of any Notes or portions thereof selected for redemption.<\/p>\n<p>                  11.  Persons Deemed  Owners.  The registered  Holder of a Note<br \/>\nshall be treated as the owner of such Note for all<\/p>\n<p>purposes.<\/p>\n<p>                  12.  Unclaimed Money. If money for the payment of principal or<br \/>\ninterest remains  unclaimed for two years, the Trustee and the Paying Agent will<br \/>\npay the money back to the Company.  After that,  Holders  entitled to money must<br \/>\nlook to the  Company  for  payment as  general  creditors  unless an  &#8220;abandoned<br \/>\nproperty&#8221; law designates another person.<\/p>\n<p>                                      A-5<\/p>\n<p>                  13. Legal Defeasance and Covenant  Defeasance.  If the Company<br \/>\nat any time deposits with the Trustee U.S. legal tender or other  obligations of<br \/>\nthe types set forth in the  Indenture  sufficient  to pay the  principal  of and<br \/>\ninterest  on the Notes to Stated  Maturity or  redemption,  if  applicable,  and<br \/>\ncomplies with the other provisions of the Indenture relating to Legal Defeasance<br \/>\nor Covenant  Defeasance,  the Company will be discharged from certain provisions<br \/>\nof the Indenture and the Notes (including certain  covenants,  but excluding its<br \/>\nobligation to pay the principal of and interest on the Notes).<\/p>\n<p>                  14. Amendments,  Supplements,  and Waivers. Subject to certain<br \/>\nexceptions,  the Indenture or the Notes may be amended or supplemented  with the<br \/>\nwritten  consent of the Holders of at least a majority in aggregate  outstanding<br \/>\nprincipal  amounts of the Notes, and any existing Default or Event of Default or<br \/>\nnoncompliance  with any provision may be waived with the written  consent of the<br \/>\nHolders  of  a  majority  in  aggregate  principal  amount  of  the  Notes  then<br \/>\noutstanding. Without notice to or consent of any Holder, the parties thereto may<br \/>\namend or supplement the Indenture or the Notes to, among other things,  cure any<br \/>\nambiguity,  defect  or  inconsistency  or make any  other  change  that does not<br \/>\nadversely affect in any material respect the rights of any Holder of a Note.<\/p>\n<p>                  15.  Restrictive  Covenants.  The  Indenture  imposes  certain<br \/>\nlimitations on the ability of the Company and its  Subsidiaries  to, among other<br \/>\nthings,  make  payments  in  respect  of its  Capital  Stock,  incur  additional<br \/>\nIndebtedness,  make certain  investments,  sell assets,  enter into transactions<br \/>\nwith  Affiliates,  create  Liens,  merge or  consolidate  with or into any other<br \/>\nPerson or sell,  lease,  convey or otherwise dispose of all or substantially all<br \/>\nof its  assets  or  create  dividend  or other  payment  restrictions  affecting<br \/>\nSubsidiaries  of the  Company.  Such  limitations  are  subject  to a number  of<br \/>\nimportant  qualifications  and exceptions.  The Company must report on an annual<br \/>\nbasis to the Trustee on compliance with such limitations.<\/p>\n<p>                  16. Successor.  When a Successor  assumes,  in accordance with<br \/>\nthe Indenture,  all the obligations of its  predecessor  under the Notes and the<br \/>\nIndenture,  and immediately  before and thereafter no Default exists and certain<br \/>\nother  conditions are satisfied,  the  predecessor  entity will be released from<br \/>\nthose obligations.<\/p>\n<p>                  17. Defaults and Remedies.  Events of Default are set forth in<br \/>\nthe  Indenture.  If an Event of Default  (other  than an Event of  Default  with<br \/>\nrespect to the Company  pursuant to Section 6.01(f) or 6.01(g) of the Indenture)<br \/>\nshall have occurred and be continuing, then the Trustee by written notice to the<br \/>\nCompany or the Holders of not less than 25% in aggregate principal amount of the<br \/>\nNotes then  outstanding may declare to be immediately due and payable the entire<br \/>\nprincipal  amount of all the Notes then outstanding plus accrued interest to the<br \/>\ndate of acceleration; provided, however, that after such acceleration but before<br \/>\na judgment or decree based on such acceleration is obtained by the Trustee,  the<br \/>\nHolders of a majority in aggregate  principal amount of the outstanding Notes by<br \/>\nwritten  notice to the  Company  and the  Trustee  may  rescind  and annul  such<br \/>\nacceleration and its consequences if all existing Events of Default,  other than<br \/>\nthe  nonpayment of principal,  make-whole  amount,  if any, or interest that has<br \/>\nbecome due solely  because of the  acceleration,  have been cured or waived.  No<br \/>\nsuch  rescission  shall  affect  any  subsequent  Default  or  impair  any right<br \/>\nconsequent  thereto.  In case an Event of Default  with  respect to the  Company<br \/>\nspecified in Section 6.01(f) or 6.01(g) of the Indenture occurs,  such principal<br \/>\namount,  together with make-whole  amount,  if any, and interest with respect to<br \/>\nall of the Notes, shall be due and payable  immediately  without any declaration<br \/>\nor other act on the part of the Trustee or the Holders of the Notes.<\/p>\n<p>                                      A-6<\/p>\n<p>                  18.  Trustee  Dealings  with  Company.  The Trustee  under the<br \/>\nIndenture,  in its individual or any other  capacity,  may make loans to, accept<br \/>\ndeposits from, and perform services for the Company, and may otherwise deal with<br \/>\nthe Company,  its Subsidiaries or their respective  Affiliates as if it were not<br \/>\nthe Trustee.<\/p>\n<p>                  19. No Recourse  Against Others.  No  incorporator,  director,<br \/>\nofficer,  employee,  stockholder or controlling  person, as such, of the Company<br \/>\nshall have any liability for any  obligations  of the Company under the Notes or<br \/>\nthe  Indenture  or for any claim  based on, in  respect  of or by reason of such<br \/>\nobligations or their creation.  By accepting a Note, each Holder shall waive and<br \/>\nrelease  all  such  liability.  The  waiver  and  release  shall  be part of the<br \/>\nconsideration for the issue of the Notes.<\/p>\n<p>                  20.  Authentication.  This Note  shall not be valid  until the<br \/>\nTrustee or Authenticating Agent manually signs the certificate of authentication<br \/>\non this Note.<\/p>\n<p>                  21.  Multiple  Counterparts.  The  parties  may sign  multiple<br \/>\ncounterparts of this Note. Each signed  counterpart  shall be deemed an original<br \/>\nbut all of them together represent one and the same Note.<\/p>\n<p>                  22.  Governing  Law.  THIS  NOTE  SHALL  BE  GOVERNED  BY  AND<br \/>\nCONSTRUED IN  ACCORDANCE  WITH THE LAWS OF THE STATE OF NEW YORK,  AS APPLIED TO<br \/>\nCONTRACTS  MADE AND PERFORMED  WITHIN THE STATE OF NEW YORK,  WITHOUT  REGARD TO<br \/>\nPRINCIPLES  OF CONFLICTS OF LAW. EACH OF THE PARTIES TO THE INDENTURE HAS AGREED<br \/>\nTO  SUBMIT  TO THE  JURISDICTION  OF THE  COURTS OF THE STATE OF NEW YORK IN ANY<br \/>\nACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE.<\/p>\n<p>                  23. Abbreviations and Defined Terms.  Customary  abbreviations<br \/>\nmay be used in the name of a Holder of a Note or an  assignee,  such as: TEN COM<br \/>\n(= tenants in common),  TEN ENT (= tenants by the  entireties),  JT TEN (= joint<br \/>\ntenants  with  right of  survivorship  and not as tenants  in  common),  CUST (=<br \/>\nCustodian), and U\/G\/M\/A (= Uniform Gifts to Minors Act).<\/p>\n<p>                  24. CUSIP Numbers.  The Company has caused CUSIP numbers to be<br \/>\nprinted on the Notes as a convenience to the Holders.  No representation is made<br \/>\nas to the  accuracy of such  numbers as printed on the Notes and reliance may be<br \/>\nplaced only on the other identification numbers printed hereon.<\/p>\n<p>                  25. Indenture.  Each Holder, by accepting a Note, agrees to be<br \/>\nbound by all of the terms and  provisions of the  Indenture,  as the same may be<br \/>\namended from time to time.<\/p>\n<p>                  The Company  will furnish to any Holder of a Note upon written<br \/>\nrequest and without  charge a copy of the  Indenture  which has the text of this<br \/>\nNote in larger  type.  Requests  may be made to:  HEALTHSOUTH  Corporation,  One<br \/>\nHealthSouth Parkway,  Birmingham,  Alabama 35243,  Telephone No. (205) 969-4977,<br \/>\nFacsimile No. (205) 969-4730, Attention: William W. Horton.<\/p>\n<p>                                      A-7<\/p>\n<p>                                 ASSIGNMENT FORM<\/p>\n<p>                  If you the Holder want to assign  this Note,  fill in the form<br \/>\nbelow and have your signature guaranteed:<\/p>\n<p>I or we assign and transfer this Note to:<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                  (Print or type name, address and zip code and<br \/>\n                  social security or tax ID number of assignee)<\/p>\n<p>and irrevocably appoint _______________________________________________________,<br \/>\nagent  to  transfer  this  Note on the  books  of the  Company.  The  agent  may<br \/>\nsubstitute another to act for him.<\/p>\n<p>Date:                                       Signed:<br \/>\n       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                  (Sign exactly as your name<br \/>\n                                                  appears on the other<br \/>\n                                                  side of this Note)<\/p>\n<p>Medallion Guarantee:<br \/>\n                      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                      A-8<\/p>\n<p>                      [OPTION OF HOLDER TO ELECT PURCHASE]<\/p>\n<p>                  If you  want to  elect  to have  this  Note  purchased  by the<br \/>\nCompany  pursuant to Section  4.12 or Section 4.15 of the  Indenture,  check the<br \/>\nappropriate box:<\/p>\n<p>                                            Section 4.12 |_|<br \/>\n                                            Section 4.15 |_|<\/p>\n<p>                  If you want to elect to have only part of this Note  purchased<br \/>\nby the Company pursuant to Section 4.12 or Section 4.15 of the Indenture,  state<br \/>\nthe amount you elect to have purchased:<\/p>\n<p>$  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>Date:<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                           NOTICE:  The  signature  on<br \/>\n                                           this     assignment    must<br \/>\n                                           correspond with the name as<br \/>\n                                           it appears upon the face of<br \/>\n                                           the  within  Note in  every<br \/>\n                                           particular          without<br \/>\n                                           alteration  or  enlargement<br \/>\n                                           or  any  change  whatsoever<br \/>\n                                           and  be  guaranteed  by the<br \/>\n                                           endorser&#8217;s bank or broker.<\/p>\n<p>Medallion Guarantee:<br \/>\n                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                      A-9<\/p>\n<p>                                                                       EXHIBIT B<\/p>\n<p>                             [FORM OF SERIES B NOTE]<\/p>\n<p>                                                           CUSIP No.:<\/p>\n<p>                             HEALTHSOUTH CORPORATION<\/p>\n<p>                           8 1\/2% SENIOR NOTE DUE 2008<\/p>\n<p>No.                                                                     $<\/p>\n<p>                  HEALTHSOUTH   CORPORATION,   a  corporation   incorporated  in<br \/>\nDelaware (the &#8220;Company,&#8221;  which term includes any successor  entity),  for value<br \/>\nreceived  promises to pay to or  registered  assigns,  the principal sum of $ on<br \/>\nFebruary 1, 2008.<\/p>\n<p>                  Interest  Payment Dates:  February 1 and August 1,  commencing<br \/>\nAugust 1, 2001.<\/p>\n<p>                  Record Dates:  January 15 and July 15.<\/p>\n<p>                  Reference  is  made to the  further  provisions  of this  Note<br \/>\ncontained  herein and the Indenture  (as  defined),  which will for all purposes<br \/>\nhave the same effect as if set forth at this place.<\/p>\n<p>                  IN WITNESS  WHEREOF,  the  Company  has caused this Note to be<br \/>\nsigned  manually or by facsimile by its duly authorized  directors,  officers or<br \/>\nother authorized signatories.<\/p>\n<p>                                               HEALTHSOUTH CORPORATION<\/p>\n<p>                                                By:<br \/>\n                                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                       Name:<br \/>\n                                                       Title:<\/p>\n<p>                                                By:<br \/>\n                                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                       Name:<br \/>\n                                                       Title:<\/p>\n<p>CERTIFICATE OF AUTHENTICATION<\/p>\n<p>Date:                          <\/p>\n<p>                  This is one of the 8 1\/2% Senior Notes due 2008 referred to in<br \/>\nthe within-mentioned Indenture.<\/p>\n<p>                                                     THE BANK OF NEW YORK,<br \/>\n                                                          as Trustee<\/p>\n<p>                                                     By:<br \/>\n                                                          &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                            Authorized Signatory<\/p>\n<p>                                      B-2<\/p>\n<p>                              (REVERSE OF SECURITY)<\/p>\n<p>                           8 1\/2% SENIOR NOTE DUE 2008<\/p>\n<p>                  1   Interest.    HEALTHSOUTH   CORPORATION,    a   corporation<br \/>\nincorporated  in  Delaware  (the  &#8220;Company&#8221;),  promises  to pay  interest on the<br \/>\nprincipal amount of this Note at the rate per annum shown above. Interest on the<br \/>\nNotes will accrue from the most recent date on which  interest  has been paid or<br \/>\nduly  provided  for,  or if no  interest  has  been  paid,  from the date of the<br \/>\noriginal  issuance of the Notes. The Company will pay interest  semi-annually in<br \/>\narrears on each Interest Payment Date,  commencing August 1, 2001. Interest will<br \/>\nbe computed on the basis of a 360-day year comprised of twelve 30-day months.<\/p>\n<p>                  The Company  shall pay  interest on overdue  principal  and on<br \/>\noverdue  installments  of  interest  (without  regard  to any  applicable  grace<br \/>\nperiods)  to the extent  lawful from time to time on demand at the rate borne by<br \/>\nthe Notes.<\/p>\n<p>                  2. Method of Payment.  The Company  shall pay  interest on the<br \/>\nNotes (except defaulted  interest) to the Persons who are the registered Holders<br \/>\nat the close of  business  on January 15 or July 15  immediately  preceding  the<br \/>\nInterest  Payment Date  (whether or not such day is a Business  Day) even if the<br \/>\nNotes are canceled on registration of transfer or registration of exchange after<br \/>\nsuch Record  Date.  Holders  must  surrender  Notes to a Paying Agent to collect<br \/>\nprincipal payments. Payments of principal and make-whole amount, if any, will be<br \/>\nmade (on  presentation  of such  Notes if in  certificated  form) in U.S.  legal<br \/>\ntender;  provided,  however,  that the  Company  may pay  principal,  make-whole<br \/>\namount, if any, and interest by check payable in U.S. legal tender.  The Company<br \/>\nmay  deliver  any such  interest  payment by check  mailed to the address of the<br \/>\nPerson entitled thereto as such address will appear on the security register.<\/p>\n<p>                  3. Paying  Agents and  Registrar.  Initially,  The Bank of New<br \/>\nYork,  a  banking  organization  organized  under  the  laws  of New  York  (the<br \/>\n&#8220;Trustee&#8221;),  will act as Paying Agent and the Trustee will act as Registrar. The<br \/>\nCompany may change any Paying Agents,  Registrar or co-Registrar  without notice<br \/>\nto the Holders.  Neither the Company nor any of its  Subsidiaries  or Affiliates<br \/>\nmay act as Paying Agent but may act as Registrar or co-Registrar.<\/p>\n<p>                  4. Indenture. The Company issued this Note under an Indenture,<br \/>\ndated as of February 1, 2001 (the &#8220;Indenture&#8221;), by and among the Company and the<br \/>\nTrustee.  This Note is one of a duly  authorized  issue of Exchange Notes of the<br \/>\nCompany designated as its 8 1\/2% Senior Notes due 2008 (the &#8220;Notes&#8221;).  The Notes<br \/>\ninclude  the  Initial  Notes  and the  Exchange  Notes  issued  pursuant  to the<br \/>\nIndenture.  The  Initial  Notes and the  Exchange  Notes are treated as a single<br \/>\nclass of securities  under the Indenture.  Capitalized  terms herein are used as<br \/>\ndefined in the Indenture unless otherwise defined herein. The terms of the Notes<br \/>\ninclude  those stated in the  Indenture  and those made part of the Indenture by<br \/>\nreference to the Trust Indenture Act of 1939 (15 U.S. Code ss.ss.  77aaa-77bbbb)<br \/>\n(the &#8220;TIA&#8221;), as in effect on the date of the Indenture. Notwithstanding anything<br \/>\nto the contrary herein,  the Notes are subject to all such terms, and Holders of<br \/>\nNotes are referred to the  Indenture  and the TIA for a statement  of them.  The<br \/>\nNotes are general unsecured obligations of the Company.<\/p>\n<p>                  5.       [Intentionally Omitted.]<\/p>\n<p>                                      B-3<\/p>\n<p>                  6.       Redemption.<\/p>\n<p>                  The  Notes  will be  redeemable,  in whole or in part,  at the<br \/>\noption of the Company at any time at a redemption  price equal to the greater of<br \/>\n(i) 100% of the principal amount of the Notes,  plus accrued interest thereon to<br \/>\nthe date of redemption  and (ii) as determined by a Quotation  Agent (as defined<br \/>\nbelow),  the sum of the present  values of the remaining  scheduled  payments of<br \/>\nprincipal  and  interest  thereon   discounted  to  the  redemption  date  on  a<br \/>\nsemi-annual  basis  (assuming a 360-day year consisting of twelve 30-day months)<br \/>\nat the Adjusted Treasury Rate, plus accrued interest on the Notes to the date of<br \/>\nredemption.  If a  redemption  date does not fall on an interest  payment  date,<br \/>\nthen, with respect to the interest payment immediately succeeding the redemption<br \/>\ndate, only the unaccrued  portion of such interest  payment as of the redemption<br \/>\ndate shall be included  in any  calculation  pursuant to clause (ii) above.  Any<br \/>\namount  payable in excess of 100% of the  principal  amount of the Notes  (other<br \/>\nthan accrued  interest  thereon) shall be referred to herein as the  &#8220;make-whole<br \/>\namount.&#8221;<\/p>\n<p>                  &#8220;Adjusted Treasury Rate&#8221; means, with respect to any redemption<br \/>\ndate, the rate per annum equal to the semi-annual  equivalent  yield to maturity<br \/>\nof the Comparable  Treasury Issue,  assuming a price for the Comparable Treasury<br \/>\nIssue  (expressed  as a  percentage  of  the  principal  amount)  equal  to  the<br \/>\nComparable Treasury Price for such redemption date, plus 0.50%.<\/p>\n<p>                  &#8220;Comparable  Treasury  Issue&#8221; means the United States Treasury<br \/>\nsecurity  selected by a Quotation  Agent as having a maturity  comparable to the<br \/>\nremaining  term of the Notes to be redeemed that would be utilized,  at the time<br \/>\nof selection and in accordance with customary financial practice, in pricing new<br \/>\nissues of corporate debt securities of comparable maturity to the remaining term<br \/>\nof such Notes.<\/p>\n<p>                  &#8220;Comparable   Treasury  Price&#8221;  means,  with  respect  to  any<br \/>\nredemption date, (i) the average of the Reference Treasury Dealer Quotations for<br \/>\nsuch redemption  date,  after excluding the highest and lowest of such Reference<br \/>\nTreasury Dealer  Quotations,  or (ii) if the Trustee obtains three or fewer such<br \/>\nReference Treasury Dealer Quotations, the average of all such quotations.<\/p>\n<p>                  &#8220;Quotation Agent&#8221; means one of the Reference  Treasury Dealers<br \/>\nappointed by the Trustee after consultation with the Company.<\/p>\n<p>                  &#8220;Reference Treasury Dealer&#8221; means (i) each of UBS Warburg LLC,<br \/>\nDeutsche Banc Alex.  Brown Inc. and Chase  Securities Inc. and their  respective<br \/>\nsuccessors;  provided, however, that if any of the foregoing shall cease to be a<br \/>\nprimary  U.S.  Government  securities  dealer in New York,  New York (a &#8220;Primary<br \/>\nTreasury  Dealer&#8221;),  the  Company  shall  substitute  therefor  another  Primary<br \/>\nTreasury  Dealer;  and (ii) any other Primary  Treasury  Dealer  selected by the<br \/>\nTrustee after consultation with the Company.<\/p>\n<p>                  &#8220;Reference  Treasury Dealer  Quotation&#8221; means, with respect to<br \/>\neach  Reference  Treasury  Dealer  and any  redemption  date,  the  average,  as<br \/>\ndetermined  by the  Trustee,  of the bid and  asked  prices  for the  Comparable<br \/>\nTreasury Issue (expressed in each case as a percentage of its principal  amount)<br \/>\nquoted in writing to the Trustee by such Reference  Treasury Dealer at 5:00 p.m.<br \/>\non the third business day preceding such redemption date.<\/p>\n<p>                  If less than all of the Notes are to be  redeemed at any time,<br \/>\nselection of the Notes to be redeemed will be made by the Trustee from among the<br \/>\noutstanding  Notes on a pro rata basis, by lot or<\/p>\n<p>                                      B-4<\/p>\n<p>by any other method  permitted  in the  Indenture.  On and after the  redemption<br \/>\ndate,  interest will cease to accrue on the Notes or portions thereof called for<br \/>\nredemption.<\/p>\n<p>                  The Notes will not be entitled to any sinking fund.<\/p>\n<p>                  7. Notice of Redemption.  Notice of redemption under paragraph<br \/>\n6 of this Note will be mailed at least 30 days but not more than 60 days  before<br \/>\nthe  Redemption  Date to each Holder of Notes to be  redeemed  at such  Holder&#8217;s<br \/>\nregistered address.<\/p>\n<p>                  Except  as set  forth  in the  Indenture,  if  monies  for the<br \/>\nredemption of the Notes called for redemption shall have been deposited with the<br \/>\nPaying Agent for redemption on such  Redemption  Date, then the Notes called for<br \/>\nredemption  will cease to bear interest from and after such  Redemption Date and<br \/>\nthe only right of the  Holders  of such Notes will be to receive  payment of the<br \/>\nRedemption Price plus interest accrued through the Redemption Date, if any.<\/p>\n<p>                  8. Offers to Purchase.  The  Indenture  provides  that,  after<br \/>\ncertain Asset Sales (as defined in the  Indenture)  and upon the occurrence of a<br \/>\nChange of  Control  (as  defined  in the  Indenture),  and  subject  to  further<br \/>\nlimitations  contained  therein,  the  Company  will  make an offer to  purchase<br \/>\ncertain  amounts of the Notes in accordance with the procedures set forth in the<br \/>\nIndenture.<\/p>\n<p>                  9.  Denominations;   Transfer;  Exchange.  The  Notes  are  in<br \/>\ndefinitive,  fully registered form, without coupons, in minimum denominations of<br \/>\n[$1,000]  [$250,000] and in integral  multiples [of $1,000 in excess] thereof. A<br \/>\nHolder shall  register the transfer or exchange of Notes in accordance  with the<br \/>\nIndenture.  The Registrar may require a Holder,  among other things,  to furnish<br \/>\nappropriate  endorsements  and transfer  documents  and to pay certain  transfer<br \/>\ntaxes or  similar  governmental  charges  payable  in  connection  therewith  as<br \/>\npermitted by the  Indenture.  The Registrar need not register the transfer of or<br \/>\nexchange of any Notes or portions thereof selected for redemption.<\/p>\n<p>                  10.  Persons Deemed  Owners.  The registered  Holder of a Note<br \/>\nshall be treated as the owner of such Note for all purposes.<\/p>\n<p>                  11.  Unclaimed Money. If money for the payment of principal or<br \/>\ninterest remains  unclaimed for two years, the Trustee and the Paying Agent will<br \/>\npay the money back to the Company.  After that,  Holders  entitled to money must<br \/>\nlook to the  Company  for  payment as  general  creditors  unless an  &#8220;abandoned<br \/>\nproperty&#8221; law designates another person.<\/p>\n<p>                  12. Legal Defeasance and Covenant  Defeasance.  If the Company<br \/>\nat any time deposits with the Trustee U.S. legal tender or other  obligations of<br \/>\nthe types set forth in the  Indenture  sufficient  to pay the  principal  of and<br \/>\ninterest  on the Notes to Stated  Maturity or  redemption,  if  applicable,  and<br \/>\ncomplies with the other provisions of the Indenture relating to Legal Defeasance<br \/>\nor Covenant  Defeasance,  the Company will be discharged from certain provisions<br \/>\nof the Indenture and the Notes (including certain  covenants,  but excluding its<br \/>\nobligation to pay the principal of and interest on the Notes).<\/p>\n<p>                  13. Amendments,  Supplements,  and Waivers. Subject to certain<br \/>\nexceptions,  the Indenture or the Notes may be amended or supplemented  with the<br \/>\nwritten  consent of the<\/p>\n<p>                                      B-5<\/p>\n<p>Holders of at least a majority in aggregate outstanding principal amounts of the<br \/>\nNotes, and any existing  Default or Event of Default or  noncompliance  with any<br \/>\nprovision may be waived with the written consent of the Holders of a majority in<br \/>\naggregate  principal amount of the Notes then outstanding.  Without notice to or<br \/>\nconsent of any Holder, the parties thereto may amend or supplement the Indenture<br \/>\nor the Notes to, among other things, cure any ambiguity, defect or inconsistency<br \/>\nor make any other change that does not adversely  affect in any material respect<br \/>\nthe rights of any Holder of a Note.<\/p>\n<p>                  14.  Restrictive  Covenants.  The  Indenture  imposes  certain<br \/>\nlimitations on the ability of the Company and its  Subsidiaries  to, among other<br \/>\nthings,  make  payments  in  respect  of its  Capital  Stock,  incur  additional<br \/>\nIndebtedness,  make certain  investments,  sell assets,  enter into transactions<br \/>\nwith  Affiliates,  create  Liens,  merge or  consolidate  with or into any other<br \/>\nPerson or sell,  lease,  convey or otherwise dispose of all or substantially all<br \/>\nof its  assets  or  create  dividend  or other  payment  restrictions  affecting<br \/>\nSubsidiaries  of the  Company.  Such  limitations  are  subject  to a number  of<br \/>\nimportant  qualifications  and exceptions.  The Company must report on an annual<br \/>\nbasis to the Trustee on compliance with such limitations.<\/p>\n<p>                  15. Successor.  When a Successor  assumes,  in accordance with<br \/>\nthe Indenture,  all the obligations of its  predecessor  under the Notes and the<br \/>\nIndenture,  and immediately  before and thereafter no Default exists and certain<br \/>\nother  conditions are satisfied,  the  predecessor  entity will be released from<br \/>\nthose obligations.<\/p>\n<p>                  16. Defaults and Remedies.  Events of Default are set forth in<br \/>\nthe  Indenture.  If an Event of Default  (other  than an Event of  Default  with<br \/>\nrespect to the Company  pursuant to Section 6.01(f) or 6.01(g) of the Indenture)<br \/>\nshall have occurred and be continuing, then the Trustee by written notice to the<br \/>\nCompany or the Holders of not less than 25% in aggregate principal amount of the<br \/>\nNotes then  outstanding may declare to be immediately due and payable the entire<br \/>\nprincipal  amount of all the Notes then outstanding plus accrued interest to the<br \/>\ndate of acceleration; provided, however, that after such acceleration but before<br \/>\na judgment or decree based on such acceleration is obtained by the Trustee,  the<br \/>\nHolders of a majority in aggregate  principal amount of the outstanding Notes by<br \/>\nwritten  notice to the  Company  and the  Trustee  may by written  notice to the<br \/>\nCompany and the Trustee rescind and annul such acceleration and its consequences<br \/>\nif all  existing  Events of Default,  other than the  nonpayment  of  principal,<br \/>\nmake-whole amount, if any, or interest that has become due solely because of the<br \/>\nacceleration,  have been cured or waived.  No such  rescission  shall affect any<br \/>\nsubsequent Default or impair any right consequent  thereto.  In case an Event of<br \/>\nDefault with respect to the Company  specified in Section  6.01(f) or 6.01(g) of<br \/>\nthe Indenture occurs, such principal amount, together with make-whole amount, if<br \/>\nany,  and interest  with  respect to all of the Notes,  shall be due and payable<br \/>\nimmediately  without any  declaration or other act on the part of the Trustee or<br \/>\nthe Holders of the Notes.<\/p>\n<p>                  17.  Trustee  Dealings  with  Company.  The Trustee  under the<br \/>\nIndenture,  in its individual or any other  capacity,  may make loans to, accept<br \/>\ndeposits from, and perform services for the Company, and may otherwise deal with<br \/>\nthe Company,  its Subsidiaries or their respective  Affiliates as if it were not<br \/>\nthe Trustee.<\/p>\n<p>                  18. No Recourse  Against Others.  No  incorporator,  director,<br \/>\nofficer,  employee,  stockholder or controlling  person, as such, of the Company<br \/>\nshall have any liability for any  obligations  of the Company under the Notes or<br \/>\nthe  Indenture  or for any claim  based on, in  respect  of or by reason of such<br \/>\nobligations or their creation.  By accepting a Note, each Holder shall waive and<br \/>\nrelease  all  such  liability.  The  waiver  and  release  shall  be part of the<br \/>\nconsideration for the issue of the Notes.<\/p>\n<p>                                      B-6<\/p>\n<p>                  19.  Authentication.  This Note  shall not be valid  until the<br \/>\nTrustee or Authenticating Agent manually signs the certificate of authentication<br \/>\non this Note.<\/p>\n<p>                  20.  Multiple  Counterparts.  The  parties  may sign  multiple<br \/>\ncounterparts of this Note. Each signed  counterpart  shall be deemed an original<br \/>\nbut all of them together represent one and the same Note.<\/p>\n<p>                  21.  Governing  Law.  THIS  NOTE  SHALL  BE  GOVERNED  BY  AND<br \/>\nCONSTRUED IN  ACCORDANCE  WITH THE LAWS OF THE STATE OF NEW YORK,  AS APPLIED TO<br \/>\nCONTRACTS  MADE AND PERFORMED  WITHIN THE STATE OF NEW YORK,  WITHOUT  REGARD TO<br \/>\nPRINCIPLES  OF CONFLICTS OF LAW. EACH OF THE PARTIES TO THE INDENTURE HAS AGREED<br \/>\nTO  SUBMIT  TO THE  JURISDICTION  OF THE  COURTS OF THE STATE OF NEW YORK IN ANY<br \/>\nACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE.<\/p>\n<p>                  22. Abbreviations and Defined Terms.  Customary  abbreviations<br \/>\nmay be used in the name of a Holder of a Note or an  assignee,  such as: TEN COM<br \/>\n(= tenants in common),  TEN ENT (= tenants by the  entireties),  JT TEN (= joint<br \/>\ntenants  with  right of  survivorship  and not as tenants  in  common),  CUST (=<br \/>\nCustodian), and U\/G\/M\/A (= Uniform Gifts to Minors Act).<\/p>\n<p>                  23. CUSIP Numbers.  The Company has caused CUSIP numbers to be<br \/>\nprinted on the Notes as a convenience to the Holders.  No representation is made<br \/>\nas to the  accuracy of such  numbers as printed on the Notes and reliance may be<br \/>\nplaced only on the other identification numbers printed hereon.<\/p>\n<p>                  24. Indenture.  Each Holder, by accepting a Note, agrees to be<br \/>\nbound by all of the terms and  provisions of the  Indenture,  as the same may be<br \/>\namended from time to time.<\/p>\n<p>                  The Company  will furnish to any Holder of a Note upon written<br \/>\nrequest and without  charge a copy of the  Indenture  which has the text of this<br \/>\nNote in larger  type.  Requests  may be made to:  HEALTHSOUTH  Corporation,  One<br \/>\nHealthSouth Parkway,  Birmingham,  Alabama 35243,  Telephone No. (205) 969-4977,<br \/>\nFacsimile No. (205) 969-4730, Attention: William W. Horton.<\/p>\n<p>                                      B-7<\/p>\n<p>                                 ASSIGNMENT FORM<\/p>\n<p>                  If you the Holder want to assign  this Note,  fill in the form<br \/>\nbelow and have your signature guaranteed:<\/p>\n<p>I or we assign and transfer this Note to:<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                 (Print or type name, address and zip code and<br \/>\n                  social security or tax ID number of assignee)<\/p>\n<p>and irrevocably appoint________________________________________________________,<br \/>\nagent  to  transfer  this  Note on the  books  of the  Company.  The  agent  may<br \/>\nsubstitute another to act for him.<\/p>\n<p>Date:                                       Signed:<br \/>\n       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                    (Sign exactly as your name<br \/>\n                                                    appears on the other<br \/>\n                                                    side of this Note)<\/p>\n<p>Medallion Guarantee:<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                      B-8<\/p>\n<p>                      [OPTION OF HOLDER TO ELECT PURCHASE]<\/p>\n<p>                  If you  want to  elect  to have  this  Note  purchased  by the<br \/>\nCompany  pursuant to Section  4.12 or Section 4.15 of the  Indenture,  check the<br \/>\nappropriate box:<\/p>\n<p>                                Section 4.12 |_|<br \/>\n                                Section 4.15 |_|<\/p>\n<p>                  If you want to elect to have only part of this Note  purchased<br \/>\nby the Company pursuant to Section 4.12 or Section 4.15 of the Indenture,  state<br \/>\nthe amount you elect to have purchased:<\/p>\n<p>$<br \/>\n   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>Date:<br \/>\n        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                      NOTICE:  The  signature on<br \/>\n                                                      this    assignment    must<br \/>\n                                                      correspond  with  the name<br \/>\n                                                      as  it  appears  upon  the<br \/>\n                                                      face of the within Note in<br \/>\n                                                      every  particular  without<br \/>\n                                                      alteration or  enlargement<br \/>\n                                                      or any  change  whatsoever<br \/>\n                                                      and be  guaranteed  by the<br \/>\n                                                      endorser&#8217;s bank or broker.<\/p>\n<p>Medallion Guarantee:<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                      B-9<\/p>\n<p>                                                                       EXHIBIT C<\/p>\n<p>                    [FORM OF RULE 144A TRANSFER CERTIFICATE]<br \/>\n                                     [Date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>                  Reference  is  hereby  made  to  the  Indenture,  dated  as of<br \/>\nFebruary 1, 2001, between  HEALTHSOUTH  Corporation,  as Issuer (the &#8220;Company&#8221;),<br \/>\nand The Bank of New York,  as  Trustee.  Capitalized  terms used but not defined<br \/>\nherein shall have the  respective  meanings given to such terms in the Indenture<br \/>\nor Rule 144A, as the case may be.<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(vi):<\/p>\n<p>                  This certificate relates to US$___________ principal amount of<br \/>\nNotes  which are held in the form of a  beneficial  interest  in the  Restricted<br \/>\nGlobal  Note  (CUSIP No.  ______________  ) with the  Depositary  in the name of<br \/>\n[insert name of transferor] (the  &#8220;Transferor&#8221;).  The Transferor has requested a<br \/>\ntransfer of such beneficial  interest for one or more  Certificated  Notes to be<br \/>\nregistered in the name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(v):<\/p>\n<p>                  This certificate relates to US$___________ principal amount of<br \/>\nNotes which are held in the form of a  beneficial  interest in the  Regulation S<br \/>\nGlobal  Note  (CUSIP No.  ______________  ) with the  Depositary  in the name of<br \/>\n[insert name of transferor] (the  &#8220;Transferor&#8221;).  The Transferor has requested a<br \/>\ntransfer of such beneficial interest for a beneficial interest in the Restricted<br \/>\nGlobal Note to be  registered  in the name of [insert name of  transferee]  (the<br \/>\n&#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(c)(iii):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes which are held in the form of one or more Certificated Notes registered in<br \/>\nthe name of [insert name of transferor  (the  &#8220;Transferor&#8221;).  The Transferor has<br \/>\nrequested a transfer of such Certificated Notes for a beneficial interest in the<br \/>\nRestricted  Global  Note  (CUSIP  No.  _____________  ) to  be  held  [with  the<br \/>\nDepositary in the name of [insert name of Transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>                  In connection with such request for transfer and in respect of<br \/>\nsuch Notes,  the  Transferor  does hereby  certify  that such  transfer is being<br \/>\neffected in accordance with the transfer restrictions set forth in the Indenture<br \/>\nand the Notes and pursuant to and in accordance  with Rule 144A, and accordingly<br \/>\nthe Transferor does hereby certify:<\/p>\n<p>                           (1) the  Transferee  is a person that the  Transferor<br \/>\n         and any person acting on behalf of the Transferor reasonably believe is<br \/>\n         purchasing such Notes for its own account,  or for one or more accounts<br \/>\n         with  respect  to  which  the  Transferee   exercises  sole  investment<\/p>\n<p>                                      C-1<\/p>\n<p>         discretion,  and the  Transferee  and each such account is a &#8220;qualified<br \/>\n         institutional buyer&#8221; within the meaning of Rule 144A;<\/p>\n<p>                           (2) the  Transferor  and  any  person  acting  on its<br \/>\n         behalf has taken  reasonable  steps to ensure  that the  Transferee  is<br \/>\n         aware that the  Transferor  may be  relying on Rule 144A in  connection<br \/>\n         with the transaction; and<\/p>\n<p>                           (3) the transaction  satisfies all other requirements<br \/>\n         of Rule  144A  and of any  applicable  Notes  laws of any  state of the<br \/>\n         United States or any other jurisdiction.<\/p>\n<p>                  You and the Company are entitled to rely upon this certificate<br \/>\nand are irrevocably  authorized to produce this  certificate or a copy hereof to<br \/>\nany  interested  party in any  administrative  or legal  proceedings or official<br \/>\ninquiry with respect to the matters covered hereby.<\/p>\n<p>                                                     [Name of Transferor]<\/p>\n<p>                                                     By:<br \/>\n                                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                        Name:<br \/>\n                                                        Title:<\/p>\n<p>                                      C-2<\/p>\n<p>                                                                       EXHIBIT D<\/p>\n<p>                   [FORM OF REGULATION S TRANSFER CERTIFICATE]<\/p>\n<p>                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>                  Reference  is  hereby  made  to  the  Indenture,  dated  as of<br \/>\nFebruary 1, 2001, between  HEALTHSOUTH  Corporation,  as Issuer (the &#8220;Company&#8221;),<br \/>\nand The Bank of New York,  as  Trustee.  Capitalized  terms used but not defined<br \/>\nherein shall have the  respective  meanings given to such terms in the Indenture<br \/>\nor Regulation S, as the case may be.<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(iii) or 2.16(b)(iv):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes  which are held in the form of a  beneficial  interest  in the  Restricted<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof such beneficial interest for a beneficial interest in the Regulation S Global<br \/>\nNote (CUSIP  No.__________)  to be held [[include the following for any transfer<br \/>\nmade pursuant to Section  2.16(b)(iii):  with [Euroclear]  [Clearstream] (Common<br \/>\nCode  No.__________)]  through  the  Depositary  in the name of [insert  name of<br \/>\ntransferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(c)(iii):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes which are held in the form of one or more Certificated Notes registered in<br \/>\nthe name of [insert name of transferor) (the  &#8220;Transferor&#8221;).  The Transferor has<br \/>\nrequested a transfer of such Certificated Notes for a beneficial interest in the<br \/>\nRegulation  S Global Note  (CUSIP  No.__________)  to be held [with  [Euroclear]<br \/>\n[Clearstream]] through the Depositary in the name of [insert name of transferee]<br \/>\n(the &#8220;Transferee&#8221;).]<\/p>\n<p>                  In connection with such request for transfer and in respect of<br \/>\nsuch Notes,  the  Transferor  does hereby  certify  that such  transfer is being<br \/>\neffected in accordance with the transfer restrictions set forth in the Indenture<br \/>\nand  the  Notes  and  pursuant  to and in  accordance  with  Regulation  S,  and<br \/>\naccordingly the Transferor does hereby certify:<\/p>\n<p>                           (1) the offer of such Notes  was not made to a person<br \/>\n         in the  United States;<\/p>\n<p>                           (2)  either  (A) at the time the buy  order  for such<br \/>\n         Notes was  originated,  the Transferee was outside the United States or<br \/>\n         the Transferor and any person acting on its behalf reasonably  believed<br \/>\n         that  the   Transferee  was  outside  the  United  States  or  (B)  the<br \/>\n         transaction was executed in, or through the facilities of, a designated<br \/>\n         offshore  securities  market and neither the  Transferor nor any person<br \/>\n         acting on its behalf knew that the transaction was pre-arranged  with a<br \/>\n         buyer in the United States,<\/p>\n<p>                           (3) no directed selling efforts have been made in the<br \/>\n         United States in  contravention  of the  requirements of Rule 903(b) or<br \/>\n         904(b) of the Securities Act, as applicable, and<\/p>\n<p>                           (4) the  transaction  is not part of a plan or scheme<br \/>\n          to evade the registration requirements of the<br \/>\n         Securities Act.<\/p>\n<p>[Add the following for transfers made during the Regulation S Restricted Period:<\/p>\n<p>                  In addition,  (A) if the  provisions of Rule 903(c)(3) or Rule<br \/>\n904(c)(1)  of  the  Securities  Act  are  applicable  to  the  transaction,  the<br \/>\nTransferor  hereby  certifies that the transfer is being made in accordance with<br \/>\nthe  requirements of Rule 903(c)(3) or Rule  904(c)(1),  as the case may be, and<br \/>\n(B) upon completion of the transaction, the Transferee will hold the transferred<br \/>\nbeneficial interest through Euroclear or Clearstream.]<\/p>\n<p>                  You and the Company are entitled to rely upon this certificate<br \/>\nand are irrevocably  authorized to produce this  certificate or a copy hereof to<br \/>\nany  interested  party in any  administrative  or legal  proceedings or official<br \/>\ninquiry with respect to the matters covered hereby.<\/p>\n<p>                                        [Name of Transferor]<\/p>\n<p>                                        By:<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                           Name:<br \/>\n                                           Title:<\/p>\n<p>                                      D-2<\/p>\n<p>                                                                       EXHIBIT E<\/p>\n<p>                     [FORM OF RULE 144 TRANSFER CERTIFICATE]<\/p>\n<p>                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<br \/>\nLadies and Gentlemen:<\/p>\n<p>                  Reference  is  hereby  made  to  the  Indenture,  dated  as of<br \/>\nFebruary 1, 2001, between  HEALTHSOUTH  Corporation,  as Issuer (the &#8220;Company&#8221;),<br \/>\nand The Bank of New York,  as  Trustee.  Capitalized  terms used but not defined<br \/>\nherein shall have the  respective  meanings given to such terms in the Indenture<br \/>\nor Rule 144, as the case may be.<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(iii):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes  which are held in the form of a  beneficial  interest  in the  Restricted<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof such beneficial interest for a beneficial interest in the Regulation S Global<br \/>\nNote (CUSIP No.__________) to be held with the Depositary in the name of [insert<br \/>\nname of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(vi):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes  which are held in the form of a  beneficial  interest  in the  Restricted<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof such beneficial  interest for one or more Certificated Notes to be registered<br \/>\nin the name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(vii):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes which are held in the form of a  beneficial  interest in the  Regulation S<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof such beneficial  interest for one or more Certificated Notes to be registered<br \/>\nin the name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>                  In connection with such request for transfer and in respect of<br \/>\nsuch Notes,  the  Transferor  does hereby  certify  that such  transfer has been<br \/>\neffected in accordance with the transfer restrictions set forth in the Indenture<br \/>\nand the  Notes,  and that the  Notes  are  being  transferred  in a  transaction<br \/>\npermitted by Rule 144 under the Securities Act.<\/p>\n<p>                  You and the Company are entitled to rely upon this certificate<br \/>\nand are irrevocably  authorized to produce this  certificate or a copy hereof to<br \/>\nany  interested  party in any  administrative  or legal  proceedings or official<br \/>\ninquiry with respect to the matters covered hereby,<\/p>\n<p>                                           [Name of Transferor]<\/p>\n<p>                                           By:<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Name:<br \/>\n                                               Title:<\/p>\n<p>                                      E-2<\/p>\n<p>                                                                       EXHIBIT F<\/p>\n<p>               [FORM OF ACCREDITED INVESTOR TRANSFER CERTIFICATE]<\/p>\n<p>                                     [date]<\/p>\n<p>[Name of Registrar]<br \/>\n[Address of Registrar]<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>                  Reference  is  hereby  made  to  the  Indenture,  dated  as of<br \/>\nFebruary 1, 2001, between  HEALTHSOUTH  Corporation,  as Issuer (the &#8220;Company&#8221;),<br \/>\nand The Bank of New York,  as  Trustee.  Capitalized  terms used but not defined<br \/>\nherein shall have the  respective  meanings given to such terms in the Indenture<br \/>\nor Regulation D, as the case may be.<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(vi):<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes  which are held in the form of a  beneficial  interest  in the  Restricted<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof  such  beneficial   interest  for  a  beneficial  interest  in  one  or  more<br \/>\nCertificated  Notes (CUSIP  No.__________) to be held with the Depositary in the<br \/>\nname of [insert name of transferee] (the &#8220;Transferee&#8221;].<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(b)(vii) of the Indenture:<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes which are held in the form of a  beneficial  interest in the  Regulation S<br \/>\nGlobal Note (CUSIP  No.__________)  with the  Depositary  in the name of [insert<br \/>\nname of transferor] (the &#8220;Transferor&#8221;).  The Transferor has requested a transfer<br \/>\nof such beneficial  interest for one or more Certificated Notes to be registered<br \/>\nin the name of [insert name of transferee] (the &#8220;Transferee&#8221;).]<\/p>\n<p>[Insert  the  following  paragraph  for any  transfer  made  pursuant to Section<br \/>\n2.16(c)(i) of the Indenture:<\/p>\n<p>                  This certificate relates to US$__________  principal amount of<br \/>\nNotes which are held in the form of one or more Certificated Notes registered in<br \/>\nthe name of [insert name of transferor] (the  &#8220;Transferor&#8221;).  The Transferor has<br \/>\nrequested a transfer  of such  Certificated  Notes for one or more  Certificated<br \/>\nNotes  to be  registered  in the  name  of  [insert  name  of  transferee]  (the<br \/>\n&#8220;Transferee&#8221;).]<\/p>\n<p>                  The undersigned represents and warrants to you that:<\/p>\n<p>                           (1) We are an institutional &#8220;accredited investor&#8221; (as<br \/>\n         defined in Rule  501(a)(1).  (2), (3) or (7) of  Regulation D under the<br \/>\n         Securities Act of 1933, as amended (the &#8220;Securities  Act&#8221;))  purchasing<br \/>\n         for  our  own  account  or for the  account  of  such an  institutional<br \/>\n         &#8220;accredited  investor&#8221;,  and we are acquiring the Notes not with a view<br \/>\n         to,  or for  offer or sale in  connection  with,  any  distribution  in<br \/>\n         violation of the Securities Act or other applicable<\/p>\n<p>         securities  law and we have such  knowledge and experience in financial<br \/>\n         and  business  matters as to be capable  of  evaluating  the merits and<br \/>\n         risks  of our  investment  in  the  Notes  and  invest  in or  purchase<br \/>\n         securities  similar to the Notes in the normal  course of our business.<br \/>\n         We and any  accounts  for which we are acting are each able to bear the<br \/>\n         economic risk of our investment.<\/p>\n<p>                           (2) We understand and acknowledge that the Notes have<br \/>\n         not been  registered  under the Securities Act or any other  applicable<br \/>\n         securities  law and  unless so  registered,  may not be sold  except as<br \/>\n         permitted in the following sentence.  We agree on our own behalf and on<br \/>\n         behalf of any  investor  account for which we are  purchasing  Notes to<br \/>\n         offer, sell or otherwise transfer such Notes prior to the date which is<br \/>\n         two (2) years  after the  later of the date of  original  issue and the<br \/>\n         last date on which the Company or any  Affiliate of the Company was the<br \/>\n         owner of such Notes (or any predecessor  thereto) (such later date, the<br \/>\n         &#8220;Resale  Restriction  Termination  Date&#8221;)  only  (a)  to  a  Person  we<br \/>\n         reasonably  believe is a qualified  institutional  buyer (as defined in<br \/>\n         Rule 144A under the Securities  Act) that purchases for its own account<br \/>\n         or for the account of a qualified institutional buyer to whom notice is<br \/>\n         given  that  the  resale,  pledge  or  transfer  is  being  made  in  a<br \/>\n         transaction  meeting the requirements of Rule 144A under the securities<br \/>\n         act, (b) in a transaction  meeting the  requirements  of Rule 144 under<br \/>\n         the  Securities  Act, (c) outside the United States to a foreign person<br \/>\n         in a transaction  meeting the  requirements of Rule 904 of Regulation S<br \/>\n         under the  Securities Act or (d) in accordance  with another  exemption<br \/>\n         from the registration requirements of the Securities Act, provided that<br \/>\n         in the case of a transfer,  pledge or sale  pursuant to this clause (d)<br \/>\n         such  transfer  is subject to the  receipt  by the  Registrar  (and the<br \/>\n         Company, if it so requests) of a certification of the transferor and an<br \/>\n         Opinion of Counsel t the effect  that such  transfer  is in  compliance<br \/>\n         with the  Securities  Act, (e) to the Company or its  Affiliates or (f)<br \/>\n         pursuant to an effective  registration  statement  under the Securities<br \/>\n         Act and, in each case, in  accordance  with any  applicable  securities<br \/>\n         laws  of any  state  of the  United  States  or  any  other  applicable<br \/>\n         jurisdiction  and the Indenture  governing  the notes.  Any transfer of<br \/>\n         Notes  pursuant  to clause  (d) above to an  institutional  &#8220;accredited<br \/>\n         investor&#8221;  within  the  meaning  of Rule  501(a)(1),  (2) (3) or (7) of<br \/>\n         Regulation D under the  Securities Act that is purchasing the Notes for<br \/>\n         its own account or for the account of such an institutional &#8220;accredited<br \/>\n         investor,&#8221;  shall involve a minimum  purchase  price of US$250,000  for<br \/>\n         such Notes,  subject in each of the foregoing  cases to any requirement<br \/>\n         of law that the  disposition  of our  property or the  property of such<br \/>\n         investor  account  or  accounts  be at all  times  within  our or their<br \/>\n         control and in compliance with any applicable  state  securities  laws.<br \/>\n         The foregoing  restrictions on resale will not apply  subsequent to the<br \/>\n         Resale Restriction Termination Date. If any resale or other transfer of<br \/>\n         the Notes is proposed to an institutional  &#8220;accredited  investor&#8221; prior<br \/>\n         to the  Resale  Restriction  Termination  Date,  the  transferor  shall<br \/>\n         deliver to the Company  and the  Trustee a letter  from the  transferee<br \/>\n         substantially  in the form of this letter,  which shall provide,  among<br \/>\n         other  things,  that the  transferee  is an  institutional  &#8220;accredited<br \/>\n         investor&#8221;  within the  meaning of Rule 501 (a)(l),  (2),  (3) or (7) of<br \/>\n         Regulation D under the  Securities  Act and that it is  acquiring  such<br \/>\n         Notes for investment  purposes and not for distribution in violation of<br \/>\n         the  Securities  Act. We  acknowledge  that the Company and the Trustee<br \/>\n         reserve  the right  prior to any offer,  sale or other  transfer of the<br \/>\n         Notes  pursuant  to  clause  (c)  or (d)  above  prior  to  the  Resale<br \/>\n         Restriction  Termination  Date to require the delivery of an opinion of<br \/>\n         counsel,  certifications  and\/or other information  satisfactory to the<br \/>\n         Company and the Trustee.<\/p>\n<p>                           (3) We are  acquiring  the Notes  purchased by us for<br \/>\n         our own  account  or for one or more  accounts  as to each of  which we<br \/>\n         exercise sole investment discretion.<br \/>\n                                      F-2<\/p>\n<p>                  You and the Company are entitled to rely upon this certificate<br \/>\nand are irrevocably  authorized to produce this  certificate or a copy hereof to<br \/>\nany  interested  party in any  administrative  or legal  proceedings or official<br \/>\ninquiry with respect to the matters covered hereby.<\/p>\n<p>                                          [Name of Transferee]<\/p>\n<p>                                          By:<br \/>\n                                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                             Name:<br \/>\n                                             Title:<\/p>\n<p>                                      F-3<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7751],"corporate_contracts_industries":[9438],"corporate_contracts_types":[9560,9566],"class_list":["post-41069","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-healthsouth-corp","corporate_contracts_industries-health__misc","corporate_contracts_types-finance","corporate_contracts_types-finance__indenture"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/41069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=41069"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=41069"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=41069"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=41069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}